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Abstract 
 
Background 
Cardiovascular disease (CVD) and ischemic heart disease (IHD) are two major health burdens. It 
has been suggested that the improvement of modifiable lifestyle factors could substantially reduce 
the CVD and IHD risk. To define and monitor the cardiovascular health (CVH) status in the general 
population, the American Heart Association has outlined seven modifiable lifestyle-related factors 
[smoking, body mass index (BMI), physical activity, dietary pattern, total cholesterol (TC), blood 
pressure (BP), and fasting plasma glucose (FPG)] and they were also called Life’s Simple 7. A 
number of studies have measured the CVH status and explored its association with CVD/IHD risk. 
However, very few studies have used Life’s Simple 7 in Australian adults.   
Methods 
Firstly, we conducted two systematic reviews to estimate the CVH status and explore the 
association between the CVH status and CVD/IHD related events in adults worldwide. We searched 
PubMed, Embase, and the Cochrane Central Register of Controlled Trials and relevant articles 
published between 2010 and 2018.   
Secondly, we used the core sample of the 2011-2012 Australian Health Survey and included 7499 
adults (≥ 18 years) with available TC and FPG tests. We estimated the proportions of ideal status 
for the seven CVH metrics and the prevalence of overall poor (having 0-2 ideal CVH metrics) and 
ideal (having 5-7 ideal CVH metrics) CVH status in the overall Australians and sex/age 
subpopulations. In addition, we explored the associations between the ideal status of individual 
metrics, using Poisson regression analysis and population attributable fractions, and overall CVH 
status, using logistic regression analysis, on the CVD and IHD prevalence in the overall Australians 
and sex/age subpopulations. 
Results 
The first systematic review indicated that FPG has the highest proportion of ideal status (69.1%) 
whereas the dietary pattern has the lowest (12.1%) for adults worldwide. 32.2% and 19.6% of adults 
have overall poor and ideal CVH status. Compared to males and older adults (≥ 60 years), females 
and younger adults (< 60 years) have lower proportions of the overall poor CVH status and higher 
proportions of ideal status for most CVH metrics and the overall ideal CVH status. The CVH status 
has improved over study time and there may exist regional variations in CVH status. The second 
systematic review suggested that a higher number of ideal CVH metrics was associated with a 
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reduced risk of CVD-related events. The separate effects of ideal metrics on CVD risk were 
inconsistent. Very few studies have explored the sex and age variations in the magnitude of 
associations between CVH status and CVD/IHD risk. 
Among Australian adults, the ideal status was highest for FPG (83.6%) and was lowest for dietary 
pattern (4.8%). 39.85% and 18.72% of adults were having overall poor and ideal status, 
respectively. Females and younger adults (18-39 years) have better CVH status, in terms of 
proportions of ideal metrics and the overall CVH status, in comparison to that in males, middle-
aged (40-59 years), and older adults (≥ 60 years). We noticed that smoking, high BMI, elevated BP, 
elevated TC, elevated FPG, and physical inactivity were significant CVD risk factors and 
contributors in Australian adults. Physical inactivity, high BMI, and elevated TC were found to be 
significant IHD risk factors and contributors. The higher number of ideal metrics was associated 
with a substantial reduction in CVD and IHD prevalence in Australian adults. Our findings 
illustrated the possible sex and age disparities in the strengths of association between the CVH 
status and CVD/IHD prevalence. 
Conclusions 
The thesis indicated that the CVH status was poor for adults worldwide and in Australia, and the 
proportion of ideal status was especially low for some metrics, such as dietary pattern. The higher 
number of ideal CVH metrics was associated with a lower risk of CVD and IHD. There existed 
some sex and age disparities in the CVH status and its association with CVD/IHD risk. More 
studies are needed to carry out population-based strategies to monitor and improve the CVH status 
in adults from worldwide and Australia. 
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Chapter 1 – Introduction 
 
Background   
    Cardiovascular disease (CVD) is still one of the leading causes of health burden worldwide. 
According to the Global Burden of Disease Study, CVD contributed to 17.6 million deaths in 2016, 
which accounted for nearly 32.3% of all deaths. 1 Ischemic heart disease (IHD), another term of 
coronary heart disease (CHD), is the most prevalent type of CVD and it contributed to 9.5 million 
deaths globally in 2016. 1 Both CVD and IHD are also major health concerns for Australians. CVD 
attributed to over 46 thousand deaths, over 30% of all deaths, among Australians in 2009 2 and 
another large-scale study reported that 22% Australians aged 45 or over have a prior history of 
CVD. 3 The 2016 Global Burden of Disease Study listed IHD as the largest causes of deaths in 
Australia. 1 
    There is a growing body of evidence indicated that the separate and combined effects of 
modifiable lifestyle factors could explain a large proportion of CVD and IHD cases. A recent meta-
analysis indicated that current smoking, physical inactivity, and raised body mass index (BMI) were 
all independently associated with higher risk of CHD incidence and CVD mortality. 4 A Chinese 
cohort study revealed that 67.9% of major coronary events could be prevented if participants 
adhered to six lifestyle-related metrics, including optimal status of smoking, alcohol consumption, 
physical activity, dietary pattern, BMI, and waist-to-hip ratio. 5 Similarly, a cohort study suggested 
that approximately 73% of CHD cases were attributable to poor adherence to six lifestyle factors. 6 
    Given the enormous global public health burden of CVD and IHD, the American Heart 
Association (AHA) has worked out the 2020 Impact Goals as follows: “By 2020, to improve the 
cardiovascular health (CVH) of all Americans by 20% while reducing deaths from CVD and stroke 
by 20%”. 7 Meanwhile, the AHA also outlined seven modifiable metrics, including non-smoking, 
BMI, physical activity, dietary pattern, total cholesterol (TC), blood pressure (BP), and fasting 
plasma glucose (FPG), to define and monitor the CVH status in the general population. 7 These 
CVH metrics were also called Life’s Simple 7. There are also other wide-used tools to explore the 
lifestyle factors and risk of CVD or IHD, such as Framingham risk score 8, 9 and absolute 
cardiovascular risk assessment.10 The AHA’s Life’s Simple 7 has its benefits over those metrics. 
Life’s Simple 7 aimed to measure the CVH and improve the distribution of CVD risk factors in the 
whole population. It corresponded to the primordial prevention of CVD in the general population. 
However, the other metrics aimed to identifying a small proportion of population with high risk of 
CVD, and they reflected the primary prevention of CVD in the high-risk population. As it is widely 
recognized that the majority of CVD events occur in individuals with average or only mildly 
adverse levels of risk factors, 7 the Life’s Simple 7 could more effectively reduce the CVD burden 
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in the whole population when compared to other metrics. Another advantage of Life’s Simple 7 is it 
contained more CVD risk factors, like dietary pattern, and it is more easily to measure in the 
population. 
    Given the advantages of Life’s Simple 7, a number of studies have used Life’s Simple 7 to 
measure the CVH status in the general population 11, 12 and explored its association with CVD/IHD 
risk. 13, 14 Most studies implied the low prevalence of the ideal CVH status in the general population 
and indicated the significant separate and combined effects of the CVH status on CVD/IHD risk. 
However, the CVH status was still unclear for adults globally and strengths of association between 
the CVH status and CVD, including IHD, risk is inconclusive. Additionally, very few studies have 
used the Life’s Simple 7 to evaluate the CVH status in Australian adults and explored its association 
with CVD/IHD risk. Furthermore, several studies have indicated that there existed sex and age 
variations in the CVH status and its magnitude of association with CVD/IHD risk while the findings 
are inconclusive. 15-18 
    Our study conducted two systematic reviews and three original research studies, based on a 
nationally representative Australian survey, to fill those knowledge gaps. 
Research aims and objectives 
    Our study aims to estimate the CVH status and explore its association with both CVD and IHD 
prevalence in Australian adults. Our findings could provide evidence to the policy makers in order 
to prioritize the CVD and IHD prevention strategies.  
    The objectives of the thesis are as follows: 
    (1) To evaluate the CVH status in adults worldwide. 
    (2) To summarize findings on the association between the CVH status and risk of CVD, 
including IHD, in adults worldwide. 
    (3) To examine the CVH status in Australian adults. 
    (4) To clarify the association between the CVH status and CVD prevalence in Australian adults. 
    (5) To illustrate the association between the CVH status and IHD prevalence in Australian adults. 
Structure of the thesis 
    The thesis consisted of seven chapters and they were shown in Figure 1.1. 
    Chapter 1 is a general introduction of the PhD thesis, including background, research objectives, 
and structure. 
    Chapter 2 is a systematic review and meta-analysis, aiming to describe the CVH status in adults 
globally. This study calculated the pooled ideal prevalence of the seven CVH metrics and the 
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proportions of overall ideal and poor CVH status, which were defined by the number of ideal CVH 
metrics, in adults worldwide. It also conducted subgroups analyses on sex, age, continents, and 
study periods. 
    Chapter 3 is a systematic review to summarize the findings on the effects of Life’s Simple 7 on 
CVD/IHD risk in adults worldwide. It examined the effects of individual metrics and the overall 
CVH status on CVD/IHD risk. It also included stratification analyses on sex and age. 
    Chapter 4 is an original research study on the CVH status of Australian adults using the core 
sample of the 2011-2012 Australian Health Survey (AHS). It described both the prevalence of the 
ideal CVH metrics and the proportions of overall poor and ideal CVH status and stratified by sex 
and age. 
    Chapter 5 is an original research study on the association between the CVH status and CVD 
prevalence among Australian adults using the core sample of the 2011-2012 AHS. It examined the 
associations between individual metrics and the overall CVH status on CVD prevalence and 
stratified by sex and age. 
    Chapter 6 is an original research study on the association between the CVH status and IHD 
prevalence among Australian adults using the core sample of the 2011-2012 AHS. It examined the 
associations between individual metrics and the overall CVH status on IHD prevalence and 
stratified by sex and age. 
    Chapter 7 summarised the findings of the thesis, discussed the implications of the findings, listed 
the strengths and limitations, and suggested future research directions. 
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Figure 1.1 Structure of thesis. 
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Chapter 2 – The CVH status in adults worldwide 
 
    The AHA released a guideline to define and monitor the CVH status in the general population 
while the global CVH status in adults was still unclear. In addition, the sex, age, continent, and 
study period variations in the CVH status were inconclusive. Understanding the global CVH in 
adults is crucial for prioritising the public health strategies for CVD prevention. This chapter 
summarized the findings from relevant studies using a systematic review and meta-analysis and it 
addressed the research objective 1 of the thesis. 
    This chapter was formatted as the following publication: 
    Peng Y, Cao S, Yao Z, Wang Z. Prevalence of the cardiovascular health status in adults: a 
systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases 2018; 28 
(12): 1197-1207. doi: 10.1016/j.numecd.2018.08.002. 
 
Contributor Statement of contribution 
Yang Peng (Candidate) Conception and design (80%) 
Data analysis and result interpretation (50%) 
Drafting of article (100%) 
Sifan Cao Data analysis and result interpretation (30%) 
Reviewing of article (30%) 
Zhenjiang Yao Data analysis and result interpretation (20%) 
Reviewing of article (30%) 
Zhiqiang Wang Conception and design (20%) 
Reviewing of article (40%) 
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Abstract 
Background and Aims: The AHA has outlined seven CVH metrics, including smoking, BMI, 
physical activity, dietary pattern, TC, and FPG, to define and monitor the CVH status. Our study 
was to evaluate the global CVH in adults. 
Methods and Results: We searched PubMed, Embase, the Cochrane Central Register of Controlled 
Trials, and reference lists of relevant articles for studies published between 1 January 2010 and 30 
June 2018. Included studies should report the proportions of ideal status for the seven CVH metrics 
and/or provide the prevalence of overall poor (having 0-2 ideal metrics) or ideal (having 5-7 ideal 
metrics) CVH status in adults. 88 articles were identified: 75 for the prevalence of ideal CVH 
metrics, 58 for the proportion of the overall poor CVH status, and 55 for the proportion of the 
overall ideal CVH status. Smoking had the highest prevalence of ideal status (69.1%) while dietary 
pattern has the lowest (12.1%). 32.2% and 19.6% of participants had overall poor and ideal CVH, 
respectively. Females and young adults had better CVH status when compared to males and older 
adults. There existed regional variations in the ideal CVH metrics and the overall CVH status. The 
overall CVH status had improved over study time. 
Conclusion: The prevalence of ideal status was low for some metrics, such as dietary pattern, and 
the overall CVH status was still unsatisfactory. We should continue to measure the CVH status and 
carry out lifestyle interventions to improve the CVH status in the whole population.  
Keywords: Cardiovascular health; Adults; Meta-analysis 
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Introduction 
    CVD is still the leading cause of health burden worldwide. A recent report confirmed that CVD 
contributed to 31.5% of the overall deaths globally in the year of 2013. 19 According to the 2011-
2014 National Health and Nutrition Examination Survey (NHANES), an estimated of 92.1 million 
US adults are suffering from CVD. 20 While a large proportion of CVD can be prevented by 
adhering to healthy lifestyle factors. In a US cohort study with nearly 90 thousand participants and a 
20 years’ follow-up duration, poor adherence to six lifestyle factors, including smoking, raised 
BMI, insufficient physical activity, long time television watching, unhealthy diet, and elevated 
alcohol consumption, explained 73% of CHD cases. 6 Similarly, a Chinese cohort indicated that 
68% of the major coronary events were attributed to poor adherence to healthy lifestyle. 5  
    In the context of the alarming situation, the AHA has set the strategic impact goal for 2020. It 
aimed to reduce deaths from CVD and stroke by 20% while improving the CVH of all Americans 
by 20%. 7 Meanwhile, the AHA identified seven CVH behaviors and factors [smoking, BMI, 
physical activity, dietary pattern, TC, BP, and FPG] to define and monitor the CVH status. 7 
According to AHA’s 2018 heart disease and stroke statistics update, the prevalence of ideal status, 
among US adults, was 77.1% for smoking, 60.3% for TC, 53.2% for FPG, 49.7% for physical 
activity, 45.4% for BP, 29.6% for BMI, and 1.1% for dietary pattern. 21 Over the past several years, 
there have been numerous studies applied the AHA’s guideline and examined the CVH status 
within and outside of the US, whereas the global CVH status is still unclear. Although a systematic 
review has summarized findings of those published on or before July 2015, it failed to provide the 
pooled proportions of the ideal CVH metrics as well as the pooled prevalence of the overall poor or 
ideal CVH status. 11 It also failed to examine the possible sex, age, and regional differences as well 
as the secular trend in the CVH status. Additionally, several studies have been published since July 
2015 and, thus, a reassessment of the topic could provide the policy makers with the up-to-date 
information on this issue. 
In this study, we aimed to synthesize data on the prevalence of ideal CVH metrics and evaluate 
the frequency of the overall ideal and poor CVH worldwide. We also examined the age, sex, 
geographical, and study period variations. 
Methods 
Data collection and extraction 
    This systematic review and meta-analysis was conducted and reported in accordance with the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-analyses Of 
Observational Studies in Epidemiology guidelines. 22, 23 Since the AHA’s statement was released in 
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early 2010, we searched relevant studies published between 1 January 2010 and 30 June 2018, by 
searching PubMed, Embase, and the Cochrane Central Register of Controlled Trials. Table 2.1 
provided the detailed search strategies. In addition, we manually reviewed the reference lists of the 
included studies. There were no language restrictions. This systematic review was registered in the 
PROSPERO (registration number: CRD 42017080678). The study outcomes included prevalence of 
ideal status of the seven CVH metrics and the proportions of overall poor and ideal CVH status. 
Participants who had 0–2, 3–4 and 5–7 CVH metrics at the ideal level were defined as having 
overall poor, intermediate and ideal CVH status, respectively. To be included, the studies should 
satisfy all of the following criteria: (a) cross-sectional or cohort studies; (b) measured seven metrics 
outlined by AHA; (c) reported proportions of the ideal status for the seven metrics or proportions of 
the overall ideal or poor CVH status; and (d) all the participants were 18 years or older. The AHA’s 
definitions of ideal status for the seven metrics were listed in Table 2.2. A study was excluded if it 
is based on a subpopulation of an included study. Reviews, conference abstracts, letters, case 
reports, and editorials were also excluded. We extracted the information of first author, year of 
publication, name of the study, country where the study was conducted, study type, study period, 
age range of participants, percentage male, indicators measurement, and number of participants. 
When relevant data were unclear in the paper, we directly contacted authors of the study for more 
details. Two investigators (YP and SC) independently assessed the articles and extracted 
information, and disagreements were resolved by consensus. 
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Table 2.1 Searching details of the meta-analysis. 
Database Search strategy 
PubMed # 1 (((("cardiovascular health") OR "CVH") OR "Life's Simple 7") OR "Life Simple 7") OR "LS7" 
# 2 (("American Heart Association"[MeSH Terms]) OR "American Heart Association") OR "AHA" 
# 3 ("adult"[MeSH Terms]) OR "adult" 
#4 #1 AND #2 AND #3 
Embase # 1   'cardiovascular health'/exp OR 'cardiovascular health' OR 'CVH' OR 'life* simple 7' OR 'life 
simple 7' OR 'LS7' 
# 2   'american heart association' OR 'aha' 
# 3   'adult'/exp OR 'adult' 
# 4    #1 AND #2 AND #3 
Cochrane Central Register of Controlled 
Trials 
#1  "cardiovascular health" OR "CVH" OR "Life's Simple 7" OR "Life Simple 7" OR "LS7" 
#2  MeSH descriptor: [American Heart Association] explode all trees OR "American Heart 
Association" OR "AHA" 
#3  MeSH descriptor: [Adult] explode all trees OR "adult" 
#4  #1 AND #2 AND #3 
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Table 2.2 Definitions of AHA’s ideal CVH metrics. 
 Metrics  Definitions 
 Smoking  Never or quit > 12 months 
 BMI  < 25 kg/m2 
 Physical activity  ≥ 150 min/week moderate intensity or 
 ≥ 75 min/week vigorous intensity or 
 ≥ 150 min/week moderate + vigorous 
 Dietary pattern  4-5 components of the following: 
 1) Fruits and vegetables: ≥ 4.5 cups per day 
 2) Fishes: ≥ two 3.5-oz servings per week 
 3) Fiber-rich whole grains (≥ 1.1 g of fiber per 10 g of 
carbohydrate): ≥ three 1-oz-equivalent servings per day 
 4) Sodium: < 1500 mg per day 
 5) Sugar-sweetened beverages: ≤ 450 kcal (36 oz) per week 
 TC  < 200 mg/dL, untreated 
 BP  < 120/80 mm Hg, untreated 
 FPG  < 100 mg/dL, untreated 
Abbreviations: AHA, American Heart Association; CVH, cardiovascular health; BMI, body mass 
index; TC, total cholesterol; BP, blood pressure; FPG, fasting plasma glucose. 
 
Study risk of bias 
    We assessed the quality of included studies using the risk of bias tool for prevalence studies, 
which was developed by Hoy and colleagues. 24 It consisted of 10 items and response options for 
each item was either yes or no. Studies with yes answered for 0 to 3, 4 to 6, and 7 to 10 items were 
regarded as having overall high, moderate and low risk of bias, respectively. Two investigators (YP 
and SC) evaluated the risk of bias separately, with disagreements reconciled through discussion. 
Statistical analysis 
    We calculated the pooled prevalence of ideal status and the corresponding 95% confidence 
intervals (CIs) for each of the seven CVH metrics. In addition, we calculated the pooled prevalence 
and 95% CIs for overall poor and ideal CVH. We used I2 statistic to quantify the heterogeneity 
between studies. A random-effect model was utilized if I2 > 30%, as it indicated possible moderate 
or high heterogeneity. Otherwise, a fixed-effect model was applied. We carried out subgroup 
analyses stratified by sex, age, region, and study period to investigate potential sources of 
heterogeneity. Subjects were classified into young (< 60 years) and older (≥ 60) age groups. Studies 
were stratified into six regions based on the continents they were conducted: North America, Asia, 
Europe, South America, Oceania, and Africa. We divided the study period into 1983-2000, 2001-
2010, and 2011-2018 and the study period of an included study was determined by its median study 
year. Firstly, we performed the overall and subgroup analyses based on all the eligible studies 
(model 1). Then, we excluded the studies that modified the AHA’s definitions of ideal CVH metrics 
12 
 
to remove the potential influences of misclassifications (model 2). As both objective measurements 
and self-reported questionnaires were used for BMI, physical activity, TC, BP, and FPG, we 
compared the prevalence by scales for the five metrics. We used Begg’s rank correlation method to 
measure the publication bias, with a significant level of P < 0.1. 25 To evaluate the influence of any 
possible publication bias, we used the trim and fill method by adding potentially missing studies for 
the analyses with significant Begg’s test results. We did all the data analyses using the Stata 
software, version 14.1 (StataCorp, College Station, Texas, USA). 
Results 
Literature flow  
    We identified 1112 articles from the literature search and 21 through reference lists search. After 
the title, abstract and full-text review, 88 studies were finally included in our study 26-113 (Figure 
2.1) and the full list and general characteristics of the included studies were available in Table 2.3. 
Due to the significant heterogeneity (I2>95%), we applied a random-effect model for all the 
analyses. We divided the study of Yang Q et al 30 into two studies, conducted in 1988-1994 and 
1999-2010, respectively, for assessing the study period differences. Similarly, we analysed the US 
and Luxembourg subjects separately when stratified by continents for another study. 45  
13 
 
 
Figure 2.1 Flow chart of studies selection. 
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Table 2.3 General characteristics of the included studies. 
Ref. First author,          
publication year 
Name of study Location Study 
type 
Study 
period 
Total 
participants 
Age range 
(years) 
% Male Indicators 
measurement 
26 Bambs C, 2011 Heart SCORE US CS 2003 1933 45-75 34 Individual 
27 Artero EG, 2012 
 
ACLS US Cohort 1987-1999 11993 20-88 76 Individual 
Combined 
28 Fang J, 2012 BRFSS US CS 2009 356441 ≥ 18 37 Combined 
29 Wu S, 2012 Kailuan Cohort China Cohort 2006-2007 91698 18-98 79 Individual 
30 Yang Q, 2012 NHANES US Cohort 1988-1994 
1999-2010 
44959 ≥ 20 49 Individual 
Combined 
31 Del Brutto OH, 2013 The Atahualpa 
Project 
Ecuador CS 2012 616 ≥ 40 41 Individual 
Combined 
32 Forget G, 2013 NA Canada Cohort 2006-2007 196 ≥ 18 27 Individual 
Combined 
33 Graciani A, 2013 
 
Study on Nutrition 
and Cardiovascular 
Risk 
Spain CS 2008-2010 11408 ≥ 18 49 Individual 
Combined 
34 Kim JI, 2013 HONU US CS 2009, 2011 4754 ≥ 18 42 Individual 
Combined 
35 Kim JY, 2013 Seoul Male Cohort 
Study 
 
South Korea Cohort 1993 14533 40-59 100 Individual 
Combined 
36 Kulshreshtha A, 2013 REGARDS US Cohort 2003-2007 22914 ≥ 45 42 Combined 
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37 Lee HJ, 2013 KNHANES South Korea CS 2005,2007-
2009 
18059 ≥ 20 41 Individual 
Combined 
38 Rasmussen-Torvik LJ, 
2013 
ARIC US Cohort 1987-1989 13253 45-64 45 Combined 
39 Reis JP, 2013 CARDIA 
 
US Cohort 2010-2011 2932 43-55 45 Individual 
Combined 
40 Wu HY, 2013 
 
CHED China CS 2009-2010 1012418 20-65 54 Individual 
41 Zeng Q, 2013 DREHM China CS 2009-2012 9962 20-83 56 Individual 
Combined 
42 Zhang Q, 2013 Kailuan Cohort China Cohort 2006-2007 91698 18-98 79 Combined 
43 Aatola H, 2014 The Cardiovascular 
Risk in Young Finns 
Study 
US CS 2007 1143 30-45 44 Individual 
44 Alman AC, 2014 CACTI US Cohort 2000-2002 1177 20-55 47 Individual 
45 Crichton GE, 2014 MSLS 
ORISCAV-LUX 
US 
Luxembourg 
CS 2001-2006 
2007-2009 
1818 30-69 46 Individual 
46 Davis SK, 2014 RAHSS US CS 2004-2005 674 18-90 0 Individual 
47 Felisbino-Mendes MS, 
2014 
NA Brazil CS 2008-2010 928 ≥ 18 47 Individual 
48 Fretts AM, 2014 SHFS US Cohort 2001-2003 1639 18-74 37 Individual 
49 Jankovic S, 2014 2010 NHS in RS, 
Bosnia and 
Herzegovina 
Republic of 
Srpska, 
Bosnia and 
Herzegovina 
CS 2010 4170 ≥ 18 46 Individual 
Combined 
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50 Kulshreshtha A, 2014 Emory Twin Study US CS 2002-2010 490 46-64 100 Individual 
51 Moghaddam MM, 
2014 
TLGS Iran CS 2009-2011 4865 ≥ 20 41 Individual 
Combined 
52 Peltonen M, 2014 National FINRISK 
Study 
Finland CS 2007 4741 25-74 45 Individual 
Combined 
53 Tully L, 2014 NA US CS 2010-2012 830 ≥ 20 74 Individual 
Combined 
54 Xanthakis V, 2014 Sixth cycle of 
Framingham 
Offspring Study 
US Cohort 1995-1998 2680 32-85 45 Combined 
55 Bi Y, 2015 China 
Noncommunicable 
Disease Surveillance 
2010 
China CS 2010 96121 ≥ 20 46 Individual 
Combined 
56 Cao X, 2015 CSWHSP China CS 2013-2014 1625 ≥ 18 0 Individual 
Combined 
57 Dhamoon MS, 2015 NOMAS US Cohort 1993-2001 3219 ≥ 40 37 Individual 
Combined 
58 Djoussé L, 2015 JHS US CS 2000-2013 5301 ≥ 20 37 Individual 
Combined 
59 Laitinen TT, 2015 
 
The Cardiovascular 
Risk in Young Finns 
Study 
Finland CS 2007 1465 33-45 44 Combined 
60 Loucks EB, 2015 LEAP US CS 2010-2011 382 36-52 43 Individual 
Combined 
61 O’Flynn AM, 2015 Mitchelstown study Ireland CS 2010-2011 362 50-69 49 Individual 
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62 Ogunmoroti O, 2015 BHSF US CS 2014 9364 18-85 26 Individual 
Combined 
63 Olson NC, 2015 REGARDS US Cohort 2003-2007 27028 ≥ 45 45 Individual 
64 Robbins JM, 2015 NHLBI FHS US Cohort 1993-1995 1731 45-69 41 Individual 
Combined 
65 Sturlaugsdottir R, 
2015 
AGES-Reykjavik Iceland CS 2002-2006 219 67-99 34 Individual 
Combined 
66 Velasquez-Melendez 
G, 2015 
PNS Brazil CS 2013 34362 ≥ 18 49 Individual 
67 Chang Y, 2016 NCRCHS China CS 2012-2013 11113 ≥ 35 46 Individual 
Combined 
68 Chou LP, 2016 NA China CS 2012 1329 21-64 17 Individual 
Combined 
69 Foraker RE, 2016 WHI US Cohort 2010 145385 50-79 0 Combined 
70 Gaye B, 2016 PPS III France CS 2008-2012 9417 50-75 61 Combined 
71 Gibbs BB, 2016 IDEA US CS 2010-2012 335 18-35 32 Individual 
Combined 
72 González HM, 2016 HCHS/SOL 
 
US CS 2008-2011 15825 18-74 43 Individual 
Combined 
73 Graciani A, 2016  NA Spain Cohort 2008-2010 1745 ≥ 60 49 Individual 
Combined 
74 Luo TY, 2016 NA China CS 2013-2014 2795 ≥ 40 50 Individual 
Combined 
75 Ogunmoroti O, 2016 BHSF US CS 2011-2013 25382 18-85 25 Individual 
Combined 
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76 Pase MP, 2016 Seventh cycle of 
Framingham 
Offspring Study 
US Cohort 1998-2001 2631 ≥ 45 45 Combined 
77 Ren J, 2016 SMASH China CS 2011-2015 15350 18-69 50 Individual 
Combined 
78 Saiz AM, 2016 SHOW US CS 2008-2014 2935 21-74 50 Individual 
79 Shen S, 2016 NA China CS 2014-2015 27824 40-64 100 Individual 
80 Zhao Y, 2016 NA China CS 2010 2693 20-80 33 Individual 
81 Benderly M, 2017 Hadera District 
Study 
Israel CS 2002-2007 1104 25-74 50 Individual 
Combined 
82 Feinstein MJ, 2017 UGANDAC 
 
Uganda CS 2005 205 >  40 49 Individual 
Combined 
83 Fernandez-Alvira JM, 
2017 
PESA Spain CS 2010-2013 3983 40-54 63 Individual 
Combined 
84 Gaye B, 2017 Three-City Study France Cohort 1999-2001 7371 ≥ 65 37 Individual 
Combined 
85 Gaye B, 2017 PRIME Northern 
Ireland, 
France 
Cohort 1991-1993 9312 50-59 100 Combined 
86 Gupta B, 2017 NA India CS 2006-2010 6198 20-75 55 Individual 
Combined 
87 Jin Y, 2017 InCHIANTI Italy Cohort 1998-2000 928 ≥ 65 45 Individual 
88 Lawrence E, 2017 Add Health IV US CS 2008-2009 12253 24-34 47 Individual 
89 Manczuk M, 2017 PONS Poland CS 2010-2011 10687 45-64 34 Individual 
90 Matthews KA, 2017 PYS US Cohort 2007 307 30-41 100 Individual 
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91 Ogunmoroti O, 2017 MESA US Cohort 2000-2002 6506 45-84 47 Individual 
Combined 
92 Perrot N, 2017 EPIC-Norfolk UK Cohort 1993-1997 14051 39-79 47 Individual 
93 Shen S, 2017 NA China CS 2014-2015 26701 40-64 100 Combined 
94 Simon M, 2017 PPS III France CS 2008-2012 9012 50-75 61 Individual 
95 Slopen N, 2017 MIDUSII US CS 2004-2005 1147 34-84 44 Individual 
96 Talegawkar SA, 2017 MASALA US CS 2010-2013 875 40-84 53 Individual 
Combined 
97 Veromaa V, 2017 PORi To Aid 
Against Threats 
Finland CS 2014 732 19-66 0 Combined 
98 Wang Y, 2017 COACS China CS 2013-2014 4313 18-64 40 Individual 
99 Wang YQ, 2017 NA China CS 2014-2016 3009 ≥ 20 67 Individual 
Combined 
100 Windham BG, 2017 ARIC US Cohort 1987-1989 15744 45-64 45 Individual 
101 Benziger CP, 2018 CRONICAS Peru CS 2010 3058 ≥ 35 49 Individual 
Combined 
102 Bueno-Antequera J, 
2018 
NA 
 
Spain CS 2014-2017 142 18-61 76 Individual 
103 García-Hermoso A, 
2018 
Chilean National 
Health Survey 
Chile CS 2009-2010 460 > 65 41 Individual 
Combined 
104 García-Hermoso A, 
2018 
EVIDENT Spain CS 2006 1365 20-80 40 Individual 
Combined 
105 Han C, 2018 China-PAR China Cohort 1998 
2000-2001 
2007-2008 
93987 ≥ 20 40 Individual 
Combined 
106 Landi F, 2018 Lookup 7+ Italy CS 2015-2017 6323 ≥ 18 43 Individual 
Combined 
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107 Machado LBM, 2018 ELSA-Brasil Brazil CS 2008-2010 13356 35-74 45 Individual 
108 Nguyen XT, 2018 
 
MVP US CS 2011-2017 201745 ≥ 18 92 Individual 
Combined 
109 Peng Y, 2018 AHS Australia CS 2011-2012 7499 ≥ 18 44 Individual 
Combined 
110 Seron P, 2018 CESCAS I Argentina 
Chile 
Uruguay 
CS 2011-2012 7524 35-74 41 Individual 
Combined 
111 Sjöholm P, 2018 ABC Australia CS 2014-2016 467 24-29 47 Individual 
112 Szlejf C, 2018 ELSA-Brasil Brazil CS 2008-2010 13743 35-74 45 Combined 
113 Zhou L, 2018 PRC-USA China Cohort 1983-1984 938 35-59 50 Individual 
Combined 
Abbreviations: SCORE, Strategies Concentrating on Risk Evaluation; CS, cross-sectional; ACLS, Aerobics Center Longitudinal Study; BRFSS, 
Behavioral Risk Factor Surveillance System; NHANES, National Health and Nutrition Examination Survey; NA, not available; HONU, Heart of New 
Ulm; REGARDS,  Reasons for Geographic and Racial Differences in Stroke; KNHANES, Korean National Health and Nutrition Examination Survey; 
ARIC, Atherosclerosis Risk In Communities; CARDIA, Coronary Artery Risk Development in Young Adults; CHED, Chinese Health Examination 
Database; DREHM, Disease Risk Evaluation and Health Management; CACTI, Coronary Artery Calcification in Type 1 Diabetes; MSLS, Maine-
Syracuse Longitudinal Study; ORISCAV-LUX, Observation of Cardiovascular Risk Factors in Luxembourg; RAHSS, Regional Assessment Health 
Surveillance Study; SHFS, Strong Heart Family Study; TLGS, Tehran Lipid and Glucose Study; CSWHSP, Changsha Women’s Health Screening 
Program; NOMAS, Northern Manhattan Study; JHS, Jackson Heart Study; LEAP, Longitudinal Effects on Aging Perinatal; BHSF, Baptist Health 
South Florida; NHLBI FHS, National Heart, Lung, and Blood Institute Family Heart Study; AGES, Age, Gene/ Environment Susceptibility; PNS, 
Population National health Survey; NCRCHS, Northeast China Rural Cardiovascular Health Study; WHI, Women's Health Initiative; PPS, Paris 
Prospective Study; IDEA, Innovative approaches to Diet, Exercise, and Activity; HCHS/SOL, Hispanic Community Health Study / Study of Latinos; 
SMASH, Shandong province and the Chinese Ministry of Health collaborative Action on Salt reduction and Hypertension; SHOW, Survey of the 
Health of Wisconsin; UGANDAC, Ugandan Non-communicable Diseases and Aging Cohort; PESA, Progression of Early Subclinical Atherosclerosis; 
PRIME,  Prospective Epidemiological Study of Myocardial Infarction; PONS, Polish Norwegian Study; PYS, Pittsburgh Youth Study; MESA, Multi-
Ethnic Study of Atherosclerosis; EPIC, European Prospective Investigation into Cancer and Nutrition; MIDUS, Midlife in the United States; 
MASALA, Mediators of Atherosclerosis in South Asians Living in America; COACS, China Suboptimal Health Cohort Study; PAR, Prediction for 
ASCVD Risk; MVP, Million Veteran Program; AHS, Australian Health Survey; CESCAS, Detection and follow-up of cardiovascular disease and risk 
factors in the Southern Cone of Latin America; ABC, Aboriginal Birth Cohort. 
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Prevalence of ideal CVH metrics 
    There were 75 studies reported the prevalence of ideal CVH metrics. 26, 27, 29-35, 37, 39-41, 43-53, 55-58, 
60-68, 71-75, 77-84, 86-92, 94-96, 98-111, 113 Smoking had the highest prevalence of ideal status (69.1%; 95% 
CI: 64.2% to 74.0%), followed by FPG (67.7%; 95% CI: 62.0% to 73.4%), TC (51.7%; 95% CI: 
47.0% to 56.4%), physical activity (40.6%; 95% CI: 34.6% to 46.6%), BMI (40.3%; 95% CI: 
35.4% to 45.1%), BP (34.6%; 95% CI: 30.9% to 38.3%), and dietary pattern (12.1%; 95% CI: 
11.5% to 12.8%) (model 1) and the ranking did not change after restricted to those followed AHA’s 
guideline (Figure 2.2). We observed that, from both models, males had greater proportions of ideal 
TC and physical activity, whereas females had higher estimates of ideal status for the other five 
metrics (Figure 2.3). Older subjects were more likely to have ideal status for smoking and dietary 
pattern and less likely to have optimal status for other metrics than did young adults (Figure 2.4). 
Since most studies were conducted in North America, Asia and Europe (88%, 66/75), we made 
proportion comparisons between the three regions. Results from both models indicated that Asians 
had the highest ideal percentages in BMI, TC, and BP, whereas North Americans and Europeans 
had the greatest frequencies in smoking and dietary pattern, respectively. For ideal physical activity, 
North Americans ranked the first in ideal proportion when analysed all the participants, while 
Europeans ranked the first after excluded those did not follow the AHA’s definition. Europeans, in 
model 1, had the greatest frequency in ideal FPG. However, North Americans had the greatest ideal 
FPG frequency in model 2 (Figure 2.5). We observed the monotonous raising tendency with study 
period regarding the proportions of ideal physical activity, TC, and BP in both models. The 
proportions of ideal FPG, in both models, displayed a dropped trend from 1983 to 2010 and 
experienced elevation since 2011. For the proportion of ideal smoking, the findings of model 1 
revealed an increasing trend over time while it altered to a U-shaped in model 2. The ideal BMI 
prevalence displayed a U-shaped relationship in model 1 and it changed to a reversed U-shape in 
model 2. The secular trend was a U-shaped for the prevalence of ideal dietary pattern in all the 
eligible studies, but it shifted to an increasing pattern when restricted to the studies that followed the 
AHA’s definition (Figure 2.6). The different scales had little effect on the prevalence of ideal 
metrics (data not shown). 
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Figure 2.2 Pooled proportions of the ideal CVH metrics in the overall population. Abbreviations: BMI, body mass index; TC, total 
cholesterol; BP, blood pressure; FPG, fasting plasma glucose; CI, confidence interval; CVH, cardiovascular health. 
 
 
Figure 2.3 Pooled proportions of the ideal CVH metrics in males and females. Abbreviations: BMI, body mass index; TC, total 
cholesterol; BP, blood pressure; FPG, fasting plasma glucose; CI, confidence interval; CVH, cardiovascular health. 
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Figure 2.4 Pooled proportions of the ideal CVH metrics in young and older adults. Abbreviations: BMI, body mass index; TC, total 
cholesterol; BP, blood pressure; FPG, fasting plasma glucose; CI, confidence interval; CVH, cardiovascular health. 
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Figure 2.5 Pooled proportions of the ideal CVH metrics in six continents. Abbreviations: BMI, body mass index; TC, total cholesterol; BP, 
blood pressure; FPG, fasting plasma glucose; CI, confidence interval; NA, not available; CVH, cardiovascular health. 
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Figure 2.6 Pooled proportions of the ideal CVH metrics over study periods. Abbreviations: BMI, body mass index; TC, total cholesterol; 
BP, blood pressure; FPG, fasting plasma glucose; CI, confidence interval; CVH, cardiovascular health. 
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Prevalence of the overall poor and ideal CVH status 
    There were 58 27, 28, 30-39, 41, 42, 49, 52-60, 62, 64, 65, 67-77, 81-86, 91, 93, 96, 97, 99, 101, 103-106, 108, 109, 112, 113 and 55 
27, 30-39, 41, 42, 49, 51-60, 62, 64, 65, 67-72, 74-77, 81-86, 93, 96, 97, 99, 101, 103-105, 108-110, 112 studies provided the 
proportions of overall poor and ideal CVH status, respectively. Our findings indicated that, in 
model 1, 32.2% (95% CI: 24.2% to 40.3%) and 19.6% (95% CI: 15.2% to 23.9%) participants were 
with poor and ideal CVH and the proportions were similar in model 2. Male participants were 
associated with a 28% higher rate of the poor CVH and a 39% lower rate of the ideal CVH when 
compared to those of females. Older adults displayed a more than doubled frequency of the poor 
CVH and a 71% lower proportion of the ideal CVH than did young adults. The sex and age 
disparities were generally consistent between the two models. Additionally, we compared the poor 
and ideal CVH status between North America, Asia, and Europe. For all the included studies, 
participants in Asia had the lowest poor CVH status and highest ideal CVH status. In contrast, 
adults from Europe had the highest poor CVH status and lowest ideal CVH status. Since only a few 
studies followed the AHA’s definition, the ranking significantly altered in model 2. We also 
observed the declining proportion of poor CVH and rising proportion of ideal CVH over survey 
years and the findings were consistent between the two models (Figure 2.7).  
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Figure 2.7 Pooled proportions of the overall poor and ideal CVH status. Abbreviations: CVH, cardiovascular health; CI, confidence 
interval; NA, not available. 
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Study quality and publication bias 
    Of the 88 included studies, 8 (9%) were regarded as having a moderate risk of bias and the others 
were having a low risk of bias (Table 2.4). There was no indication of significant publication bias 
for proportions of ideal smoking, physical activity, TC, BP, and FPG (P > 0.1 for Begg’s test). 
There was potential significant publication bias for proportions of ideal BMI, dietary pattern, as 
well as the percentages of the overall poor and ideal CVH (P < 0.1 for Begg’s test). Nevertheless, 
the results altered slightly after included the missing studies identified through the trim and fill 
method (data not shown).  
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Table 2.4 Quality assessment of the included studies. 
Ref. Item 1* Item 2* Item 3* Item 4* Item 5* Item 6*  Item 7* Item 8* Item 9* Item 10* Overall risk of bias 
26 No Yes No Yes Yes No Yes Yes Yes Yes Low risk 
27 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
28 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
29 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
30 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
31 No Yes No No Yes Yes Yes Yes Yes Yes Low risk 
32 No No No Yes Yes No Yes Yes Yes Yes Moderate risk 
33 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
34 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
35 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
36 No No Yes Yes Yes No Yes Yes Yes Yes Low risk 
37 Yes Yes Yes No Yes No Yes Yes Yes Yes Low risk 
38 No Yes Yes Yes Yes Yes Yes Yes Yes Yes Low risk 
39 No Yes No No Yes No Yes Yes Yes Yes Moderate risk 
40 Yes Yes Yes No Yes Yes Yes Yes Yes Yes Low risk 
41 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Low risk 
42 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
43 No Yes Yes No Yes No Yes Yes Yes Yes Low risk 
44 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
45 Yes No No Yes Yes No Yes Yes Yes Yes Low risk 
46 No Yes Yes No Yes No Yes Yes Yes Yes Low risk 
47 Yes Yes No Yes Yes No Yes Yes Yes Yes Low risk 
48 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
49 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
50 No Yes Yes No Yes No Yes Yes Yes Yes Low risk 
51 Yes Yes Yes No Yes Yes Yes Yes Yes Yes Low risk 
52 Yes Yes Yes No Yes No Yes Yes Yes Yes Low risk 
53 No Yes No No Yes No Yes Yes Yes Yes Moderate risk 
54 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
55 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Low risk 
56 No Yes No Yes Yes No Yes Yes Yes Yes Low risk 
57 No Yes Yes Yes Yes Yes Yes Yes Yes Yes Low risk 
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58 No Yes Yes Yes Yes Yes Yes Yes Yes Yes Low risk 
59 No Yes Yes No Yes No Yes Yes Yes Yes Low risk 
60 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
61 No No Yes No Yes No Yes Yes Yes Yes Moderate risk 
62 No Yes Yes No Yes No Yes Yes Yes Yes Low risk 
63 No No Yes Yes Yes No Yes Yes Yes Yes Low risk 
64 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
65 No Yes Yes No Yes No Yes Yes Yes Yes Low risk 
66 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
67 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
68 Yes No No Yes Yes No Yes Yes Yes Yes Low risk 
69 No Yes Yes Yes Yes Yes Yes Yes Yes Yes Low risk 
70 No Yes No Yes Yes No Yes Yes Yes Yes Low risk 
71 No Yes No No Yes No Yes Yes Yes Yes Moderate risk 
72 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Low risk 
73 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
74 No Yes No Yes Yes Yes Yes Yes Yes Yes Low risk 
75 No Yes Yes No Yes No Yes Yes Yes Yes Low risk 
76 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
77 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Low risk 
78 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
79 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
80 No No Yes Yes Yes No Yes Yes Yes Yes Low risk 
81 Yes No No No Yes Yes Yes Yes Yes Yes Low risk 
82 No No No No Yes No Yes Yes Yes Yes Moderate risk 
83 No Yes No Yes Yes Yes Yes Yes Yes Yes Low risk 
84 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
85 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
86 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
87 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
88 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
89 No Yes No Yes Yes No Yes Yes Yes Yes Low risk 
90 No No Yes Yes Yes No Yes Yes Yes Yes Low risk 
91 No Yes No Yes Yes Yes Yes Yes Yes Yes Low risk 
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92 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
93 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
94 No Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
95 No Yes No No Yes Yes Yes Yes Yes Yes Low risk 
96 No Yes No Yes Yes Yes Yes Yes Yes Yes Low risk 
97 Yes Yes No Yes Yes No Yes Yes Yes Yes Low risk 
98 Yes No Yes No Yes No Yes Yes Yes Yes Low risk 
99 Yes Yes Yes No Yes Yes Yes Yes Yes Yes Low risk 
100 No Yes Yes Yes Yes Yes Yes Yes Yes Yes Low risk 
101 Yes Yes Yes Yes Yes No Yes                  Yes Yes Yes Low risk 
102 No Yes No No Yes No Yes Yes Yes Yes Moderate risk 
103 No Yes Yes No Yes No Yes Yes Yes Yes Low risk 
104 Yes Yes No Yes Yes No Yes Yes Yes Yes Low risk 
105 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
106 Yes Yes No Yes Yes No Yes Yes Yes Yes Low risk 
107 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
108 No Yes No No Yes No Yes Yes Yes Yes Moderate risk 
109 Yes Yes Yes No Yes No Yes Yes Yes Yes Low risk 
110 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
111 No Yes No Yes Yes No Yes Yes Yes Yes Low risk 
112 Yes Yes Yes Yes Yes No Yes Yes Yes Yes Low risk 
113 No Yes No Yes Yes No Yes Yes Yes Yes Low risk 
* Item 1: Was the study’s target population a close representation of the national population in relation to relevant variables? 
Item 2: Was the sampling frame a true or close representation of the target population? 
Item 3: Was some form of random selection used to select the sample, OR, was a census undertaken? 
Item 4: Was the likelihood of non-response bias minimal? 
Item 5: Were data collected directly from the subjects? 
Item 6: Was an acceptable case definition used in the study? 
Item 7: Was the study instrument that measured the parameter of interest shown to have reliability and validity? 
Item 8: Was the same mode of data collection used for all subjects? 
Item 9: Was the length of the shortest prevalence period for the parameter of interest appropriate? 
Item 10: Were the numerator and denominator for the parameter of interest appropriate? 
 
 
32 
 
Discussion 
    This study observed that ideal status was most prevalent for smoking and was least prevalent for 
dietary pattern. Nearly one-third of participants were with the overall poor CVH status, while, in 
contrast, only less than one-fifth were with the overall ideal CVH status. Females and young adults 
had higher frequencies of ideal status for most metrics and better overall CVH status than their 
males and older counterparts. We also observed the disparities in the proportions of ideal CVH 
metrics and overall CVH status across continents. In addition, our findings indicated the 
improvement over survey periods in most CVH metrics and overall CVH status. 
    We have identified smoking and FPG as two metrics with the highest ideal levels and the finding 
was in agreement with the findings of a previous systematic review. 11 They observed that 21 out of 
29 studies had ideal smoking and FPG percentages greater than 60%. The high optimal prevalence 
of smoking status may partly be explained by the effectiveness of governmental tobacco control 
policies, including mass media campaigns and the rise of tobacco products’ price. 114, 115 The 
appealing ideal FPG proportion may partially due to the subtle improvement of physical activity 116, 
117 and dietary pattern, 118 which were found to be significant influencing factors of diabetes and 
elevated FPG. 119 In contrast, our study revealed that merely 12.1% and 34.6% of participants were 
having ideal dietary pattern and BP and the proportions even dropped when we applied strict AHA 
definitions, which was in agreement with the previous systematic review. 11 The poor status of 
dietary pattern was also noticed in several large-scale studies. In a Chinese cohort with around 0.5 
million adults, only 7% of participants were classified as having an ideal status of dietary pattern. 5 
An Australian nationally representative survey indicated that 72% of adults did not meet the 
recommended amount of whole grain intake. 120 Our results of BP status were generally in line with 
two recent reports from two nationally representative surveys from US and China. 16, 121 They 
reported that merely 42.3% and 35.5% of US and Chinese adults reached BP level below 120/80 
mm Hg. To be noticed, the American College of Cardiology/AHA released a guideline in 2017 and 
lowered the thresholds of defining hypertension, 122 which in turn greatly raised the prevalence and 
hypertension-related CVD burden. 123 Thus, our findings underscored the importance of dietary 
pattern and BP promotion in improving the overall CVH status and reducing the related CVD 
burden. We reported that 51.7%, 40.6% and 40.3% of participants were having ideal TC, physical 
activity, and BMI. Compared to the recent US nationally statistics indicated by AHA’s 2018 update, 
21 we reported a higher proportion of ideal BMI and lower proportions of ideal TC and physical 
activity. Since our results were collected from a global scale during 1983-2018, the decreasing trend 
in ideal BMI and increasing trend in ideal TC and physical activity, along with the possible regional 
disparities in metrics distribution, could partially account for the variations. 117, 124, 125 
33 
 
     Although applied a less strict definition of the overall ideal CVH (five to seven ideal metrics) 70 
when compared to the definition of AHA (seven ideal metrics), 7 we noted that less than twenty 
percent of participants were with the overall ideal CVH status. In contrast, more than thirty percent 
of subjects were deemed as having a poor CVH status. Our findings were in agreement with a 
previous systematic review by Younus A et al. 11 They reported that, according to our ideal and 
poor CVH definitions, 17 out of 25 studies reported a poor CVH status proportion greater than 30% 
and 16 out of 25 studies reported an ideal CVH status proportion less than 20%. The right skewed 
distribution of ideal metrics number in our study was also supported by several recent studies. A 
report of China Kadoorie Biobank described the distribution of six lifestyle factors and 26% of 
participants have 0-1 optimal lifestyle factors. However, only 1% of participants have an optimal 
status for 5-6 lifestyle factors. 5 The Singapore Chinese Health Survey also indicated the right 
skewed distribution of healthy lifestyles number in 45-74 years old adults. 126 A number of factors 
could lead to the unsatisfactory CVH status in the general population. One explanation is many 
countries, especially Asian countries, are experiencing dramatic westernization of lifestyle, such as 
taking less physical activity and consuming more carbohydrates, which could act as barriers to the 
CVH improvement. 127, 128 In addition, several studies suggested that the primordial prevention 
efforts of CVD, measures to prevent the appearances of CVD risk factors, were most effective if 
performed among infants and children. 129, 130 However, the population-wide CVD primordial 
prevention efforts, starting from the early phase of life, were extremely scarce worldwide, 131 which 
precluded us from gaining the maximum cardiovascular benefits. Furthermore, given that the CVH 
metrics were internally correlated 132, 133 and had a combined effect on CVD risk, finding an 
appropriate multicomponent intervention strategy may effectively alter the distribution of CVD risk 
factors. Although we have identified a range of population-based intervention strategies, including 
media and education campaigns, labeling and consumer information, taxation, school and 
workplace approaches, community environmental changes, and direct restrictions, 134 it is still 
unclear the combined effects of these interventions on metrics distribution, which need further 
explorations. 
    Another striking finding of our study was the sex, age, regional and study period variations in the 
ideal CVH metrics and the overall CVH status. It appeared that males and older adults displayed 
lower frequencies in the overall ideal CVH status, as well as ideal status of most CVH metrics, and 
higher frequencies in the overall poor CVH status than did the females and young adults. The sex 
and age inequalities in CVD risk factors distribution were also noticed in recent reports. 135, 136 
Nevertheless, cardiovascular benefits of the favorable CVH metrics applied to all sex and age-
specific populations. 6, 84, 113, 137 In addition, the ideal CVH status was less than 30% in all sex and 
age subgroups, which further emphasized the urgent need for primordial prevention of CVD risk 
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factors in the whole population. For geographical variations, it seems that Asians had better CVH 
status compared to those from Europe and North America, whereas we cannot draw a conclusion 
due to the limited studies in each subgroup. The possible regional variations in exposure to CVD 
influencing factors were also suggested elsewhere. 138 Of concern is very limited studies were 
conducted in South America, Oceania and Africa, it is crucial to conduct more studies in those 
regions to inform the local policy makers the magnitude of the public health problem. One 
promising finding of our study was the improvement of the overall CVH and most metrics over 
study time. However, we could not predict whether the AHA’s goal of improving the overall CVH 
by 20% will be attainable in 2020. 139 A report using NHANES data predicted that the overall CVH 
status would improve by 6% by 2020 and, therefore, we call for more efforts to measure the 
progress of CVH improvement and work out a schedule for the coming few years.    
    One striking strength of our study was it is the first meta-analysis that calculated the pooled 
prevalence estimates of the ideal status for the seven CVH metrics as well as the overall poor and 
ideal CVH status. Second, our study should provide reliable estimates as we have a relatively large 
sample size. We included 75 studies for the prevalence estimates of the ideal CVH metrics, yielding 
over 1.8 million participants. For the overall poor and ideal CVH status, we included over fifty 
studies and more than 0.9 million subjects. Third, we took the effects of metrics misclassification, a 
potential confounder, into consideration by restricted the studies followed AHA’s guideline in the 
second model. Finally, we conducted subgroup analyses based on age, sex, region, and survey time. 
    Our study, however, has several limitations. First, there were significant between-study variances 
and age, sex, region and survey time were unable to explain the heterogeneity. Other factors, such 
as socioeconomic status and genetic elements, may contribute to the variations and we were unable 
to explore their effects due to limited data. The included studies had different designs, screening 
instruments and trainee demographics, which may also contribute to the heterogeneity. Second, we 
were not able to provide accurate comparisons of the CVH between geographical regions, as there 
were very limited reports in some regions, like South America, Africa, and Oceania. Third, 
publication bias tests were significant for the prevalence of ideal BMI, dietary pattern, as well as the 
proportions of the overall poor and ideal CVH status. The imputation of potentially missing studies, 
however, displayed similar results and, thus, the potential publication bias has little impact on 
conclusions. In addition, some studies did not strictly follow the metric definitions of AHA and the 
phenomenon was especially obvious for dietary pattern and physical activity, which may preclude 
direct comparisons between studies and lead to loss of information. 
Conclusion 
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    In summary, the findings of this study displayed the low prevalence of ideal CVH status. Among 
the seven CVH metrics, ideal status was most prevalent for smoking and least observed for dietary 
pattern. Generally, females and young adults displayed better CVH status than males and older 
adults. There also existed some regional variations in the ideal CVH metrics and the overall CVH 
status. Current evidence also indicated an improvement of the CVH status over time and more 
efforts are warranted to keep on monitoring the CVH status trend. Additionally, we should initiate 
multiple high-quality interventions to improve the population-wide CVH status globally.   
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Chapter 3 – The CVH status and CVD/IHD risk in adults worldwide 
 
    Since the release of the AHA’s Impact Goals, a number of studies have explored the separate and 
combined effects of Life’s Simple 7 on CVD/IHD risk. The magnitude of the association between 
Life’s Simple 7 and CVD/IHD risk is unclear. Additionally, the sex and age variations of the 
strength of association were inconclusive. Measuring the CVH status on CVD/IHD risk has 
significant implications on the CVD/IHD prevention strategies. This chapter summarized the 
findings from relevant studies using a systematic review and it addressed the research objective 2 of 
the thesis. 
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The association between cardiovascular health metrics and risk of cardiovascular disease in 
adults: A systematic review 
 
Abstract 
Our study was to investigate the association between the seven CVH metrics and CVD risk in 
adults by conducting a systematic review. We searched PubMed, Embase, Cochrane Central 
Register of Controlled Trials, and reference lists of relevant articles for cross-sectional or cohort 
studies published between January 1, 2010, and June 10, 2018. 27 studies, 22 cohort and 5 cross-
sectional studies, were included in our study. We observed the higher number of ideal CVH metrics 
was associated with a substantial reduction in CVD risk and they displayed a dose-response pattern. 
The individual effects of the CVH metrics on different types of CVD are inconsistent. There exist 
some age and sex variances in the association magnitude. Promoting the CVH status, even minor 
improvement, could benefit CVD risk reductions. The association between individual metrics and 
CVD, especially some CVD types, still need further explorations. 
Keywords: cardiovascular health metrics; cardiovascular disease; systematic review 
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Introduction 
    CVD is still one of the major health burdens worldwide. It has been estimated that CVD 
accounted for 32.1% of all deaths globally in 2015. 140 While, several studies have indicated that the 
majority of CVD burden can be explained by modifiable risk factors, like physical activity, BMI 
and smoking. 5, 6 In 2010, the AHA outlined the seven CVH metrics, including smoking, BMI, 
physical activity, dietary pattern, TC, BP, and FPG to define and measure the CVH status in the 
general population. 7 A number of studies have explored the individual and combined effects of 
those metrics on the risk of CVD and several systematic reviews and meta-analyses have indicated 
the negative relationship between the number of ideal CVH metrics and CVD risk in adults. 11, 14, 141 
However, they ignored several studies that were cross-sectional design and chosen certain types of 
CVD as outcomes, like heart failure (HF) and atrial fibrillation (AF). In addition, they only 
summarized articles that were published before February 2017 and several studies have been 
published since then.  
    Our study aimed to synthesize data on both the individual and combined associations between the 
CVH metrics and CVD risk in adults. We also explored the possible age and sex variations in the 
strength of the associations.  
Methods 
Data sources and study selection 
    Since the AHA’s guideline was released in early 2010, we searched relevant studies published 
between January 1, 2010, and June 10, 2018, using PubMed, Embase, and the Cochrane Central 
Register of Controlled Trials. Moreover, we manually reviewed references of selected articles and 
citations of the AHA’s guideline. 7 There were no language restrictions. The detailed search 
strategies were provided in Table 3.1. 
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Table 3.1 Searching details of the systematic review. 
Database Search strategy 
PubMed 
 
# 1 (((("cardiovascular health") OR "CVH") OR "Life's Simple 7") OR "Life Simple 7") OR "LS7" 
# 2 (("American Heart Association"[MeSH Terms]) OR "American Heart Association") OR "AHA" 
# 3 ("adult"[MeSH Terms]) OR "adult" 
# 4 ((("cardiovascular diseases"[MeSH Terms]) OR "cardiovascular diseases") OR "cardiovascular disease") OR "CVD" 
#5  #1 AND #2 AND #3 AND #4 
Embase 
 
# 1   'cardiovascular health'/exp OR 'cardiovascular health' OR 'CVH' OR 'life* simple 7' OR 'life simple 7' OR 'LS7' 
# 2   'american heart association' OR 'aha' 
# 3   'adult'/exp OR 'adult' 
# 4   'cardiovascular disease'/exp OR 'cardiovascular disease' OR 'cvd' 
# 5    #1 AND #2 AND #3 AND #4 
Cochrane Central 
Register of 
Controlled Trials 
#1  "cardiovascular health" OR "CVH" OR "Life's Simple 7" OR "Life Simple 7" OR "LS7" 
#2  MeSH descriptor: [American Heart Association] explode all trees OR "American Heart Association" OR "AHA" 
#3  MeSH descriptor: [Adult] explode all trees OR "adult" 
#4 MeSH descriptor: [Cardiovascular diseases] explode all trees OR "Cardiovascular diseases" OR "Cardiovascular 
disease" OR "CVD" 
#5  #1 AND #2 AND #3 AND #4 
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    To be included, the studies should in accordance with the following criteria: (a) cross-sectional or 
cohort studies; (b) measured the seven CVH metrics; (c) provided the effect sizes and 95% CIs of 
the associations between the CVH metrics and CVD prevalence, incidence, or mortality; and (d) all 
the participants were aged 18 years or over. We excluded reviews, conference abstracts, letters, case 
reports, and editorials. Two investigators (YP and ZW) performed the article screening and 
selection and disagreements were resolved by consensus. 
Data extraction and risk of bias assessment 
For each included article, we extracted first author, year of publication, name of the study, 
country where the study was conducted, study type, study period, number of participants, age range 
and male percentage of the participants, and outcomes. We directly contacted authors for more 
details if relevant data were unclear in the paper. We used the Newcastle-Ottawa Scale (NOS) to 
evaluate the quality of the included studies. A 9 stars and an adapted 10 stars scale were used for 
cohort and cross-sectional studies, respectively. 142 Two authors (YP and ZW) independently 
extracted the information and assessed the study quality and disagreements were settled down by 
discussion. 
Statistical analysis 
    We summarized the effect sizes, including hazard ratio, odds ratio (OR), and relative risk, and 
95% CIs between the number of ideal metrics/ideal status of individual metrics and CVD related 
outcomes. The significance of associations was determined by the two-sided P values, with 0.05 as 
the cut-off point. As there are limited studies for each outcome and different definitions of 
outcomes, we did not calculate the pooled effect sizes and 95% CIs.    
Results 
Study characteristics 
    A total of 27 studies 12, 27, 29, 30, 35, 36, 42, 63, 69, 84, 85, 91, 105, 113, 143-155 were included in our study and 
Figure 3.1 shows the details of the literature search. Around half of the studies were conducted in 
the United States (48%, 13/27). Of the 27 included studies, 22 (81.5%) were cohort studies and the 
remaining 5 (18.5%) were cross-sectional studies. Overall, the quality of the included studies was 
high according to the NOS (≥ 7 stars). The general characteristics of the included studies were listed 
in Table 3.2. 
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Figure 3.1 Flow chart of study selection. Abbreviations: CVH, cardiovascular health; CVD, 
cardiovascular disease. 
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Table 3.2 General characteristics of the included studies. 
First author, 
publication year 
Name of study Location Study type Study period Total 
participants 
Age range 
(years) 
% 
Male 
Outcomes NOS 
Folsom AR, 2011 12 ARIC United States Cohort 1987-1989 12744 45-64 44 CVD incidence 8 
Artero EG, 2012 27 ACLS United States Cohort 1987-1999 11993 20-88 76 CVD mortality 8 
Wu S, 2012 29 KaiLuan Study China Cohort 2006-2007 91698 18-98 79 CVD incidence 8 
Yang Q, 2012 30 NHANES United States Cohort 1988-1994 16215 ≥ 20 48 CVD mortality 
IHD mortality 
9 
Kim JY, 2013 35 Seoul Male Cohort 
Study 
South Korea Cohort 1993 12538 40-59 100 CVD mortality 8 
Kulshreshtha A, 2013 36 REGARDS United States Cohort 2003-2007 22914 ≥ 45 42 Stroke incidence 8 
Zhang Q, 2013 42 KaiLuan Study China Cohort 2006-2007 91698 18-98 79 Stroke incidence 8 
Olson NC, 2015 63 REGARDS United States Cohort 2003-2007 27402 ≥ 45 45 VTE incidence 8 
Foraker RE, 2016 69 WHI United States Cohort 1992 115306 50-79 0 CVD incidence 8 
Gaye B, 2017 84 Three-City Study France Cohort 1999-2001 7371 ≥ 65 37 CVD mortality 
CHD incidence 
Stroke incidence 
8 
Gaye B, 2017 85 PRIME France 
Ireland 
Cohort 1991-1993 9312 50-59 100 CHD incidence 
Stroke incidence 
8 
Ogunmoroti O, 2017 91 MESA United States Cohort 2000-2002 6506 45-84 47 HF incidence 8 
Han C, 2018 105 China-PAR China Cohort 1988 
2000-2001 
2007-2008 
93987 ≥ 20 40 CHD incidence 
Stroke incidence 
9 
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Zhou L, 2018 113 China-USA China Cohort 1981 938 35-59 50 CVD mortality 
CVD incidence 
CHD incidence 
Stroke incidence 
7 
Dong C, 2012 143 NOMAS United States Cohort 1993-2001 2981 ≥ 40 36 CVD incidence 
MI incidence 
Stroke incidence 
CVD mortality 
7 
Ford ES, 2012 144 NHANES United States Cohort 1999-2002 7622 ≥ 20 48 CVD mortality 9 
Zhang Q, 2013 145 APAC China CS 2010-2011 5412 ≥ 40 60 ICAS prevalence 9 
Liu Y, 2014 146 KaiLuan Study China Cohort 2006-2007 95429 18-98 80 CVD mortality 8 
Folsom AR, 2015 147 ARIC United States Cohort 1987-1989 13462 45-64 45 HF incidence 8 
Guo L, 2016 148 NA China CS 2012-2013 11417 ≥ 35 46 Stroke 
prevalence 
9 
Lachman S, 2016 149 EPIC-Norfolk United 
Kingdom 
Cohort 1993-1997 10043 39-79 44 CVD incidence 8 
Ommerborn MJ, 2016 150 JHS United States Cohort 2000-2004 4702 ≥ 20 36 CVD incidence 7 
Peng Y, 2017 151 AHS Australia CS 2011-2012 7499 ≥ 18 44 CVD prevalence 8 
Peng Y, 2017 152 AHS Australia CS 2011-2012 7499 ≥ 18 44 IHD prevalence 8 
Yang Y, 2017 153 NA China CS 2013-2014 4477 40-82 49 AF prevalence 8 
Garg PK, 2018 154 ARIC United States Cohort 1987-1989 13182 45-64 44 AF incidence 8 
Garg PK, 2018 155 REGARDS United States Cohort 2003-2007 9576 ≥ 45 43 AF incidence 8 
Abbreviations: NOS, Newcastle-Ottawa Scale; ARIC, Atherosclerosis Risk in Communities; CVD, cardiovascular disease; ACLS, Aerobics 
Centre Longitudinal Study; NOMAS, Northern Manhattan Study; MI, myocardial infarction; NHANES, National Health and Nutrition 
Examination Survey; IHD, ischemic heart disease; REGARDS, Reasons for Geographic and Racial Differences in Stroke; APAC, Asymptomatic 
Polyvascular Abnormalities Community; CS, cross-sectional; ICAS, intracranial arterial stenosis; HF, heart failure; VTE, venous 
thromboembolism; WHI, Women’s Health Initiative; NA, not available; JHS, Jackson Heart Study; CHD, coronary heart disease; PRIME, 
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Prospective Epidemiological Study of Myocardial Infarction; MESA, Multi-Ethnic Study of Atherosclerosis; AHS, Australian Health Survey; AF, 
atrial fibrillation.   
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Number of ideal CVH metrics and CVD risk 
    Table 3.3 listed the results of associations between number of ideal metrics and CVD related 
outcomes. In all studies, persons with higher numbers of ideal CVH metrics had a lower risk of 
overall CVD mortality, 27, 30, 35, 84, 113, 143, 144, 146 incidence, 12, 29, 69, 113, 143, 150 and prevalence 151 than 
did those with fewer ideal CVH metrics. Compared with persons in the lowest ideal metrics 
categories, persons in the highest categories had 42% to 90%, 59% to 89%, and 66% reduction in 
the risk of CVD mortality, incidence, and prevalence, respectively.   
    Several studies have explored the association between ideal CVH metrics number and IHD 
mortality, 30 IHD prevalence, 152 CHD incidence, 84, 85, 105, 113 stroke incidence, 36, 42, 84, 85, 105, 113, 143 
and stroke prevalence 148 and they all demonstrated an inverse association. Participants in the 
highest categories had 70%, 78% and 42%-73% reduced risk of IHD mortality, IHD prevalence, 
and CHD incidence compared with those in the lowest categories. For stroke incidence and 
prevalence, the odds had reduced by 55%-83% and 77%, respectively. 
    A few studies also indicated that the greatest number of the ideal CVH metrics could eliminate 
84% of myocardial infarction incidence, 143 64% of intracranial artery stenosis (ICAS) prevalence, 
145 83%-85% of HF incidence, 91, 147 50% of AF incidence, 154 and 56% of AF prevalence 153 
compared to those with fewest number of the ideal CVH metrics.   
    In addition, several studies have focused on the sex and age disparities in the association 
magnitude. It has been reported that the effects of the ideal CVH metrics number are more 
pronounced among females than among males regarding the incidence of overall CVD 29, 150 and 
stroke. 42 However, the effects are more obvious in males in females for ICAS prevalence 145 and 
HF incidence. 91 Two studies have found the association strength is more significant in younger 
adults compared to that in older adults for stroke 42 and HF incidence, 91 whereas a study observed 
an opposite association for ICAS prevalence. 145  
Individual CVH metrics and CVD risk 
    Several studies have explored the effects of the individual CVH metrics on the risk of CVD 
mortality, 27, 30, 35, 144, 146 CVD incidence, 29, 149 CVD prevalence, 151 CHD incidence, 105 IHD 
mortality, 30 IHD prevalence, 152 stroke incidence, 36, 42, 105 stroke prevalence, 148 HF incidence, 91 
ICAS prevalence, 145 venous thromboembolism (VTE) incidence, 63 AF incidence, 155 and AF 
prevalence. 153 The detailed information on the association was shown in Table 3.4. 
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Table 3.3 The associations between the number of ideal CVH metrics and CVD-related outcomes. 
First author, publication year Outcome Number of ideal metrics Effect size (95% CI) 
Folsom AR, 2011 12 CVD incidence 0 Referent 
  1 0.65 (0.55-0.77) 
  2 0.46 (0.39-0.54) 
  3 0.34 (0.28-0.40) 
  4 0.24 (0.20-0.29) 
  5 0.18 (0.14-0.23) 
  6 0.11 (0.07-0.17) 
Artero EG, 2012 27 CVD mortality 0-2 Referent 
  3-4 0.45 (0.27-0.77) 
  5-7 0.37 (0.15-0.95) 
Wu S, 2012 29 CVD incidence 0 Referent 
  1 0.88 (0.68-1.13) 
  2 0.63 (0.49-0.81) 
  3 0.47 (0.36-0.60) 
  4 0.34 (0.26-0.44) 
  5 0.24 (0.17-0.34) 
  6-7 0.18 (0.08-0.40) 
Yang Q, 2012 30 CVD mortality 0-1 Referent 
  2 0.73 (0.59-0.91) 
  3 0.56 (0.44-0.71) 
  4 0.52 (0.41-0.66) 
  5 0.44 (0.30-0.65) 
  6-7 0.24 (0.13-0.47) 
 IHD mortality 0-1 Referent 
  2 0.74 (0.55-1.00) 
  3 0.54 (0.40-0.72) 
  4 0.51 (0.37-0.72) 
  5 0.43 (0.26-0.72) 
  6-7 0.30 (0.13-0.68) 
Kim JY, 2013 35 CVD mortality 0-2 Referent 
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  3 0.77 (0.46-1.29) 
  4 0.46 (0.27-0.76) 
  5 0.31 (0.18-0.53) 
  6-7 0.10 (0.03-0.29) 
Kulshreshtha A, 2013 36 Stroke incidence 0 Referent 
  1 0.70 (0.42-1.19) 
  2 0.67 (0.40-1.13) 
  3 0.53 (0.31-0.90) 
  4 0.40 (0.23-0.73) 
  5 0.50 (0.25-1.00) 
  6 0.34 (0.08-1.52) 
Zhang Q, 2013 42 Stroke incidence 0 Referent 
  1 0.92 (0.69-1.23) 
  2 0.69 (0.52-0.92) 
  3 0.52 (0.39-0.68) 
  4 0.38 (0.28-0.51) 
  5 0.27 (0.18-0.40) 
  6-7 0.24 (0.11-0.54) 
Foraker RE, 2016 69 CVD incidence 0-1 6.83 (5.83-8.00) 
  2 4.43 (3.91-5.03) 
  3 2.77 (2.45-3.13) 
  4 2.06 (1.83-2.33) 
  5 1.46 (1.29-1.66) 
  6-7 Referent 
Gaye B, 2017 84 CVD mortality 0-2 Referent 
  3-4 0.85 (0.69-1.03) 
  5-7 0.54 (0.29-0.98) 
 CHD incidence 0-2 Referent 
  3-4 0.63 (0.52-0.77) 
  5-7 0.27 (0.13-0.57) 
 Stroke incidence 0-2 Referent 
  3-4 0.82 (0.64-1.06) 
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  5-7 0.45 (0.20-1.03) 
Gaye B, 2017 85 CHD incidence 0-2 Referent 
  3-4 0.58 (0.49-0.68) 
  5-7 0.28 (0.17-0.46) 
 Stroke incidence 0-2 Referent 
  3-4 0.84 (0.58-1.21) 
  5-7 0.24 (0.06-0.98) 
Ogunmoroti O, 2017 91 HF incidence 0-1 Referent 
  2 0.93 (0.60-1.44) 
  3 0.68 (0.45-1.05) 
  4 0.52 (0.33-0.83) 
  5 0.34 (0.18-0.63) 
  6-7 0.15 (0.04-0.65) 
Han C, 2018 105 CHD incidence 0-2 Referent 
  3 0.72 (0.57-0.90) 
  4 0.52 (0.42-0.65) 
  5 0.48 (0.38-0.61) 
  6 0.36 (0.27-0.49) 
  7 0.35 (0.22-0.58) 
 Stroke incidence 0-2 Referent 
  3 0.87 (0.76-0.99) 
  4 0.71 (0.62-0.81) 
  5 0.56 (0.49-0.65) 
  6 0.45 (0.39-0.53) 
  7 0.21 (0.15-0.28) 
Zhou L, 2018 113 CVD mortality 0-2 Referent 
  3 0.50 (0.19-1.31) 
  4-7 0.43 (0.16-1.16) 
 CVD incidence 0-2 Referent 
  3 0.59 (0.33-1.04) 
  4-7 0.24 (0.12-0.47) 
 CHD incidence 0-2 Referent 
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  3 0.42 (0.10-1.84) 
  4-7 0.58 (0.15-2.31) 
 Stroke incidence 0-2 Referent 
  3 0.58 (0.32-1.08) 
  4-7 0.17 (0.08-0.38) 
Dong C, 2012 143 CVD incidence 0-1 Referent 
  2 0.73 (0.60-0.89) 
  3 0.61 (0.50-0.76) 
  4 0.49 (0.38-0.63) 
  5-7 0.41 (0.26-0.63) 
 MI incidence 0-1 Referent 
  2 0.78 (0.54-1.12) 
  3 0.57 (0.38-0.84) 
  4 0.53 (0.33-0.85) 
  5-7 0.16 (0.05-0.52) 
 Stroke 0-1 Referent 
  2 0.71 (0.51-0.99) 
  3 0.60 (0.42-0.84) 
  4 0.49 (0.31-0.76) 
  5-7 0.43 (0.21-0.91) 
Ford ES, 2012 144 CVD mortality 0 Referent 
  1 0.40 (0.15-1.09) 
  2 0.46 (0.17-1.22) 
  3 0.25 (0.09-0.67) 
  4 0.27 (0.10-0.72) 
  5-7 0.12 (0.03-0.57) 
Zhang Q, 2013 145  ICAS prevalence 0-1 Referent 
  2 0.76 (0.58-0.99) 
  3 0.55 (0.43-0.72) 
  4 0.49 (0.37-0.65) 
  5 0.43 (0.31-0.61) 
  6-7 0.36 (0.22-0.62) 
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Liu Y, 2014 146 CVD mortality 0-1 Referent 
  2 0.88 (0.69-1.12) 
  3 0.71 (0.55-0.90) 
  4 0.58 (0.44-0.77) 
  5-7 0.61 (0.41-0.89) 
Folsom AR, 2015 147 HF incidence 0 Referent 
  1 0.75 (0.65-0.85) 
  2 0.52 (0.43-0.64) 
  3 0.39 (0.31-0.48) 
  4 0.27 (0.22-0.34) 
  5 0.17 (0.13-0.23) 
  6 0.17 (0.11-0.28) 
Guo L, 2016 148 Stroke incidence 1 4.44 (1.66-11.79) 
  2 4.03 (1.62-10.00) 
  3 3.60 (1.46-8.85) 
  4 3.27 (1.33-8.03) 
  5 2.26 (0.91-5.61) 
  6 2.24 (0.88-6.59) 
  7 Referent 
Ommerborn MJ, 2016 150 CVD incidence 0-1 Referent 
  2 0.66 (0.49-0.88) 
  3 0.45 (0.32-0.64) 
  4-7 0.29 (0.17-0.52) 
Peng Y, 2017 151 CVD prevalence 0-2 Referent 
  3-4 0.67 (0.56-0.81) 
  5-7 0.34 (0.22-0.55) 
Peng Y, 2017 152 IHD prevalence 0-2 Referent 
  3-4 0.55 (0.39-0.77) 
  5-7 0.22 (0.03-1.96) 
Yang Y, 2017 153 AF prevalence 0-2 Referent 
  3-4 0.41 (0.22-0.80) 
  5-7 0.44 (0.20-0.98) 
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Garg PK, 2018 154 AF incidence 0-1 Referent 
  2-3 0.75 (0.68-0.83) 
  4-7 0.50 (0.44-0.56) 
Abbreviations: CVH, cardiovascular health; CVD, cardiovascular disease; CI, confidence interval; IHD, ischemic heart disease; CHD, coronary 
heart disease; HF, heart failure; MI, myocardial infarction; ICAS, intracranial arterial stenosis; AF, atrial fibrillation. 
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Table 3.4 The associations between the seven CVH metrics and CVD-related outcomes. 
Outcomes Smoking BMI Physical activity Dietary 
pattern 
TC BP FPG 
CVD mortality 27,30,35,144,146 +/- - +/- - +/- + +/- 
CVD incidence 29,149 + + +/- +/- + + + 
CVD prevalence 151 + + + - + + + 
CHD incidence 105 + - + - + + + 
IHD mortality 30 + - - + - - + 
IHD prevalence 152 - + + - + - - 
Stroke incidence 36,42,105 + +/- +/- +/- +/- + + 
Stroke prevalence 148 - + NA + + + + 
HF incidence 91 + + + - - + + 
ICAS prevalence 145 + - - - + + + 
VTE incidence 63 - + + - - - - 
AF incidence 155 - + - - - + - 
AF prevalence 153 - - + - - - - 
Abbreviations: CVH, cardiovascular health; CVD, cardiovascular disease; BMI, body mass index; TC, total cholesterol; BP, blood pressure; FPG, 
fasting plasma glucose; CVD, cardiovascular disease; CHD, coronary heart disease; IHD, ischemic heart disease; NA, not available; HF, heart 
failure; ICAS, intracranial arterial stenosis; VTE, venous thromboembolism; AF, atrial fibrillation. 
“+”, “-” and “+/-” indicate significant, non-significant, and inconsistent associations, respectively. The association between physical activity and 
stroke prevalence was not available because all the participants were having ideal physical activity status. 
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    Two studies have provided the sex and age-specific associations between those metrics and ICAS 
145 and AF 153 prevalence. As a result, smoking is significant ICAS risk factors in males and older 
adults (≥ 60 years) instead of in females and younger adults (40-59 years). Elevated TC was a 
significant ICAS risk factor in males, but the association disappeared in females. The other metrics 
have similar effects on ICAS prevalence for sex and age subgroups. For AF prevalence, sufficient 
physical activity could significantly reduce the AF risk for females and older adults (60-82 years), 
whereas it is not significant for males and younger adults (40-59 years). Ideal dietary pattern could 
lead to AF prevalence reduction in males instead of in females and optimal FPG could reduce AF 
risk in younger adults rather than in older adults. There are not apparent age and sex disparities for 
other metrics. 
Discussion 
    Our study, based on included cohort and cross-sectional studies, reached a consistent conclusion 
that greater number of the ideal CVH metrics was associated with significant risk reductions in not 
only overall CVD but also in specific types of CVD. For each CVH metric, there exist association 
magnitude variances with different CVD outcomes. 
    The findings of an inverse relationship between the ideal CVH metrics number and CVD risk 
were consistent with previous reports. A recent meta-analysis indicated that, compared to the 
subjects in the lowest CVH categories, those in the highest CVH categories have 70%, 78%, and 
67% reduced risk of CVD mortality, CVD events, and stroke events. 148 In a Chinese cohort study 
with nearly 0.5 million participants, having an optimal status of 5 or 6 lifestyle factors, compared to 
having 0 optimal lifestyle factor, were associated with 63%, 50%, and 50% reduced risk of major 
coronary heart events, IHD events, and ischemic stroke events, respectively. 5 A cohort study, 
conducted in 84537 women in the United States, observed that 4 lifestyle factors (smoking, dietary 
pattern, BMI, and physical activity) could explain 77% of HF risk. 156 Furthermore, we found a 
dose-response fashion between the number of ideal CVH metrics and CVD risk in most included 
studies, indicating even minor improvement in the CVH status could result in benefits of CVD risk. 
Thus, initiating multiple lifestyle interventions in the general population level could bring about 
substantial improvement in the CVH distribution. 
    Another striking finding is individual metrics displayed different association strength regarding 
different CVD outcomes. For example, ideal BMI could lead to a significant reduction in overall 
CVD incidence, 29, 149 while the association disappeared for AF prevalence. 153 One possible 
explanation is the risk factor profile disparities for various types of CVD. A recent meta-analysis 
also supports the hypothesis, which identified processed meat intake as a significant risk factor of 
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CHD instead of stroke. 157 Another possible explanation is the limited available data, especially for 
some less prevalent types of CVD. As shown, only less than ten studies have focused on the CVD 
outcomes other than overall CVD, CHD/IHD, or stroke. While, there are numerous CVD related 
outcomes, as indicated by the AHA’s guideline. 7 Understanding the association between the CVH 
metrics and those CVDs could facilitate the prevention and treatment of those conditions and, thus, 
finally reduce the overall CVD burden. 
    We also observed the sex and age differences in the association between the CVH metrics and 
CVD risk. The specific sex and age CVD risk factor profiles, which have been suggested by 
previous studies, may partly account for the phenomenon. The China Kadoorie Biobank Study 
revealed that the association and contribution of uncontrolled hypertension to vascular mortality 
were more pronounced in younger adults (35-59 years) than in older adults (60-79 years). 158 A 
review indicated that the effects of smoking and diabetes on CHD risk were greater in women than 
in men, whereas the impact of elevated BMI was more obvious in men instead. 159 Given the 
situation, studies are needed on how to implement sex and age specific prevention and treatment 
strategies to maximize the CVH benefits. 
    One strength of our study is the inclusion more recent studies on the relationship between AHA’s 
CVH metrics and CVD outcomes. Another advantage is the exploration of age/sex distinctions in 
the association pattern. Our study also has several limitations. First, there exists some variances in 
the population characteristics, in terms of age, sex, and socioeconomic status, as well as 
measurements of the CVH metrics and outcomes. Second, some other lifestyle factors, like alcohol 
intake, were not included in our analysis. Third, there are significant heterogeneity in the 
measurements of outcomes and metrics, which precluded the calculation of pooled effect sizes. For 
example, some studies strictly followed the AHA’s definition of dietary pattern, 69, 143, 160 while 
others only included a few components of the AHA’s definition. 30, 151 
Conclusion 
    Our study demonstrated that higher number of the ideal CVH metrics was associated with 
substantial CVD reductions. We also observed that, for each metric, the effect magnitudes on 
different CVD outcomes varied. The impacts of the CVH metrics on some less prevalent types of 
CVD are still poorly understood. 
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Chapter 4 – The CVH status in Australian adults 
 
    As described in Chapter 2, the overall CVH is poor worldwide and there existed disparities 
regarding the proportion of ideal status for the seven metrics. In addition, we also observed regional 
variations in the CVH status. However, very few studies have explored the CVH status in 
Australian adults. Since CVD is a great health burden in Australia, understanding the CVH status in 
Australian adults has significant benefits for health promotion. In this chapter, we measured the 
CVH status in Australian adults using the core sample of the 2011-2012 AHS. Furthermore, we 
conducted subgroup analyses by sex and age. The chapter addressed the research objective 3 of the 
thesis. 
    This chapter was formatted as the following publication: 
    Peng Y, Wang Z. Cardiovascular health status among Australian adults. Clinical Epidemiology 
2018; 10: 167-178. doi: 10.2147/CLEP.S155783. 
Contributor Statement of contribution 
Yang Peng (Candidate) Conception and design (80%) 
Data analysis and result interpretation (100%) 
Drafting of article (100%) 
Reviewing of article (40%) 
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Abstract 
Background: The AHA committee recently set a guideline to define and monitor the CVH status. 
The current study is to estimate the CVH status among Australian adults using the guideline. 
Methods: We used data from a nationally representative sample of 7499 adults (age ≥ 18 years) 
from the 2011-2012 AHS. We applied the modified AHA’s definition to estimate the ideal 
proportions of the seven metrics and the overall CVH status.    
Results: Ideal status was most prevalent for FPG (83.6%) and least observed for dietary pattern 
(4.8%). The estimated percentages of the overall poor (having 0-2 ideal metrics) and ideal CVH 
(having 5-7 ideal metrics) were 39.85% and 18.72% in Australian adults. There exist some age and 
sex variations for the ideal status of individual metric and the overall CVH. 
Conclusion: The percentage of the overall ideal CVH in Australian adults is extremely low. Public 
health policies should be implemented to improve the population-wide CVH status in Australia. 
Keywords: cardiovascular health, Australian adults, cross-sectional study, risk factors 
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Introduction 
    Although a recent report has indicated the CVD mortality declined, 161 CVD is still a leading 
cause of deaths over time. 19 In 2013, CVD contributed to > 17 million deaths globally, with an age-
standardized death rate of 293.2 per 100000. 19 Previous studies have identified the substantial role 
of modifiable factors in CVD prevention. Among 42847 men aged 40 to 75, Chiuve et al 137 defined 
5 healthy lifestyle factors, including being a non-smoker, having a BMI < 25 kg/m2, taking 
moderate to vigorous physical activity for at least 30 minutes daily, consuming 5-30 g of alcohol 
daily, and having a healthy diet. After 16 years of follow-up, each of the five factors was associated 
with a substantially lower risk of CHD incidence. In addition, 62% of coronary events may have 
been prevented by better adherence to these lifestyle factors. 137 In the NHANES, participants with 
untreated BP <120/<80 mmHg and untreated glycated hemoglobin < 5.7% had 36% and 29% lower 
risk of CVD mortality, respectively. In this context, the AHA has set the following goals for 2020: 
“by 2020, to improve the CVH of all Americans by 20% while reducing deaths from CVD and 
stroke by 20%”. 7 In the meanwhile, the AHA identified seven modifiable metrics, called Life’s 
Simple 7, to define and monitor the CVH status and prompt the achievement of the 2020 goals. 
Life’s Simple 7 consisted of BMI, physical activity and dietary pattern as health behaviors, TC, BP 
and FPG as health factors and smoking as both health behavior and health factor. 7 Several recent 
studies have observed the separate and combined effects of Life’s Simple 7 on the reductions of 
CVD mortality, 30, 144 incidence, 150 and presence. 162 There are also a number of reports on the CVH 
status. 49, 55, 58, 163 
    Australia is also suffering from the enormous burden of CVD in terms of death, hospitalization, 
and incidence. CVD attributed to 46106 deaths, nearly one third of the total deaths, among 
Australians in the year of 2009. 2 In Australia from 2009 to 2010, there were almost 0.5 million 
hospitalizations with a principal diagnosis of CVD. 2 It has reported that one out of five Australians 
aged 45 to 74 years had a high risk of CVD event in the subsequent 5 years. 164 Another large-scale 
study based on Australians aged 45 or over observed that 22% of participants have a prior history of 
CVD. 3 Therefore, obtaining the national data for the CVH status is crucial in Australia, while such 
data has been limited until now. 
    In the current study, we used data from a nationally representative survey, the 2011-2012 AHS, 
to evaluate the status of the CVH in Australian adults. We hypothesized that the Australian adults 
are suffering from the poor CVH status. Young and females may have better CVH status. 
Methods 
Study design and subjects  
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    The current study was based on the core sample of the 2011-2012 AHS, which was a national 
wide and population-based combined sample of three surveys: National Health Survey (NHS), 
National Nutrition and Physical Activity Survey (NNPAS), and National Health Measures Survey 
(NHMS). Australian Bureau of Statistics (ABS) organized the three surveys. NHS and NNPAS 
used complex, multistage and probability sampling design to select usual residents from private 
dwellings in urban and rural areas of all states and territories in Australia, covering about 97% of 
the people living in Australia. Overseas visitors staying or intending to stay in Australia for 12 
months or more were also in scope. Households in Very Remote areas of Australia and discrete 
Aboriginal and Torres Strait Islander communities were excluded. All participants aged 12 or over 
and aged 5 or over in both NHS and NNPAS were asked to voluntarily provide fasting blood 
samples and urine samples, which constituted the NHMS. The 2011-2012 AHS core sample 
combined subjects from NHS and NNPAS and contained variables that co-existed in the two 
surveys. Biomedical results from NHMS were also included. The core sample consisted of 24910 
adults (≥ 18 years old) and the present study restricted those who voluntarily participated in both 
TC and FPG tests (n=7499), yielding an overall response rate of 30.1%.  
All participants provided written informed consent and our study was approved by The School of 
Medicine Low Risk Ethical Review Committee at the University of Queensland (approval number 
2016-SOMILRE-0161). 
Data collection 
    Trained interviewers obtained the NHS and NNPAS information through face-to-face Computer 
Assisted Personal Interview. For the 24-hour dietary recall collection, Computer Assisted 
Telephone Interview was used. Participants provided their biomedical samples to the convenient 
collection centers and Sonic Healthcare processed those samples. 
    Smoking status was based on participants’ self-reported currently, ever or never smoke. Height 
and weight were measured during the interview and BMI was computed as weight in kilograms 
divided by height in meters squared. ABS staff used a series of questions to obtain the physical 
activity that the subjects undertook in the last week and calculated the total minutes of moderate and 
vigorous physical activity. To assess the fruits and vegetables consumption, participants were asked 
to report the number of vegetables and fruits serves they usually ate each day. For BP, interviewers 
undertook two BP readings using an automated BP monitor in which systolic and diastolic 
pressures were displayed. If the difference between the readings was greater than 10 mm Hg, for 
either the diastolic or systolic, a third reading was taken. If there were three readings, the average of 
the second and third readings was used for the analysis. For those with one and two readings, the 
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first and second readings were utilized, respectively. Serum TC was measured by using the 
Cholesterol Oxidase method and analyser Architect ci16200. Additionally, participants were asked 
whether taking lipid-lowing medications or not. FPG was assessed by using Hexokinase method 
and analyser Integra 800. 
Life’s Simple 7 
    We adopted the AHA’s definition of Life’s Simple 7 based on our dataset structure and the 
modified definition was detailed in Table 4.1. The overall poor and ideal CVH were defined as 
having 0-2 and 5-7 ideal CVH metrics. 84 
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Table 4.1 The modified definition of the CVH metrics in the present study. 
Metrics Ideal status Unideal status 
Smoking status Never smokers Current and former smokers 
BMI < 25 kg/m2 ≥ 25 kg/m2 
Physical activity ≥ 150 min/week moderate or ≥ 75 min/week vigorous or 
≥ 150 min/week moderate + vigorous 
< 150 min/week moderate, < 75 min/week vigorous and 
< 150 min/week moderate + vigorous 
Dietary pattern Having met the fruits and vegetables intake requirement 
defined by 2013 Australian Dietary Guidelines 
Having not met the fruits and vegetables intake 
requirement defined by 2013 Australian Dietary 
Guidelines 
BP Systolic BP < 120 mm Hg and diastolic BP < 80 mm Hg Systolic BP ≥ 120 mm Hg and/or diastolic BP ≥ 80 mm 
Hg 
TC < 200 mg/dL and not taking cholesterol-lowing 
medication 
≥ 200 mg/dL and/or taking cholesterol-lowing 
medication 
FPG < 100 mg/dL  ≥ 100 mg/dL 
Abbreviations: CVH, cardiovascular health; BMI, body mass index; BP, blood pressure; TC, total cholesterol; FPG, fasting plasma glucose. 
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Statistical analysis 
    We compared the demographic and CVH metrics, except for TC and FPG, between the 
participants and non-participants using person weight and jackknife method. Proportions and 
corresponding CIs of ideal status for each metric were calculated in the total population as well as 
by sex and age, categorized as young adults (ages 18-39 years), middle-aged adults (ages 40-59 
years), and older adults (ages ≥ 60 years), subgroups. Proportions and CIs of the number of the ideal 
CVH metrics from 0 to 7 were also computed in the overall population and subgroups. Participants 
with available CVH metrics were included in ideal proportion estimates for specific metrics. 
Participants with complete information on all CVH metrics were included for proportion estimates 
of the numbers of the ideal CVH metrics. Survey-based chi-square tests were conducted to make 
comparisons between subgroups. Weights were applied to account for the sampling strategy and 
represent the overall Australian adults. Since our study based on those with biomedical samples, we 
used biomedical weights as recommended by ABS. In addition, we used the jackknife method to 
estimate the sampling error.  
    All the analyses were performed in the ABS Remote Access Data Laboratory (RADL) and we 
used Stata version 10.0, which is the available software of RADL. A two-tailed P-value < 0.05 was 
considered statistically significant. 
Results 
    The comparisons of the characteristics of participants and non-participants are listed in Table 
4.2. The distributions of the seven CVH metrics in the total population and subgroups are displayed 
in Table 4.3. In the overall population, the weighted proportions of the ideal CVH metrics were as 
follows: FPG, 83.6%; smoking, 55.6%; TC 45.5%; BP, 44.2%; BMI, 39.2%; physical activity, 
26.7%; and dietary pattern 4.8%. Men and women have similar ideal proportions regarding the TC 
(P = 0.70). A significantly higher proportion of males had ideal physical activity compared with 
females (P < 0.01). More women than men met the favorable status of the other five metrics (P < 
0.01). The distinctions in the ideal proportions of these metrics were also noted across the three age 
groups. There is an increasing trend regarding the ideal proportion of dietary pattern with aging 
(P=0.01), whereas the tendency was reversed for the other six metrics (P < 0.01). 
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Table 4.2 Comparisons of demographics and CVH metrics between participants and non-participants. 
Items Participants (%)* Non-participants (%)*    P* 
Smoking, ideal         53.3           50.2 < 0.01 
BMI, ideal         35.5           38.0    0.01 
Physical activity, ideal         24.3           24.3    0.98 
Dietary pattern, ideal           5.2             3.9 < 0.01 
BP, ideal         40.8           43.0    0.01 
Age, < 60 years         68.0           78.7 < 0.01 
Sex, male         48.2           49.8    0.07 
Education, high         52.2           54.4    0.02 
Income, high         50.6           51.7    0.31 
Region   < 0.01 
  Major cities         69.0           72.2  
  Inner regional         22.2           17.8  
  Other           8.8           10.0  
Abbreviations: BMI, body mass index; BP, blood pressure. 
* Weighted prevalence and chi-square tests using person weight. 
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Table 4.3 Weighted proportions of the CVH metrics in Australian adults. 
Metrics Total Males Females Young Middle-aged Older 
 n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) 
Smoking status           
Ideal 3762 55.6 (54.0-57.2) 1420 49.8 (47.7-52.0) 2342 61.1 (58.7-63.5) 1146 64.8 (62.2-67.5) 1375 49.5 (47.1-51.9) 1241 49.0 (46.3-51.8) 
Unideal 3737 44.4 (42.8-46.0) 1909 50.2 (48.0-52.3) 1828 38.9 (36.5-41.3)   743 35.2 (32.5-37.8) 1559 50.5 (48.1-52.9) 1435 51.0 (48.2-53.7) 
BMI           
Ideal 2395 39.2 (37.3-41.1)   833 32.3 (29.6-35.0) 1562 46.2 (43.7-48.6)   873 53.7 (50.0-57.4)   877 30.9 (28.7-33.1)   645 27.2 (25.0-29.5) 
Unideal 4732 60.8 (58.9-62.7) 2388 67.7 (65.0-70.4) 2344 53.8 (51.4-56.3)   916 46.3 (42.6-50.0) 1927 69.1 (66.9-71.3) 1889 72.8 (70.5-75.0) 
Physical activity           
Ideal 1774 26.7 (25.2-28.3)   945 32.7 (30.4-35.1)   829 20.9 (18.9-22.9)   630 35.4 (32.3-38.5)   690 23.9 (21.7-26.1)   454 16.6 (14.7-18.5) 
Unideal 5721 73.3 (71.7-74.8) 2382 67.3 (64.9-69.6) 3339 79.1 (77.1-81.1) 1257 64.6 (61.5-67.7) 2243 76.1 (73.9-78.3) 2221 83.4 (81.5-85.3) 
Dietary pattern           
Ideal   434       4.8 (4.1-5.4)     93       2.1 (1.5-2.6)   341       7.4 (6.2-8.6)     73       3.7 (2.3-5.1)   150       4.5 (3.5-5.5)   211       6.9 (5.7-8.2) 
Unideal 7065 95.2 (94.6-95.9) 3236 97.9 (97.4-98.5) 3829 92.6 (91.4-93.8) 1816 96.3 (94.9-97.7) 2784 95.5 (94.5-96.5) 2465 93.1 (91.8-94.3) 
BP           
Ideal 2828 44.2 (42.8-45.7) 1047 36.7 (34.3-39.2) 1781 51.6 (49.6-53.6) 1114 61.2 (58.5-63.8) 1120 40.0 (37.6-42.4)   594 21.9 (19.5-24.3) 
Unideal 4393 55.8 (54.3-57.2) 2189 63.3 (60.8-65.7) 2204 48.4 (46.4-50.4)   714 38.8 (36.2-41.5) 1713 60.0 (57.6-62.4) 1966 78.1 (75.7-80.5) 
TC           
Ideal 2827 45.5 (43.8-47.2) 1259 45.1 (42.8-47.5) 1568 45.8 (43.4-48.2) 1210 66.8 (63.6-69.9) 1036 36.1 (33.3-39.0)   581 23.9 (21.7-26.0) 
Unideal 4672 54.5 (52.8-56.2) 2070 54.9 (52.5-57.2) 2602 54.2 (51.8-56.6)   679 33.2 (30.1-36.4) 1898 63.9 (61.0-66.7) 2095 76.1 (74.0-78.3) 
FPG           
Ideal 5939 83.6 (82.5-84.8) 2426 79.4 (77.7-81.2) 3513 87.7 (86.5-89.0) 1771 94.6 (93.5-95.8) 2391 81.6 (79.4-83.9) 1777 68.4 (66.0-70.8) 
Unideal 1560 16.4 (15.2-17.5)   903 20.6 (18.8-22.3)   657 12.3 (11.0-13.5)   118       5.4 (4.2-6.5)   543 18.4 (16.1-20.6)   899 31.6 (29.2-34.0) 
Abbreviations: CVH, cardiovascular health; BMI, body mass index; BP, blood pressure; TC, total cholesterol; FPG, fasting plasma glucose. 
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Only 0.15% of the total adults had all 7 ideal CVH metrics and the percentages are low across all 
the subgroups (Figures 4.1, 4.2 and 4.3). 18.72% of participants had 5 to 7 ideal CVH metrics and 
the proportions varied by sex and age. It was 22.37% for women, 15.12% for men, 36.14% for 
young adults, 9.20% for middle-aged population, and 3.36% for older adults. 39.85% of participants 
had 0 to 2 ideal CVH metrics and it also varied by sex and age. It was 34.25% for women, 45.39% 
for men, 18.24% for young adults, 48.2% for middle-aged population, and 63.94% for older adults. 
Both males and females most commonly had 2 to 3 ideal components. Young adult subjects most 
frequently had 4 to 5 ideal metrics, whereas middle-aged and older subjects most frequently had 2 
to 3 and 1 to 2 ideal metrics, respectively. 
Figure 4.1 Weighted proportions of subjects with different numbers of ideal CVH metrics in 
the overall population. Error bars indicate 95% CIs. Abbreviations: CI, confidence interval; 
CVH, cardiovascular health. 
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Figure 4.2 Weighted proportions of subjects with different numbers of ideal CVH metrics, 
stratified by sex. Error bars indicate 95% CIs. Abbreviations: CI, confidence interval; CVH, 
cardiovascular health. 
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Figure 4.3 Weighted proportions of subjects with different numbers of ideal CVH metrics, 
stratified by age. Error bars indicate 95% CIs. Abbreviations: CI, confidence interval; CVH, 
cardiovascular health. 
 
 
Discussion 
    To the best of our knowledge, the current study is the first to assess the CVH status, defined by 
the guidelines of AHA, in Australian adults using a nationally representative sample. There is a 
substantial difference between the ideal percentages of the seven metrics. Additionally, we observed 
a very low percentage of the ideal CVH. 
    Among the seven metrics, FPG (83.6%) and smoking (55.6%) were with the highest proportions 
of ideal status. In contrast, very few participants have the ideal dietary pattern (4.8%) and physical 
activity (26.7%) status. Generally, the ranking in our study is consistent with the findings of a 
systematic review, which summarized the prevalence estimates from ~30 US and non-US studies. 11 
The AHA Committee has reported that the estimated ideal percentages of the seven metrics among 
American adults: smoking status, 73%; BMI, 33%; physical activity, 45%; dietary pattern, < 0.5%; 
TC, 45%; BP, 42%; and FPG, 58%. 7 In comparison, Australians displayed higher percentages of 
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ideal BMI, dietary pattern and FPG and lower percentages of ideal smoking and physical activity. 
They have similar proportions of ideal TC and BP. 
We estimated that only 0.15% of Australian adults have ideal status on all of the seven metrics, 
and a number of studies from US, 12, 26, 27, 58 China 55, 80 and Korea 35 also reported the proportion of 
ideal status for all the seven metrics was below 1%. A large proportion, ~40%, of subjects have 
ideal status for ≤ 2 metrics, and it is generally consistent with two studies. 12, 27 However, several 
investigations reported higher 58, 143 or lower 30, 144 rates, indicating the possibilities of regional 
differences. Given the severe situation, AHA’s goal to improve the overall CVH by 20% by 2020 is 
tricky. 
Another interesting phenomenon is the age and sex distinctions in the CVH status. Middle-aged 
and older adult were more likely to consume sufficient fruits and vegetables when compared to 
younger adults. A possible explanation is participants in those two groups were tend to have higher 
income, which was positively associated with fruits’ and vegetables’ consumption. 165 Younger 
adults demonstrated better status in other six metrics as well as the overall CVH status. Thus, it is 
urgent to promote the CVH status in middle- and older-aged individuals as adhering and 
maintaining a healthy lifestyle has dramatic effects on CVD risk reduction among those age groups. 
137, 166 Females tend to take fewer physical activities than males do, and a relatively longer duration 
of TV viewing time among women may be partly responsible for the sex difference. 167 We 
observed larger proportions of ideal status for the other metrics, as well as greater number of ideal 
overall CVH status, among females when compared to males. Given the situation, the policy 
makers should pay more attention to the alarming CVH status of Australian males in order to close 
the sex gap.     
To our delight, some Australian research institutions have also recognized the significance of 
CVD prevention. The National Vascular Disease Prevention Alliance has updated the guidelines for 
the management of absolute CVD risk in 2012 and extended the age range, from 45 to 74 years to 
45 years or older, of eligible participants for CVD risk assessment. 10 The Australian Diabetes, 
Obesity and Lifestyle Study has explored the relationships between several risk factors, like longer 
television viewing time 167 and diabetes, 168 with CVD mortality in a large national cohort. Our 
findings have extended their efforts by including all adults, aged 18 years or older, and analysing 
the combined effects of multiple CVD contributors. Given the fact that only a small proportion of 
subjects, < 40% for all age and sex subgroups, were with 5-7 ideal CVH metrics, the population-
wide strategy should be promoted to shift the entire distribution of CVD risk. The low prevalence of 
ideal dietary pattern and physical activity suggests that we should put in more efforts to improve the 
status of these two metrics. Public awareness of CVD modifiable factors, promotion of laws and 
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regulations to restrict unhealthy food, as well as improvement of access to fitness facilities could be 
effective measures to enhance the overall CVH status among Australian adults.  
Several limitations of the current study should be considered. First, although our study was based 
on a nationally representative sample and used biomedical sampling weight, it may still have the 
risk of selection bias, as there are some differences for some demographic factors and CVH metrics 
between participants and non-participants (Table 4.2). Second, the current study was a cross-
sectional study and, thus, we cannot explore the temporal trend of the CVH status as well as Life’s 
Simple 7 and future CVD risk. Third, we were unable to take some other CVD influencing factors, 
such as menopause, into consideration due to limited variables and sample size. Fourth, our study 
only used one recall to measure dietary intake. Finally, we modified the AHA’s definition of CVH 
due to the data structures, and it may lead to some misclassifications. For instance, we only used 
fruits and vegetables to measure dietary pattern, as other dietary components defined by the AHA 
were not existed in our survey. 
Conclusion 
    Our study demonstrates that the prevalence of the ideal CVH is very low amongst Australian 
adults. The ideal status is less prevalent for some metrics, such as the dietary pattern and physical 
activity. Public health policies should be implemented to promote the overall CVH status. 
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Chapter 5 – The CVH status and CVD prevalence in Australian adults 
 
    Chapter 3 has summarized the findings on the associations between the CVH status the CVD 
risk. The separate effects of the CVH metrics on CVD risk are limited and inconsistent and the 
strength of association between the ideal CVH number and CVD risk varied by studies. Therefore, 
we illustrated the separate and combined associations between the CVH status and CVD prevalence 
in overall Australian adults using the core sample of the 2011-2012 AHS (Chapter 5.1). The sex and 
age variations in the magnitude of association were also explored (Chapter 5.2). This chapter 
addressed the research objective 4 of the thesis. 
5.1 The CVH status and CVD prevalence in the overall Australian adults 
 
    This section was formatted as the following publication: 
 
    Peng Y, Wang Z. Association of Life’s Simple 7 and presence of cardiovascular disease in 
general Australians. Open Heart 2017; 4(2): e000622. doi: 10.1136/openhrt-2017-000622.  
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Data analysis and result interpretation (100%) 
Drafting of article (100%) 
Reviewing of article (50%) 
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ABSTRACT 
Objective: The AHA developed Life’s Simple 7 to define and monitor the CVH, but their 
associations and contributions to CVD prevalence in general Australians are still unclear. Our study 
is to evaluate the separate and combined associations and contributions of Life’s Simple 7 and self-
reported CVD prevalence among Australians. 
Methods: We performed a cross-sectional study based on 7499 adults (≥18 years) who have tested 
for TC and FPG as part of the 2011-2012 AHS. The self-reported CVD prevalence was the outcome 
of our study, and it was based on the 10th version of International Classification of Diseases, codes 
I00-I99. Poisson regression analyses were used to estimate the incidence rate ratios (IRRs) and 
population attributable fractions (PAFs) of those metrics to CVD prevalence. Participants were 
classified into three CVH status groups based on the number of ideal metrics: poor (0-2), 
intermediate (3-4), and ideal (5-7). Logistic regression analyses were performed to illustrate the 
relationships between the overall CVH and CVD prevalence.  
Results: Two thousand one hundred (21.0%) participants had CVD. Smoking, elevated BMI, BP, 
TC, FPG, and physical inactivity were observed as significant indicators of CVD prevalence. 
Compared to the inadequate category, participants in the optimal and average category have a 66% 
[adjusted OR, 0.34; 95% CI, 0.22-0.54] and a 33% (adjusted OR, 0.67; 95% CI, 0.56-0.81) lower 
CVD prevalence. One more ideal metric was associated with a 21% reduced CVD prevalence 
(adjusted OR, 0.79; 95% CI, 0.73-0.84).  
Conclusions: We have identified several modifiable risk factors and contributors of CVD 
prevalence in general Australians. The improvement of the overall CVH may also reduce CVD 
prevalence. 
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KEY QUESTIONS 
What is already known about this subject? 
Life’s Simple 7 is associated with the CVD prevalence in US and some other regions. The 
magnitudes of individual and/or combined associations of Life’s Simple 7 varied across studies. 
What might this study add? 
Most factors of the Life’s Simple 7 and the overall CVH were significantly related to CVD 
prevalence in general Australians.  
How might this impact on secondary prevention of CVD? 
Life’s Simple 7 is an easily implementable tool in secondary prevention of CVD. Hence, doctors 
and other professionals can provide CVD prevention tips to CVD patients based on their Life’s 
Simple 7 status. 
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Introduction 
    CVD is still a leading cause of mortality and, in 2013, it contributed to over 0.8 million deaths in 
the USA. 169 According to the Global Burden of Disease Study, CVD accounted for more than 30% 
global overall deaths in 2013. 19 In Australia, CVD is also one of the major contributors to 
mortality. IHD, the most common type of CVD, ranked as the first cause of mortality among 
Australians. 170  
    To define and monitor the CVH in general Americans, the AHA released 7 modifiable 
cardiovascular behaviors [including smoking status, BMI, physical activity and dietary pattern] and 
factors [including smoking status (also treated as a behavior), TC, BP and FPG] and they are also 
called Life’s Simple 7. 7 To date, a number of studies have examined the individual and combined 
effects of Life’s Simple 7 on CVD risk. Several cohort studies have observed the significant graded 
relationship between the number of ideal CVH metrics and CVD incidence 143, 160 and CVD 
mortality. 35, 146 It is also reported that the ideal status of most CVH metrics were significantly 
associated with reduction of CVD mortality. 35, 146 However, few studies have explored the 
association between Life’s Simple 7 and CVD risk in Australian adults. 
    The present study used an Australian representative sample collected from the 2011-2012 AHS, 
aiming to clarify the individual and combined associations between Life’s Simple 7 and CVD 
prevalence. We hypothesized that there is a negative association between number of ideal CVH 
metrics and CVD prevalence in Australian adults, and most metrics were significantly associated 
with CVD prevalence. 
Methods 
Study design and subjects 
    We retrospectively analyzed data from the core sample of the 2011-2012 AHS, a national wide 
and population-based combined sample of three surveys: NHS, NNPAS, and NHMS, which 
included participants from the first two surveys who provided biomedical samples. ABS organized 
the three surveys. NHS and NNPAS used a stratified multistage random sample from private 
dwellings usual residents in urban and rural areas of all states in Australia, covering about 97% of 
the people living in Australia. Overseas visitors staying or intending to stay in Australia for 12 
months or more are in scope. Households in Very Remote areas of Australia and discrete Aboriginal 
and Torres Strait Islander communities were excluded. Trained interviewers obtained the NHS and 
NNPAS information through face-to-face Computer Assisted Personal Interview. For the 24-hour 
dietary recall collection, Computer Assisted Telephone Interview was used. All participants aged 12 
or over and aged 5 or over in both NHS and NNPAS were asked to voluntarily provide fasting 
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blood samples and urine samples, which constituted the NHMS, to the convenient collection centers 
and Sonic Healthcare processed the samples. The current NHS was the sixth in a series of regular 
population surveys and previous ones were conducted in 1989-90, 1995, 2001, 2004-05 and 2007-
08. NNPAS and NHMS were new surveys. NHS, NNPAS and NHMS were enumerated from 6 
March 2011 to 17 March 2012, 29 May 2011 to 9 June 2012 and March 2011 to September 2012, 
respectively. The core sample consisted of 24910 adults (≥ 18 years old) and age was determined by 
the NHS or NNPAS interview date. We restricted our study to those who voluntarily participated in 
both TC and FPG tests (n=7499), yielding an overall response rate of 30.1%. All participants 
provided written informed consent and our study was approved by The School of Medicine Low 
Risk Ethical Review Committee in the University of Queensland (approval number 2016-
SOMILRE-0161). 
Life’s Simple 7 
    All modifiable metrics were divided into ideal and non-ideal status. The detailed classification 
criteria were shown in Table 5.1. Based on the number of ideal metrics, participants were grouped 
into 3 CVH categories: poor (0-2), intermediate (3-4) and ideal (5-7). 171  
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Table 5.1 Definition of Life’s Simple 7 ideal and unideal status in our study. 
Factors Ideal Non-ideal 
Smoking Never smokers Current and former smokers 
BMI < 25 kg/m2 ≥ 25 kg/m2 
Physical activity* ≥ 150 min/week moderate or ≥ 75 min/week vigorous 
or ≥ 150 min/week moderate + vigorous 
< 150 min/week moderate, < 75 min/week vigorous 
and < 150 min/week moderate + vigorous 
Dietary pattern# Having met the fruits and vegetables intake requirement 
defined by 2013 Australian Dietary Guidelines 
Having not met the fruits and vegetables intake requirement 
defined by 2013 Australian Dietary Guidelines 
TC TC < 200 mg/dL and not taking cholesterol-lowing 
medication 
TC ≥ 200 mg/dL and/or taking cholesterol-lowing 
medication 
BP Systolic BP < 120 mm Hg and diastolic BP < 80 mm Hg Systolic BP ≥ 120 mm Hg and/or diastolic BP ≥ 80 mm Hg 
FPG < 100 mg/dL ≥ 100 mg/dL 
Abbreviations: BMI, body mass index; TC, total cholesterol; BP, blood pressure; FPG, fasting plasma glucose. 
* Moderate physical activity refers to any exercise that caused a moderate increase in heart rate or breathing (e.g. gentle swimming, social tennis, golf). 
Vigorous physical activity refers to any exercise that caused a large increase in heart rate or breathing (e.g. jogging, cycling, aerobics, competitive 
tennis). 
# The 2013 Australian Dietary Guidelines recommended at least 2 serves of fruits for all adults, 5 serves of vegetables for males aged over 70 and all 
females, 5.5 serves of vegetables for males aged between 51 and 70 and 6 serves of vegetables for males aged 50 or younger. 
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Outcome measurement 
    The self-reported CVD prevalence was based on the 10th version of International Classification 
of Diseases (ICD), codes I00-I99. To be more specific, our study treated angina, stroke, rheumatic 
heart disease, heart attack, HF, hypertension, hypotension, hardening of the 
arteries/atherosclerosis/arteriosclerosis, varicose veins, rapid or irregular 
heartbeats/tachycardia/palpitations and any other participant self-entered I00-I99 conditions as 
CVD. Respondents were asked whether a doctor or a nurse has ever told them that they have those 
conditions, respectively. They were asked whether they currently have the condition if they have 
chosen yes to any of them. Those who have been told and currently have at least one of the above 
conditions were regarded as positive for CVD prevalence in our study.  
Covariates 
    The following variables were adjusted as covariates in the present study: age (continuous), sex, 
education attainment, income status, and residence region. Education attainment was categorized as 
high (≥ 12 school years) and low (< 12 school years). Income status was evaluated by household 
income and dichotomized as low (≤ 50th percentile equivalised weekly household income) and high 
(> 50th percentile equivalised weekly household income). Residence region was classified into 
major cities, inner regional areas and other areas (outer regional and remote areas). 
Statistical analysis 
    Firstly, we used univariate and multivariate Poisson regression analysis to calculate crude 
(unadjusted) and adjusted IRRs and corresponding 95% CIs and, thus, to elucidate the association 
between preventable factors and CVD prevalence. 
    Secondly, we calculated the adjusted PAFs based on the following equation to measure the 
effects of each component on CVD reduction. 172 Pe is the prevalence of exposure and Rate Ratios 
(RRs) were replaced with adjusted IRRs. 
𝑃𝐴𝐹 =
𝑃𝑒 × (𝑅𝑅 − 1)
1 + 𝑃𝑒 × (𝑅𝑅 − 1)
 
    Thirdly, we calculated ORs using logistic regression analyses to explore the relationship between 
the overall CVH and CVD prevalence. Participants with missing values in one or more of Life’s 
Simple 7 components were not included in the analyses. 
    To infer results for the total in-scope population, we used biomedical weight and Jackknife 
method in the Life’s Simple 7 and CVD association analyses. All analyses were conducted within 
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the ABS’s RADL with Stata version 10.0. A two-sided P value < 0.05 was used to determine 
statistical significance. 
Results 
    For the 7499 participants, 2100 are positive for CVD, with a weighted prevalence of 21.0%. 
Among the 7 metrics, FPG has the highest weighted ideal proportion (83.6%), followed by smoking 
status (55.6%), TC (45.5%), BP (44.2%), BMI (39.2%), physical activity (26.7%), and dietary 
pattern (4.8%). The metrics and covariates details of the participants are summarized in Table 5.2. 
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Table 5.2 Characteristics of Life’s Simple 7 and covariates in the current study. 
Variables Status          With CVD       Without CVD                  Overall 
         n/N    %*          n/N    %*          n/N    %* 
Smoking Ideal   947/2100   47.2     2815/5399   57.8     3762/7499   55.6 
 Unideal 1153/2100   52.8     2584/5399   42.2     3737/7499   44.4 
BMI Ideal   462/1977   25.2     1933/5150   42.9     2395/7127   39.2 
 Unideal 1515/1977   74.8     3217/5150   57.1     4732/7127   60.8 
Physical activity Ideal   326/2099   16.0     1448/5396   29.6     1774/7495   26.7 
 Unideal 1773/2099   84.0     3948/5396   70.4     5721/7495   73.3 
Dietary pattern Ideal   141/2100     5.4       293/5399     4.6       434/7499     4.8 
 Unideal 1959/2100   94.7     5106/5399   95.4     7065/7499   95.2 
TC Ideal   506/2100   28.0     2321/5399   50.1     2827/7499   45.5 
 Unideal 1594/2100   72.0     3078/5399   49.9     4672/7499   54.5 
BP Ideal   523/2019   25.8     2305/5202   49.1     2828/7221   44.2 
 Unideal 1496/2019   74.2     2897/5202   50.9     4393/7221   55.8 
FPG Ideal 1376/2100   68.8     4563/5399   87.6     5939/7499   83.6 
 Unideal   724/2100   31.2       836/5399   12.4     1560/7499   16.4 
Age < 60 years   753/2100   40.8     4070/5399   84.7     4823/7499   75.5 
 ≥ 60 years 1347/2100   59.3     1329/5399   15.3     2676/7499   24.5 
Sex Male   952/2100   47.1     2377/5399   49.9     3329/7499   49.3 
 Female 1148/2100   52.9     3022/5399   50.1     4170/7499   50.7 
Education level High    682/2100   35.7     3051/5399   63.7     3733/7499   57.9 
 Low 1418/2100   64.3     2348/5399   36.3     3766/7499   42.1 
Income High   674/1918   36.1     2726/4899   57.9     3400/6817   53.2 
 Low 1244/1918   63.9     2173/4899   42.1     3417/6817   46.8 
Region Major cities 1184/2100   66.7     3378/5399   74.0     4562/7499   72.5 
 Inner regional   553/2100   23.1     1156/5399   18.7     1709/7499   19.6 
 Other   363/2100   10.1       865/5399     7.3     1228/7499     7.9 
Abbreviations: BMI, body mass index; TC, total cholesterol; BP, blood pressure; FPG, fasting plasma glucose; CVD, cardiovascular disease. 
* Weighted prevalence using biomedical weight. 
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    In the univariate analysis, all of the factors, except for dietary pattern, are positively associated 
with CVD prevalence. The relationships still exist after adjusted for covariates. High BMI (adjusted 
IRR: 1.37; 95% CI: 1.21-1.55, P<0.01), elevated FPG (adjusted IRR: 1.34; 1.21-1.49, P<0.01), 
elevated BP (adjusted IRR: 1.27; 1.10-1.47, P<0.01), physical inactivity (adjusted IRR: 1.23; 1.00-
1.52, P=0.049), elevated TC (adjusted IRR: 1.21; 1.06-1.38, P=0.01) and smoking (adjusted IRR: 
1.18; 1.04-1.34, P=0.01) are significantly associated with higher CVD prevalence (Table 5.3). We 
calculated adjusted PAFs to quantify the contributions of certain factors to CVD prevalence (Figure 
5.1). High BMI is the largest significant contributor to CVD prevalence, with adjusted PAF of 20%, 
followed by physical inactivity (15%), elevated BP (14%), elevated TC (12%), smoking (8%) and 
elevated FPG (7%). 
Table 5.4 displays the relationship between the number of ideal metrics and CVD prevalence. 
Compared to those in the poor category, those in the ideal category had a reduction of 66% in CVD 
prevalence (adjusted OR: 0.34; 95% CI: 0.22-0.54) and those in the intermediate category had a 
reduction of 33% in CVD prevalence (adjusted OR: 0.67; 95% CI: 0.56-0.81). On average, one 
more ideal metric was associated with a 21% reduced risk of CVD prevalence (adjusted OR: 0.79; 
95% CI: 0.73-0.84). 
 
Figure 5.1 Adjusted PAFs of the CVH metrics to CVD prevalence in the overall population. 
Abbreviations: TC, total cholesterol; FPG, fasting plasma glucose; CVH, cardiovascular 
health; CVD, cardiovascular disease. 
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Table 5.3 IRRs between the individual CVH metrics and CVD prevalence in the overall population. 
Variables Crude IRR (95% CI)       P Adjusted* IRR (95% CI)      P 
Smoking 1.40 (1.24-1.58) < 0.01 1.18 (1.04-1.34)    0.01 
Elevated BMI 1.92 (1.64-2.24) < 0.01 1.37 (1.21-1.55) < 0.01 
Physical inactivity 1.91 (1.59-2.30) < 0.01 1.23 (1.00-1.52)    0.049 
Unideal dietary pattern 0.88 (0.69-1.12)    0.29 1.13 (0.94-1.37)    0.19 
Elevated TC 2.14 (1.88-2.44) < 0.01 1.21 (1.06-1.38)    0.01 
Elevated BP 2.28 (1.96-2.66) < 0.01 1.27 (1.10-1.47) < 0.01 
Elevated FPG 2.32 (2.09-2.57) < 0.01 1.34 (1.21-1.49) < 0.01 
Abbreviations: IRR, incidence rate ratio; CVH, cardiovascular health; CVD, cardiovascular disease; BMI, body mass index; TC, total cholesterol; BP, 
blood pressure; FPG, fasting plasma glucose; CI, confidence interval. 
* Adjusted for age (continuous), sex, education attainment, income, and residence region. 
 
 
Table 5.4 ORs between the number of ideal metrics and CVD prevalence in the overall population. 
Ideal metrics number CVD cases/participants Crude OR (95% CI)      P Adjusted* OR (95% CI)      P 
0-2           1283/3342 Referent      -- Referent      -- 
3-4             585/2786 0.41 (0.35-0.48)  < 0.01 0.67 (0.56-0.81)  < 0.01 
5-7                 70/874 0.09 (0.06-0.14)  < 0.01 0.34 (0.22-0.54)  < 0.01 
One more ideal metric                  -- 0.60 (0.57-0.63)  < 0.01 0.79 (0.73-0.84)  < 0.01     
Abbreviations: OR, odds ratio; CVD, cardiovascular disease; CI, confidence interval. 
* Adjusted for age (continuous), sex, education attainment, income, and residence region. 
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Discussion 
    To the best of our knowledge, it is the first study that explored the individual and combined 
effects of Life’s Simple 7 on CVD prevalence among general non-indigenous Australians. We 
observed that raised BMI, physical inactivity, increased BP, unideal TC, smoking and elevated FPG 
are independent risk factors and contributors of CVD. Higher number of ideal metrics is associated 
with reduced CVD prevalence. 
High BMI was the largest contributor to CVD prevalence in our study. Several previous reports 
also identified overweight/obesity as a significant risk factor of CVD. 42, 173, 174 Moreover, it has 
reported that the prevalence of obese is still increasing over time. In Australia, the age-standardized 
obesity prevalence has more than doubled from 1980 to 2000. 175 Similar increased trends in 
overweight and/or obesity were also observed in adults from China, 176 USA, 177 Mongolia 178 and 
Polish. 179 Additionally, we noticed that unideal status of physical activity, BP, TC, smoking and 
FPG are also significant contributors to CVD prevalence in our study. Their roles in elevating the 
CVD risks were also been confirmed in a number of studies, 146, 174, 180, 181 which suggested the 
relevant intervention programs are needed to improve the CVH. 
Similar to our findings, two US studies also identified BMI as the most crucial contributor to 
coronary artery calcification 182, and VTE, 63 respectively, while a number of studies from USA, 30, 
36, 144, 171 China 42, 146, 174 and Korea 35 ranked unideal BP as the most significant contributor of CVD 
mortality, 30, 35, 144, 146, 171 CVD incidence 174 and stroke incidence. 36, 42 The inconsistency in 
rankings may suggestive of various risk factor patterns of different diseases and populations.   
Dietary pattern was not independently related to CVD reduction in the current study. Several 
studies have identified dietary pattern 174, 183, 184 as a CVD risk factors. However, some studies failed 
to reveal the association. 35, 36 A possible explanation of the conflicting findings may due to the 
various definitions of dietary pattern status in each study. Thus, more studies are warrant to test the 
relationship more accurately.    
   We have observed that CVD prevalence showed declining trends with increasing number of the 
ideal CVH metrics, behaviors and factors. Our findings are consistent with several studies, which 
also found the graded inverse relationship between favorable ideal metrics and CVD mortality 143, 
144, 146, 171 and incidence. 12, 36, 63, 180 Our results, along with those of previous studies, suggested that 
those factors may interrelate with each other and a small improvement of the CVH might have a 
dramatic reduction of CVD burden. 
There are some limitations to our study. First, it is a cross-sectional study and we are unable to 
examine temporality between Life’s Simple 7 and CVD incidence or mortality. More cohort studies 
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are needed to explore the causal relationship between Life’s Simple 7 and CVD incidence and 
mortality. Second, we used modified metrics definitions owing to the AHS dataset structures. For 
example, the AHA guideline included five components for dietary pattern. However, our study only 
included fruits and vegetables as other components were not available in our survey. Third, the 
CVD prevalence was self-reported, and it may not be completely accurate. Previous studies 
observed that, when compared between self-reported questionnaire and medical record data, there 
are fair to substantial agreement for MI 185-187 and stroke. 185, 186 Fourth, as most of the CVD types 
in our study were coded as other CVDs, we are unable to provide detailed prevalence and risk 
factors for certain types of CVDs. Fifth, the sample excluded those living in the very remote areas 
and indigenous communities, though their population proportion is very small. Although our 
findings are representative of the target population by using the biomedical weight, we may still 
have the risk of selection bias because there are some differences in demographic characteristics 
and CVH metrics between participants and non-participants (Table 4.2). Sixth, since the log-
binomial regression was not allowed in the ABS system, the usage of logistic/poisson regression 
may overestimate the association between the number of ideal CVH metrics and CVD prevalence.    
In summary, we identified BMI, increased BP, physical inactivity, unideal TC, smoking and 
elevated FPG as significant risk factors and contributors of CVD prevalence in the general 
Australians. The higher number of ideal Life’s Simple 7 metrics was associated with reduced risk of 
CVD. 
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5.2 The CVH status and CVD prevalence in the Australian sex and age subgroups 
 
    This chapter was based on a paper submitted: 
    Peng Y, Wang Z. Sex and age disparities in the association between cardiovascular health metrics 
and self-reported cardiovascular disease prevalence in Australian adults. Open Heart. 
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Abstract 
Background: The AHA outlined seven CVH metrics to define and monitor the CVH status. Our 
study aimed to evaluate the sex and age disparities in the association between these metrics and 
CVD prevalence using a nationally representative survey.  
Methods: We included 7499 adults (≥ 18 years) from the core sample of the 2011-2012 AHS. The 
exposures included seven CVH metrics and overall CVH status, defined by the number of ideal 
metrics. The outcome was the self-reported CVD prevalence. We calculated the IRRs and ORs to 
measure the associations between individual CVH metric/ the ideal metrics number and CVD 
prevalence in each sex and age subgroup and entered the interaction terms to compare the strengths 
of associations between subgroups. In addition, we obtained the PAFs to measure the contributions 
of CVH metrics to CVD prevalence in each age/sex subgroup. 
Results: The associations and contributions of elevated TC and BP to CVD prevalence were 
stronger in males than in males. Physical inactivity and unhealthy dietary pattern have stronger 
impacts on CVD prevalence in older and young adults, respectively. The association between ideal 
metrics number and CVD prevalence was more pronounced among males compared to females. 
Conclusion: We observed the sex and age variations in the magnitude of associations between 
CVH metrics and CVD prevalence. The findings need further explorations in large-scale 
prospective studies. 
Keywords: cardiovascular health, cardiovascular disease; sex; age 
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KEY QUESTIONS 
What is already known about this subject? 
► The CVH metrics were associated with CVD risk.  
► Little was known about the sex and age variations in the magnitude of the association. 
What does this study add? 
► Elevated BP, elevated TC, and the number of ideal metrics have greater impacts on CVD 
prevalence in males than females. 
► Physical inactivity has a stronger association with CVD prevalence in older adults. 
► The association between unhealthy dietary pattern and CVD prevalence was more obvious in 
young adults. 
How might this impact on clinical practice? 
► Sex and age-specific strategies should be developed and implemented to improve the CVH 
status. 
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Introduction 
    CVD is still one of the major contributors to health burden globally. CVD has contributed to over 
17.6 million deaths, almost one-third of all deaths, globally in 2016. 1 Previous studies suggested 
that a healthy lifestyle factors played a central role in the prevention of CVD. 5, 6 A study of The 
China Kadoorie Biobank reported that 67.9% of major coronary events were attributable to poor 
status of six lifestyle factors. 5 Similarly, a US study revealed that non-ideal status of six lifestyle-
related metrics was associated with more than 70% of CHD cases. 6 
    In this context, the AHA established the concept of CVH status. In addition, the AHA identified 
seven lifestyle-related behaviors and factors (smoking status, BMI, physical activity, healthy diet, 
TC level, BP level, and FPG level) to measure CVH status in the general subjects. 7 A number of 
studies reported that these metrics were significantly associated with CVD risk reduction. 91, 149, 151 
A European cohort observed the significant association between CVH status and incidence of CVD, 
CHD, and stroke. 149 A cohort study in US found the negative association between the number of 
CVH metrics and HF incidence. 91 An Australian cross-sectional study noticed the CVH metrics 
correlated to the CVD prevalence. 151 However, very few studies have focused on the impacts 
sex/age on the association strengths between CVH metrics and CVD risk. Identification of sex and 
age variances in the relationships between CVH metrics and CVD risk is crucial for prioritizing 
preventive strategies in sex and age subpopulations.  
    Our study aimed to elucidate the individual and combined associations between the CVH metrics 
and CVD prevalence in sex and age-specific populations. We hypothesized that the CVH metrics 
have greater impacts on CVD prevalence among males and older adults. We used a nationally 
representative sample, the core sample of the 2011-2012 AHS, to conduct our analyses.  
Methods 
Study design and participants 
Details of the study design and participants have been described previously. 151, 188 Briefly, our study 
used the core sample of the 2011-2012 AHS, a nationwide and population-based combined sample 
of three surveys: National Health Survey (NHS), National Nutrition and Physical Activity Survey 
(NNPAS), and National Health Measures Survey (NHMS), which included participants from the first 
two surveys who provided biomedical samples. NHS and NNPAS used a stratified multistage random 
sample from private dwellings usual residents in urban and rural areas of Australia. Overseas visitors 
staying or intending to stay in Australia for 12 months or more are in scope. Households in very 
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remote areas and discrete Aboriginal and Torres Strait Islander communities were excluded. Trained 
interviewers obtained the 24-hour dietary recall collection via computer-assisted telephone interview 
and other NHS and NNPAS information via face-to-face, computer-assisted personal interview. All 
participants aged 12 or over and 5 or over in both NHS and NNPAS were asked to voluntarily provide 
fasting blood samples and urine samples, which constituted the NHMS, to the convenient collection 
centres. As a number of participants have no information on TC and FPG, we restricted to adults (≥ 
18 years) with available data of TC and FPG tests, yielding to an overall sample size of 7499 and a 
response rate of 30.1%. According to the guideline of the survey, the analyses on the included subjects 
could be nationally representative of the health status of general Australians using the biomedical 
weight. A small proportion of participants have missing data on other metrics, and the group Jackknife 
weights could correct the possible non-response bias. The sample sizes for the associations between 
individual metrics and CVD prevalence ranged from 7127 to 7499. A total of 7002 participants have 
no missing data on all seven metrics, and they were included in the analyses between overall CVH 
status and CVD prevalence. Participants were classified into young (18-39 years), middle-aged (40-
59 years), and older (≥ 60 years) adults based on the age while taking the survey. All participants 
provided written informed consent, and our study was approved by The University of Queensland 
Medicine, Low & Negligible Risk Ethics Sub-Committee (approval number 2018000244). 
CVH metrics 
We divided all CVH metrics into ideal and non-ideal status (Table 5.5). 151, 188 We modified the 
definitions of ideal smoking, dietary pattern, BP and FPG due to the lack of information on the time 
since quit smoking, several dietary components, and medications on BP and FPG in our survey. On 
the interview date, information on smoking, physical activity, and cholesterol-lowering medication 
was collected through questionnaires. BMI and BP were measured by digital scales and automated 
BP monitor, respectively. The 24-hour dietary recall determined the dietary pattern. Blood samples 
were used for TC and FPG measurements, and they were measured by Cholesterol Oxidase assay 
and Hexokinase assay, respectively. Participants having 0-2, 3-4, and 5-7 ideal metrics were 
referred to as being in overall poor, intermediate, and ideal CVH status. 84 
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Table 5.5 Classifications of the seven CVH metrics in our study. 
Metrics Ideal Non-ideal 
Smoking Never smokers Current and former smokers 
BMI < 25 kg/m2 ≥ 25 kg/m2 
Physical activity ≥ 150 min/week moderate or ≥ 75 
min/week vigorous or ≥ 150 
min/week moderate + vigorous 
< 150 min/week moderate, < 75 
min/week vigorous and < 150 
min/week moderate + vigorous 
Dietary pattern Having met the fruits and vegetables 
intake requirement defined by 2013 
Australian Dietary Guidelines 
Having not met the fruits and 
vegetables intake requirement 
defined by 2013 Australian Dietary 
Guidelines 
TC < 200 mg/dL and not taking 
cholesterol-lowering medicine 
≥ 200 mg/dL and/or taking 
cholesterol-lowering medicine 
BP Systolic BP < 120 mm Hg and 
diastolic BP < 80 mm Hg 
Systolic BP ≥ 120 mm Hg and/or 
diastolic BP ≥ 80 mm Hg 
FPG < 100 mg/dL ≥ 100 mg/dL 
Abbreviations: CVH, cardiovascular health; BMI, body mass index; TC, total cholesterol; BP, 
blood pressure; FPG, fasting plasma glucose. 
 
Outcome measurement 
    The CVD prevalence was self-reported and based on the 10th version of International 
Classification of Diseases, codes I00-I99. To be more specific, participants were regarded as having 
a CVD condition if they had been told by a doctor or nurse that they had CVD and they currently 
have CVD while taking the survey. 
Covariates 
    The following variables were adjusted as they previously are shown to relate to CVD risk 189, 190 
and their information was available in our study: age (continuous), sex, education attainment, 
income status, and residence region. Education attainment was categorized as high (≥ 12 school 
years) and low (< 12 school years). Income status was evaluated by household income and 
dichotomized as low (≤ 50th percentile equivalised weekly household income) and high (> 50th 
percentile equivalised weekly household income). Residence region was classified into major cities, 
inner regional areas and other areas (outer regional and remote). 
Statistical analysis 
    Firstly, we compared CVD prevalence, ideal metrics, and covariates between sex and age groups 
using weighted chi-square tests.  
    Secondly, we explored the possible sex and age variations in the associations and contributions of 
individual metrics and CVD prevalence. We calculated IRRs and corresponding 95% CIs, using 
univariate and multivariate Poisson regression analysis, to elucidate the association between CVH 
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metrics and CVD prevalence in each sex- and age-specific group. Interaction terms between sex/age 
and metrics were included in the adjusted models to explore the potential sex/age differences in the 
association. 
    Additionally, we calculated adjusted PAFs and corresponding 95% CIs, for each sex and age 
group, based on the following equation to measure the impact of each metric on CVD prevalence 
reduction. Pe is the prevalence of non-ideal metric and RRs were replaced with adjusted IRRs. 
𝑃𝐴𝐹 =
𝑃𝑒 × (𝑅𝑅 − 1)
1 + 𝑃𝑒 × (𝑅𝑅 − 1)
 
    Thirdly, we calculated ORs and corresponding 95% CIs using logistic regression analyses to 
explore the relationship between overall CVH status, defined by the number of ideal metrics, and 
CVD prevalence in sex and age subgroups. Interaction terms between sex/age and the CVH 
categories/the ideal metrics number were included in the adjusted models. Participants with missing 
values in one or more of CVH metrics were not included in the analyses. 
To infer results for the in-scope population, we used biomedical weight, and group Jackknife 
method with 60 replicate weights in the analyses. All analyses were conducted within the ABS’s 
RADL with Stata 10.0. A two-sided P value < 0.05 was used to determine statistical significance. 
Results 
Baseline characteristics 
The baseline characteristics of the included participants were listed in Table 5.6. Overall, 
weighted 21.0% participants were positive for CVD prevalence (2100/7499). Males and females 
have similar CVD prevalence (20.0% versus 21.9%, P = 0.051) whereas there is a raising CVD 
prevalence with the increase of age (4.0% for young adults, 19.7% for middle-aged adults, and 
50.6% for older adults, P < 0.01). Females have markedly higher rates of ideal smoking, BMI, 
dietary pattern, BP, and FPG while having a lower rate of ideal physical activity compared with 
males. Females have higher proportions of middle-aged/older adults and lower income. There is no 
statistical differences regarding education status, residential region distribution, and ideal TC in 
both sexes. With the increase of age, there is a significantly higher prevalence of ideal dietary 
pattern and lower prevalence of ideal status for the other six metrics. Older adults tend to have a 
lower proportion of males, lower income, and lower education level and less likely to reside in 
major cities as compared to middle-aged and young counterparts. 
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Table 5.6 Baseline characteristics of the included participants. 
Metrics Status Males, n (%) Females, n (%)      P Young, n (%) Middle-aged, n (%) Older, n (%)        P 
CVD Yes     952 (20.0)      1148 (21.9)    0.051        104 (4.0)                649 (19.7)   1347 (50.6)   < 0.01 
 No   2377 (80.0)      3022 (78.1)     1785 (96.0)              2285 (80.3)   1329 (49.4)  
Smoking Ideal   1420 (49.8)      2342 (61.1) < 0.01    1146 (64.8)              1375 (49.5)   1241 (49.0)   < 0.01 
 Non-ideal   1909 (50.2)      1828 (38.9)       743 (35.2)              1559 (50.5)   1435 (51.0)  
BMI Ideal     833 (32.3)      1562 (46.2) < 0.01      873 (53.7)                877 (30.9)     645 (27.2)   < 0.01 
 Non-ideal   2388 (67.7)      2344 (53.8)       916 (46.3)              1927 (69.1)   1889 (72.8)  
Physical 
activity 
Ideal     945 (32.7)        829 (20.9) < 0.01      630 (35.4)                690 (23.9)     454 (16.6)   < 0.01 
 Non-ideal   2382 (67.3)      3339 (79.1)     1257 (64.6)              2243 (76.1)   2221 (83.4)  
Dietary pattern Ideal         93 (2.1)          341 (7.4) < 0.01          73 (3.7)                  150 (4.5)       211 (6.9)   < 0.01 
 Non-ideal   3236 (97.9)      3829 (92.6)     1816 (96.3)              2784 (95.5)   2465 (93.1)  
TC Ideal   1259 (45.1)      1568 (45.8)    0.70    1210 (66.8)              1036 (36.1)     581 (23.9)   < 0.01 
 Non-ideal   2070 (54.9)      2602 (54.2)       679 (33.2)              1898 (63.9)   2095 (76.1)  
BP Ideal   1047 (36.7)      1781 (51.6) < 0.01    1114 (61.2)              1120 (40.0)     594 (21.9)   < 0.01 
 Non-ideal   2189 (63.3)      2204 (48.4)       714 (38.8)              1713 (60.0)   1966 (78.1)  
FPG Ideal   2426 (79.4)      3513 (87.7) < 0.01    1771 (94.6)              2391 (81.6)   1777 (68.4)   < 0.01 
 Non-ideal     903 (20.6)        657 (12.3)         118 (5.4)                543 (18.4)     899 (31.6)  
Age 18-39 years     783 (41.4)      1106 (39.2)    0.01  1889 (100.0)                      0 (0.0)           0 (0.0)       NA 
 40-59 years   1295 (34.8)      1639 (35.5)             0 (0.0)            2934 (100.0)           0 (0.0)  
 ≥ 60 years   1251 (23.8)      1425 (25.3)             0 (0.0)                      0 (0.0) 2676 (100.0)  
Sex Male 3329 (100.0)              0 (0.0)     NA      783 (50.7)              1295 (48.8)   1251 (47.8)      0.01 
 Female           0 (0.0)    4170 (100.0)     1106 (49.3)              1639 (51.2)   1425 (52.2)  
Education 
level 
High   1620 (57.6)      2113 (58.1)    0.76    1474 (81.1)              1495 (51.9)     764 (28.3)   < 0.01 
 Low   1709 (42.4)      2057 (41.9)       415 (18.9)              1439 (48.1)   1912 (71.7)  
Income High   1642 (56.5)      1758 (49.9) < 0.01    1072 (60.8)              1699 (63.4)     629 (26.6)   < 0.01 
 Low   1441 (43.5)      1976 (50.1)       645 (39.2)                983 (36.6)   1789 (73.4)  
Region Major cities   2024 (72.0)      2538 (73.0)    0.71    1284 (79.0)              1728 (68.7)   1550 (67.2)   < 0.01 
 Inner 
regional 
    760 (20.0)        949 (19.2)       341 (15.1)                684 (21.9)     684 (23.7)  
 Other       545 (8.0)          683 (7.8)         264 (5.9)                  522 (9.4)       442 (9.1)  
Numbers and percentages were expressed as unweighted and weighted and P values were from weighted chi-square tests. Abbreviations:  CVD, 
cardiovascular disease; BMI, body mass index; TC, total cholesterol; BP, blood pressure; FPG, fasting plasma glucose; NA, not applicable. 
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Sex- and age-specific associations between individual metrics and CVD prevalence 
    Table 5.7 and figure 5.2 displayed the sex-specific IRRs and PAFs between individual CVH 
metrics and CVD prevalence, respectively. After adjusted for covariates, high BMI, elevated BP, 
and elevated FPG were significant CVD risk factors in both sexes. Smoking was associated with 
CVD prevalence for females only and elevated TC was associated with CVD prevalence for males 
only. The magnitude of associations, for elevated TC (P interaction < 0.01) and elevated BP (P interaction 
= 0.04), were stronger in males than in females. Among males, high BMI ranked first among the 
CVD contributions (PAF = 0.297), followed by elevated TC (PAF = 0.211), elevated BP (PAF = 
0.196), and elevated FPG (PAF = 0.061). High BMI was the most important CVD contributor for 
females (PAF = 0.130), followed by elevated BP (PAF = 0.130), smoking (PAF = 0.081), and 
elevated FPG (PAF = 0.066). 
    Table 5.8 and figure 5.3 displayed the age-specific IRRs and PAFs between individual CVH 
metrics and CVD prevalence, respectively. High BMI and elevated FPG were associated with CVD 
prevalence in both middle-aged and older participants. Smoking, elevated BP, and physical 
inactivity were significant CVD risk factors for young, middle-aged and older adults, respectively. 
The magnitude of associations between physical inactivity (P interaction < 0.01) and dietary pattern (P 
interaction < 0.01) and CVD prevalence were diverse between age subgroups. For young adults, 
smoking was the only CVD contributor, and it could explain around one-third of the CVD burden 
(PAF = 0.329). For middle-aged adults, elevated BP was the largest CVD contributor (PAF=0.318), 
followed by high BMI (PAF = 0.244) and elevated FPG (PAF = 0.095). Physical inactivity was the 
most significant CVD contributor for older adults (PAF = 0.240), followed by high BMI (PAF = 
0.112) and elevated FPG (PAF = 0.066). 
Sex- and age-specific associations between overall CVH status and CVD prevalence 
    Table 5.9 showed the association between overall CVH status and CVD prevalence in both 
sexes. We observed a significant dose-response relationship between the number of ideal CVH 
metrics and CVD prevalence in both sexes while it is more striking in males. Compared to the 
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participants with overall poor CVH status, those with overall intermediate and ideal CVH status, 
after adjusting for covariates, have a 39% and an 80% reduced CVD prevalence in males and a 26% 
and a 60% reduced CVD prevalence in females. One more ideal CVH metric was associated with a 
27% and a 17% reduced CVD prevalence in males and females, respectively. The analyses of 
interaction terms implied the impacts of overall CVH status on CVD prevalence were more 
pronounced among males than females (P = 0.01 for interaction between sex and CVH categories; 
P = 0.03 for interaction between sex and the ideal metric number). 
    The age-specific association between overall CVH status and CVD prevalence was shown in 
Table 5.9. We noticed a significant dose-response relationship between the ideal CVH metrics 
number and CVD prevalence in middle-aged and older adults instead of young adults. Compared to 
the subjects with overall poor CVH status, those with overall intermediate and ideal CVH status, 
after adjusting for covariates, have a 45% and a 55% reduced CVD prevalence in middle-aged 
adults and a 24% and a 76% reduced CVD prevalence in older adults. One more ideal CVH metric 
was associated with a 25% and an 18% reduced CVD prevalence in middle-aged and older adults, 
respectively. The findings of interaction terms suggested overall CVH status has a similar 
association with CVD prevalence for the three age groups (P = 0.99 for interaction between age and 
CVH categories; P = 0.88 for interaction between age and the ideal metric number). 
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Table 5.7 IRRs between the individual CVH metrics and CVD prevalence, stratified by sex. 
Metrics Population Crude IRR (95% CI)      P Adjusted IRR* (95% CI)      P Pinteraction 
Smoking Males 1.65 (1.36-1.99) < 0.01 1.12 (0.95-1.33)    0.18    0.68 
 Females 1.25 (1.05-1.48)    0.01 1.20 (1.02-1.42)    0.03  
High BMI Males 2.33 (1.80-3.01) < 0.01 1.57 (1.29-1.92) < 0.01    0.06 
 Females 1.75 (1.47-2.10) < 0.01 1.25 (1.05-1.49)    0.01  
Physical inactivity Males 2.10 (1.66-2.67) < 0.01 1.28 (0.99-1.64)    0.06    0.20 
 Females 1.69 (1.33-2.13) < 0.01 1.17 (0.91-1.50)    0.21  
Unhealthy dietary pattern Males 0.58 (0.40-0.84)    0.01 1.31 (0.90-1.90)    0.16    0.59 
 Females 1.06 (0.77-1.44)    0.73 1.08 (0.89-1.32)    0.43  
Elevated TC Males 2.18 (1.80-2.64) < 0.01 1.43 (1.21-1.70) < 0.01 < 0.01 
 Females 2.11 (1.75-2.56) < 0.01 1.06 (0.88-1.27)    0.55  
Elevated BP Males 2.14 (1.75-2.62) < 0.01 1.36 (1.15-1.61) < 0.01    0.04 
 Females 2.51 (2.11-2.99) < 0.01 1.27 (1.06-1.54)    0.01  
Elevated FPG Males 2.33 (1.99-2.73) < 0.01 1.24 (1.07-1.44)    0.01    0.59 
 Females 2.44 (2.11-2.83) < 0.01 1.45 (1.26-1.67) < 0.01  
*Adjusted for age (continuous), education attainment, income, and residence region. 
Abbreviations: CVH, cardiovascular health; CVD, cardiovascular disease; IRR, incidence risk ratio; CI, confidence interval; BMI, body mass index; 
TC, total cholesterol; BP, blood pressure; FPG, fasting plasma glucose. 
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Table 5.8 IRRs between the individual CVH metrics and CVD prevalence, stratified by age. 
Metrics Population Crude IRR (95% CI)      P Adjusted IRR* (95% CI)      P Pinteraction 
Smoking Young adults        1.79 (1.10-2.92)    0.02               2.25 (1.18-4.29)    0.02     0.49 
 Middle-aged adults        1.18 (0.95-1.46)    0.13               1.12 (0.91-1.38)    0.29  
 Older adults        1.05 (0.94-1.18)    0.36               1.05 (0.93-1.18)    0.42  
High BMI Young adults        1.70 (0.96-3.02)    0.07               1.42 (0.77-2.62)    0.26     0.45 
 Middle-aged adults        1.45 (1.14-1.85) < 0.01               1.47 (1.14-1.90) < 0.01  
 Older adults        1.17 (1.05-1.31)    0.01               1.17 (1.06-1.30) < 0.01  
Physical inactivity Young adults        1.03 (0.52-2.05)    0.93               0.76 (0.35-1.65)    0.48  < 0.01 
 Middle-aged adults        1.45 (1.05-2.02)    0.03               1.20 (0.84-1.70)    0.31  
 Older adults        1.38 (1.17-1.63) < 0.01               1.38 (1.15-1.65) < 0.01  
Unhealthy dietary pattern Young adults      1.66 (0.12-22.63)    0.70             1.50 (0.11-19.65)    0.75  < 0.01 
 Middle-aged adults        1.06 (0.64-1.76)    0.82               0.98 (0.60-1.59)    0.92  
 Older adults        1.09 (0.90-1.31)    0.37               1.14 (0.96-1.36)    0.14  
Elevated TC Young adults        1.63 (0.84-3.16)    0.14               1.43 (0.75-2.73)    0.28     0.81 
 Middle-aged adults        1.24 (0.95-1.60)    0.11               1.13 (0.87-1.48)    0.36  
 Older adults        1.08 (0.94-1.23)    0.29               1.08 (0.94-1.23)    0.28  
Elevated BP Young adults        1.27 (0.67-2.44)    0.46               1.35 (0.74-2.46)    0.32     0.23 
 Middle-aged adults        1.86 (1.48-2.34) < 0.01               1.77 (1.38-2.28) < 0.01  
 Older adults        1.01 (0.88-1.16)    0.89               0.95 (0.83-1.08)    0.41  
Elevated FPG Young adults        1.46 (0.52-4.09)    0.46               0.75 (0.13-4.41)    0.75     0.22 
 Middle-aged adults        1.74 (1.37-2.22) < 0.01               1.57 (1.24-2.00) < 0.01  
 Older adults        1.22 (1.09-1.36) < 0.01               1.21 (1.07-1.36) < 0.01  
*Adjusted for age (continuous), sex, education attainment, income, and residence region. 
IRR, incidence risk ratio; CVH, cardiovascular health; CVD, cardiovascular disease; CI, confidence interval; BMI, body mass index; TC, total 
cholesterol; BP, blood pressure; FPG, fasting plasma glucose. 
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Figure 5.2 Adjusted PAFs of the CVH metrics to CVD prevalence, stratified by sex. 
Abbreviations: PAF, population attributable fraction; CVH, cardiovascular health; CVD, 
cardiovascular disease. 
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Figure 5.3 Adjusted PAFs of the CVH metrics to CVD prevalence, stratified by age. 
Abbreviations: PAF, population attributable fraction; CVH, cardiovascular health; CVD, 
cardiovascular disease. 
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Table 5.9 ORs between the number of ideal metrics and CVD prevalence, stratified by sex and age. 
Participants Ideal metrics number CVD cases/participants Crude OR (95% CI)      P Adjusted* OR (95% CI)      P 
Males 0-2 654/1741           Reference     NA                  Reference     NA 
 3-4 219/1147       0.34 (0.25-0.45) < 0.01              0.61 (0.47-0.81) < 0.01 
 5-7     19/285       0.06 (0.03-0.13) < 0.01              0.20 (0.10-0.42) < 0.01 
 One more ideal metric          NA       0.56 (0.51-0.61) < 0.01              0.73 (0.66-0.82) < 0.01 
Females 0-2 629/1601           Reference     NA                  Reference     NA 
 3-4 366/1639       0.46 (0.38-0.57) < 0.01              0.74 (0.58-0.94)    0.02 
 5-7     51/589       0.11 (0.07-0.18) < 0.01              0.40 (0.23-0.70) < 0.01 
 One more ideal metric          NA       0.61 (0.57-0.66) < 0.01              0.83 (0.75-0.91) < 0.01 
Young 0-2     28/365           Reference     NA                   Reference     NA 
 3-4     50/864       0.94 (0.43-2.03)    0.86               1.20 (0.51-2.82)    0.67 
 5-7     15/536       0.42 (0.16-1.12)    0.08               0.38 (0.09-1.56)    0.18 
 One more ideal metric           NA       0.83 (0.66-1.03)    0.09               0.86 (0.68-1.09)    0.21 
Middle-aged 0-2  377/1343           Reference     NA                   Reference     NA 
 3-4  195/1164       0.53 (0.42-0.68) < 0.01               0.55 (0.42-0.73) < 0.01 
 5-7      35/256       0.34 (0.19-0.62) < 0.01               0.50 (0.27-0.93)    0.03 
 One more ideal metric            NA       0.73 (0.66-0.81) < 0.01               0.75 (0.67-0.85) < 0.01 
Older 0-2   878/1634           Reference     NA                   Reference     NA 
 3-4     340/758       0.75 (0.60-0.95)    0.02               0.76 (0.60-0.96)    0.02 
 5-7         20/82       0.24 (0.12-0.49) < 0.01               0.24 (0.10-0.58) < 0.01 
 One more ideal metric            NA       0.82 (0.75-0.89) < 0.01               0.82 (0.75-0.90) < 0.01 
*Adjusted for age (continuous), education attainment, income, and residence region for sex-specific population and additionally adjusted for sex for 
age-specific population.  
Abbreviations: OR, odds ratio; CVD, cardiovascular disease; CI, confidence interval; NA, not applicable. 
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Discussion 
    Our study indicated that elevated BP and TC were stronger CVD risk factors for males than for 
females. The associations and contributions of physical inactivity on CVD prevalence were more 
evident among older adults than did middle-aged and young adults. For unhealthy dietary pattern, 
although its association with CVD prevalence was non-significant in the three age subgroups, the 
strength of the association was stronger in young adults. We also observed that the association 
between the ideal metric number and CVD prevalence was more striking among men than among 
woman. 
    Based on the results of interaction terms and PAFs, our findings, together with that of a recent 
Chinese cohort study, 191 suggested that high BP was more harmful to males than females, which 
contradicted to previous studies that have reported similar association in both sexes 192 or stronger 
association in females. 193-196 One possible explanation of the different conclusions is the definitions 
of non-ideal BP status in each study. For instance, one study defined non-ideal BP as self-reported 
hypertension or BP ≥ 140/90 mm Hg 195 while our study used BP ≥ 120/80 mm Hg instead. Besides, 
our study did not include medication for high BP in the definition. We also noticed a stronger 
adverse influence of increasing TC level in men than in women, which was supported by recent 
studies. 193, 197 A recent cohort study also indicated the more pronounced effects of TC on MI in 
males (IRR: 1.19) than in females (IRR: 1.12). 193 A large-scale meta-analysis also observed a 
stronger effect of 1 mmol/L elevated TC in men (RR: 1.24) compared to women (RR: 1.20). 197 We 
found that the association between physical inactivity and CVD prevalence was more obvious 
among older adults compared to young and middle-aged adults (P for interaction < 0.01). Also, 
physical inactivity contributed to 24.0% CVD burden in older adults whereas it was not a 
significant CVD contributor in young and middle-aged adults. The greater impact of physical 
activity on CVD prevalence among older adults was in agreement with previous reports. 194, 195 The 
INTERHEART study observed that self-reported physical activity was associated with more 
significant reductions in the odds of MI in those aged 60 years or over compared to those younger 
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than 60 years and the age variances were consistent in both males and females. 194 The 
INTERSTROKE study revealed that self-reported physical inactivity was a slightly stronger stroke 
contributor in older adults (> 55 years) compared with young adults (≤ 55 years) (PAF: 35.9% 
versus 35.3%). 195 We reported that the magnitude of the association between dietary pattern and 
CVD prevalence was more apparent in young adults, although the association failed to reach a 
statistically significant level in all the three age groups. Similarly, a large-scale Chinese cohort 
indicated one daily portion of fresh fruit was associated with a 45% cardiovascular deaths reduction 
in those aged 35-59 years while the proportion reduced to 25% and 39% for those aged 60-69 years 
and 70-79 years, respectively. 198 Nevertheless, contradicted to our findings, another study revealed 
that diet played a more significant role in the development of stroke among older adults. 195 The 
variations in dietary pattern components and the age classifications across the studies could partly 
account for the inconsistent conclusions. Although we failed to detect the sex and age variations in 
the magnitude of associations and contributions between other CVH metrics and CVD prevalence, 
previous studies, however, suggested the existence of possible sex and/or age disparities. For 
example, two recent meta-analyses indicated that female smokers had a higher risk of CHD and 
stroke than male smokers did. 199, 200 The impact of high BMI on the risk of IHD and stroke, as 
reported by another study, has attenuated with age. 17 Hence, we still need further explorations for 
the sex and age-specific associations between CVH metrics and CVD risk to prioritize CVD 
prevention strategies. 
We observed that the increased ideal CVH metrics number was significantly associated with 
reduced CVD prevalence in most sex and age subgroups and the dose-response fashion was also 
noticed in a few recent meta-analyses. 14, 141 The number of ideal metrics has more significant 
influences on CVD prevalence in men compared with women in our study. Two studies indicated 
the association strengths between the number of ideal CVH metrics and HF incidence/asymptomatic 
ICAS prevalence were similar in both sexes 91, 145 whereas several studies found that males are more 
likely to influenced by the CVH metrics for CVD events 29, 150 and stroke. 42 The different risk 
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factor profiles of CVD subtypes, study designs (cohort versus cross-sectional), and outcomes 
(incidence/mortality versus prevalence) could partially explain the conflicting conclusions. Several 
sex-specific CVD risk factors may also contribute to the variations. For example, it has been 
reported that both gestational diabetes mellitus 201 and hypertensive disorders of pregnancy 202 could 
substantially raise the CVD risk in females. The findings of interaction terms indicated that the ideal 
metrics number has similar association with CVD prevalence across the three age subpopulations. 
Few studies focused on the age differences in the associations between the number of ideal CVH 
metrics and risk of CVD-related events while they reached inconclusive findings. 42, 91, 145 A cohort 
study in the US suggested that the ideal CVH metrics number played a stronger role in the risk of 
HF incidence among those aged < 65 years compared with those aged 65 or over. 91 A Chinese 
cross-sectional study indicated the impacts of CVH metrics number on asymptomatic ICAS 
prevalence was more evident in older adults (≥ 60 years) than in middle-aged adults (40-59 years). 
145 However, a Chinese cohort study demonstrated that the magnitude of the association between 
the CVH metrics number and stroke incidence was stronger in middle-aged adult (40-59 years) 
compared with older adults (≥ 60 years). 42 Thus, whether age played a role in the association 
between CVH metrics and CVD prevalence is still unclear, and the topic warrants further 
explorations. 
    To the best of our knowledge, our study firstly explored the possible sex and age variances in the 
associations between AHA’s CVH metrics and CVD prevalence in Australian adults. The present 
study was among one of the few studies that focused on the sex- and age-specific associations between 
CVH metrics and CVD risk globally. As CVD is the leading cause of deaths in Australia, 1 it could 
provide clues for the strategies of CVD risk reduction in Australian sex and age subgroups. The 
National Vascular Disease Prevention Alliance released the guidelines for CVD risk management in 
2012, and it focused on the Australian adults aged 45 or over and it lacked the detailed information 
on the measurements of CVH status in the general population. 10 Since our results showed that young 
adults are also suffering from poor CVH status, we recommend including young adults as a target 
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population for future CVD prevention guidelines. The AHA’s 2020 Impact Goal was not only used 
in the American subjects but also commonly used in populations across the world. 203 When compared 
to CVH status from adults worldwide, 203 the Australian adults have a lower prevalence of ideal status 
for most metrics, and poorer overall CVH status and the results were generally consistent in all age 
and sex subgroups. Since the AHA’s 2020 Impact Goal was to improve CVH of all Americans by 
20%, 7 the goal of CVH improvement should be even greater in Australia and, therefore, the 
promotion of modifiable lifestyles in the general Australian adults are urgently needed. Since the 
AHS excluded the indigenous Australians, we need more studies to describe CVH status and its 
association with CVD risk among indigenous communities. Additionally, more cohort studies and 
interventional studies should be implemented to estimate the long-term effects of those modifiable 
metrics on CVD risk.   
    We should notice some limitations to our study. Firstly, although we used a nationally 
representative sample and applied the biomedical weight, we may still suffer from the selection bias 
as we noticed the differences for some demographic factors and CVH metrics between participants 
and non-participants (Table 4.2). Secondly, our study was a cross-sectional study, and we could not 
establish the causal relationship between CVH metrics and CVD risk. It is unable to explore the sex 
and age disparities in the effects of CVH metrics on CVD incidence or mortality. It could also induce 
reverse causality as those diagnosed with CVD may take lifestyle modifications or medicines, and it 
may bias the associations between CVH metrics and CVD prevalence. Thirdly, we modified the 
classification criteria of some metrics, when compared to the AHA’s classifications, based on our 
dataset, which may lead to classification bias. Fourthly, as most of the CVD types in our study were 
coded as other CVDs, we are unable to provide age- and sex-specific prevalence and risk factors for 
CVD subtypes. Besides, we used self-reported CVD prevalence, and it may underestimate or 
overestimate the CVD prevalence. Other variables, including demographic factors, smoking, dietary 
pattern, and physical activity, were also self-reported and they may not be entirely accurate. 
CONCLUSIONS 
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Our results suggested that the associations and contributions of elevated BP, elevated TC and the 
ideal CVH metrics number on CVD prevalence were more pronounced in males than in females. 
Physical inactivity and dietary pattern played a more significant role in CVD prevalence among older 
and young adults, respectively. Population-based and sex/age-specific strategies should be 
implemented to promote CVH status and reduce the burden of CVD in Australian adults.  
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Chapter 6 – The CVH status and IHD prevalence in Australian adults 
    Chapter 3 has summarized the findings on the associations between the CVH status the IHD risk. 
As a result, few studies have focused on the effects of Life’s Simple 7 and IHD risk. Thus, we 
examined the separate and combined associations between the CVH status and IHD prevalence in 
overall Australian adults using the core sample of the 2011-2012 AHS (Chapter 6.1). The sex and 
age variations in the magnitude of the association were also explored (Chapter 6.2). This chapter 
addressed the research objective 5 of the thesis. 
6.1 The CVH status and IHD prevalence in the overall Australian adults 
 
    This section was formatted as the following publication: 
    Peng Y, Wang Z, Dong B, Cao S, Hu J, Adegbija O. Life's Simple 7 and ischemic heart disease 
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10.1371/journal.pone.0187020. 
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Abstract 
Background: The AHA released 7 modifiable factors, Life’s Simple 7, that are expected to 
improve the CVH, but their contributions to IHD prevalence in the general Australians are not well 
clarified. 
Methods: We performed a cross-sectional study based on 7499 adults (≥18 years) who have tested 
for TC and FPG as part of the 2011-2012 AHS. The exposures included seven CVH metrics and 
overall CVH status, defined by the number of ideal metrics. The outcome was the self-reported IHD 
prevalence. Poisson regression analyses were used to estimate the IRRs and PAFs of those factors 
to IHD prevalence. Participants were classified into three CVH groups based on the number of ideal 
metrics: inadequate (0-2), average (3-4), and optimal (5-7). Logistic regression analyses were 
performed to elucidate the relationship between the overall CVH and IHD prevalence. 
Results: 357 participants were self-reported having IHD condition, with a weighted prevalence of 
3.3%. Physical inactivity, elevated BMI and TC were independently associated with IHD 
prevalence. Compared to the inadequate category, participants in the optimal and average categories 
have a 78% (adjusted OR, 0.22; 95% CI, 0.03-1.96) and a 45% (adjusted OR, 0.55; 95% CI, 0.39-
0.77) lower IHD prevalence. One more optimal metric was associated with an 18% lower IHD 
prevalence (adjusted OR, 0.82; 95% CI, 0.71-0.93). 
Conclusions: Our findings indicate that physical inactivity, raised BMI, and elevated TC were 
independent modifiable risk factors of IHD prevalence in the general Australian population. The 
improvement of the overall CVH may also reduce IHD prevalence among the general Australian 
adults.
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Introduction 
    IHD, one of the most popular CVDs, accounted for 13.3% of global all-causes of death in 2010 
and the proportion has increased by more than one third compared to that in 1990. 170 IHD ranked 
first in causes of both death and years of life lost (YLLs) worldwide. 140 In Australia, IHD is also 
one of the leading contributors to mortality and YLLs. It was reported that 17.9% of all-cause 
mortality was due to IHD among Australians. 204 According to the 2013 Global Burden of Disease 
Study, IHD was the leading cause of YLLs in Australia. 19 
    To measure and improve the CVH in the general American population, the AHA recommended 
seven modifiable factors, also called Life’s Simple 7, namely are smoking status, BMI, physical 
activity, dietary pattern, TC, BP, and FPG. 7 In a nationally representative survey of US, most of the 
metrics were significantly associated with risk of IHD mortality and there is a negative association 
between the number of ideal metrics and IHD mortality. 30 The strong associations between Life’s 
Simple 7 and incidence of CHD, another term of IHD, are noticed in several cohort studies in 
Europe 84 and China. 113 The associations between Life’s Simple 7 and IHD risk were still not well 
examined in the general Australian adults. 
    Our current study was based on an Australian representative sample, the core sample of the AHS, 
aiming to clarify the separate and combined associations between Life’s Simple 7 and IHD 
prevalence. We hypothesized that, in Australian adults, most CVH metrics were associated with 
IHD prevalence and there is a negative association between number of ideal metrics and IHD 
prevalence. 
Subjects and Methods 
Study Design and Subjects 
    We used data from the core sample of the 2011-2012 AHS, a national wide and population-based 
survey consisting of three arms: a general health survey, a nutrition and physical activity survey, 
and a voluntary biomedical survey which included participants from the first two arms. The survey 
was conducted using a stratified multistage sample that is representative of the general Australian 
population. Households that were living in very remote areas of Australia and discrete Aboriginal 
and Torres Strait Islander communities were not in scope. The core sample consisted of 24910 
adults (≥ 18 years old). We restricted our study to those with TC and FPG (n=7499). All 
participants provided written informed consent and our study was approved by The School of 
Medicine Low Risk Ethical Review Committee in the University of Queensland (approval number 
2016-SOMILRE-0161). 
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Life’s Simple 7 
    Individual modifiable factors were categorized as ideal and unideal, respectively. For smoking 
status, the participants were categorized into current/former smokers (unideal) and never smokers 
(ideal). For BMI status, participants were classified into the ideal category if they had BMI values 
less than 25 kg/m2. Participants were regarded as having an ideal physical activity status if they had 
taken 150 minutes moderate, 75 minutes vigorous or 150 minutes combined moderate and vigorous 
physical activity last week. We included two dietary factors, usual daily intake of fruits and 
vegetables, in our analyses. Participants were categorized as having an ideal dietary pattern if they 
had sufficient fruits and vegetables intake, which was determined by 2013 Australian Dietary 
Guidelines. Participants were considered to have an ideal TC status if they had TC concentration < 
200 mg/dL and were not taking cholesterol-lowing medication. Participants were considered to 
have an ideal BP status if they had systolic BP <120 mmHg and diastolic BP <80 mm Hg. For FPG, 
a value less than 100 mg/dL was considered as ideal status. We used the number of ideal metrics to 
measure the overall CVH and participants were divided into three groups (0-2, 3-4 and 5-7 ideal 
metrics), accordingly. 27 
Outcome Measurement 
    The self-reported IHD prevalence was based on ICD-10, codes I20-I25. To be more specific, 
respondents were regarded as having an IHD condition if they had been told by a doctor or nurse 
that they had IHD and they currently have IHD while taking the survey.  
Covariates 
    The following variables were adjusted as covariates in our study: age (continuous), sex, 
education attainment, income status, and residence region. Education attainment was categorized as 
high (≥ 12 school years) and low (< 12 school years). Income status was evaluated by household 
income and dichotomized as low (≤ 50th percentile equivalised weekly household income) and high 
(> 50th percentile equivalised weekly household income). Residence region was classified into 
major cities, inner regional areas and other areas (outer regional and remote). They were included in 
the multivariate models along with the individual metric, the number of ideal metrics or CVH 
categories.  
Statistical analysis 
    Firstly, we applied univariate and multivariate Poisson regression analysis to obtain the crude and 
adjusted IRRs and corresponding 95% CIs and they were used to measure the associations between 
modifiable factors and IHD occurrence.  
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    Secondly, we calculated adjusted PAFs based on the following equation to quantify the effects of 
each component on IHD reduction. 172 Pe is the prevalence of exposure and RRs were replaced with 
adjusted IRR. Participants with available CVH metrics were included in the first and second 
analyses for specific metrics. 
𝑃𝐴𝐹 =
𝑃𝑒 × (𝑅𝑅 − 1)
1 + 𝑃𝑒 × (𝑅𝑅 − 1)
 
    Thirdly, we calculated ORs and 95% CIs using logistic regression analyses to explore the 
relationship between the overall CVH and IHD prevalence. We treated the number of ideal metrics 
as a continuous and a categorical variable, respectively. Participants with missing values in one or 
more of Life’s Simple 7 components were not included in the analyses. 
    Biomedical weights were applied, using the Jackknife method, as recommended by the ABS to 
representative the in-scope population. All analyses used expanded confidentialised unit record files 
of the AHS core sample and were conducted within the ABS’s RADL with Stata, version 10.0. A 
two-sided P value < 0.05 was considered statistically significant. 
Results 
Among the 7499 eligible participants, 357 were positive for IHD occurrence and the weighted 
prevalence was 3.3%. For the seven metrics, FPG had the highest weighted ideal prevalence 
(83.6%), followed by smoking status (55.6%), BP (44.2%), BMI (39.2%), TC (45.5%), physical 
activity (26.7%) and dietary pattern (4.8%). The details of metrics and covariates are summarized in 
Table 6.1. 
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Table 6.1 Distribution of IHD cases, stratified by the metrics and covariates. 
Variables Status IHD, n (%) a Non-IHD, n (%) a    P b 
Smoking Ideal   132 (2.5)   3630 (97.5) < 0.01 
 Unideal   225 (4.3)   3512 (95.7)  
BMI Ideal     71 (1.9)   2324 (98.1) < 0.01 
 Unideal   262 (4.1)   4470 (95.9)  
Physical activity Ideal     35 (1.0)   1739 (99.0) < 0.01 
 Unideal   322 (4.1)   5399 (95.9)  
Dietary pattern Ideal     22 (3.6)     412 (96.4)   0.72 
 Unideal   335 (3.3)   6730 (96.7)  
TC Ideal     64 (1.5)   2763 (98.5) < 0.01 
 Unideal   293 (4.8)   4379 (95.2)  
BP Ideal     96 (1.9)   2732 (98.1) < 0.01 
 Unideal   246 (4.5)   4147 (95.5)  
FPG Ideal   214 (2.5)   5725 (97.5) < 0.01 
 Unideal   143 (7.3)   1417 (92.7)  
Age < 60 years     72 (1.1)   4751 (98.9) < 0.01 
 ≥ 60 years 285 (10.2)   2391 (89.8)  
Sex Male   214 (4.2)   3115 (95.8) < 0.01 
 Female   143 (2.5)   4027 (97.5)  
Education level High     80 (1.6)   3653 (98.4) < 0.01 
 Low   277 (5.7)   3489 (94.4)  
Income High     73 (1.6)   3327 (98.4) < 0.01 
 Low   257 (5.8)   3160 (94.2)  
Region Major cities   178 (2.6)   4384 (97.4) < 0.01 
 Inner regional   114 (5.1)   1595 (94.9)  
 Other     65 (5.4)   1163 (74.6)  
a Numbers and percentages were presented as unweighted and weighted, respectively. 
b P values were from weighted chi-square tests. 
Abbreviations: IHD, ischemic heart disease; BMI, body mass index; TC, total cholesterol; BP, 
blood pressure; FPG, fasting plasma glucose. 
 
In the univariate analysis, all the seven components, except for dietary pattern, were positively 
associated with increased IHD prevalence. After adjusted for confounders, physical inactivity 
(adjusted IRR: 2.10; 95% CI: 1.28-3.45, P<0.01), unideal TC (adjusted IRR: 1.58; 95% CI: 1.10-
2.25, P=0.01) and elevated BMI (adjusted IRR: 1.40; 1.05-1.87, P=0.02) were still significantly 
associated with raised IHD risk (Table 6.2). We calculated adjusted PAFs to quantify the relative 
contributions of target influencing factors to IHD prevalence (Figure 6.1). Insufficient physical 
activity was the largest contributor to IHD prevalence (adjusted PAF: 46%; 95% CI: 0.18-0.65), 
followed by elevated TC (adjusted PAF: 26%; 95% CI: 0.06-0.44), and elevated BMI (adjusted 
PAF: 21%; 95% CI: 0.03-0.37). 
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Table 6.2 IRRs between the individual CVH metrics and IHD prevalence in the overall 
population. 
Variables Crude IRR (95% CI)   P Adjusteda IRR (95% CI) P 
Smoking 1.70 (1.25-2.30) < 0.01 1.22 (0.89-1.67)  0.22 
Elevated BMI 2.16 (1.58-2.94) < 0.01 1.40 (1.05-1.87)  0.02 
Physical inactivity 3.92 (2.39-6.45) < 0.01 2.10 (1.28-3.45)  < 0.01 
Unideal dietary pattern 0.90 (0.50-1.62)    0.73 1.21 (0.71-2.07)  0.48 
Elevated TC 3.25 (2.28-4.64) < 0.01 1.58 (1.10-2.25)  0.01 
Elevated BP 2.33 (1.61-3.39) < 0.01 0.83 (0.58-1.18)  0.29 
Elevated FPG 2.86 (2.13-3.84) < 0.01 1.19 (0.84-1.68)  0.32 
a Adjusted for age (continuous), sex, education attainment, income, and residence region. 
Abbreviations: IRR, incidence rate ratio; CVH, cardiovascular health, IHD, ischemic heart disease; 
CI, confidence interval; BMI, body mass index; TC, total cholesterol; BP, blood pressure; FPG, 
fasting plasma glucose. 
 
 
 
 
 
 
Figure 6.1 Adjusted PAFs of the CVH metrics to IHD prevalence in the overall population. 
Abbreviations: TC, total cholesterol; FPG, fasting plasma glucose; CVH, cardiovascular 
health; IHD, ischemic heart disease. 
 
Table 6.3 shows the relationship between Life’s Simple 7 overall categories and IHD prevalence. 
Compared to those in the inadequate category, those in the optimal category had a 78% lower risk 
of IHD (adjusted OR: 0.22; 95% CI: 0.03-1.96) and those in the average category had a 45% lower 
risk (adjusted OR: 0.55; 95% CI: 0.39-0.77). On average, one more ideal metric was associated with 
an 18% lower risk of IHD prevalence (adjusted OR: 0.82; 95% CI: 0.71-0.93). 
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Table 6.3 ORs between the number of ideal metrics and IHD prevalence in the overall population. 
Ideal metrics number IHD cases/participants Crude OR (95% CI)       P Adjusted a OR (95% CI)      P 
0-2           241/3342 Referent    -- Referent   -- 
3-4             73/2786 0.28 (0.19-0.41) < 0.01 0.55 (0.39-0.77) < 0.01 
5-7                 4/874 0.03 (0.00-0.23) < 0.01 0.22 (0.03-1.96)    0.17 
One more ideal metric                  -- 0.56 (0.50-0.63) < 0.01 0.82 (0.71-0.93) < 0.01 
a Adjusted for age (continuous), sex, education attainment, income, and residence region. 
Abbreviations: IHD, ischemic heart disease; OR, odds ratio; CI, confidence interval.
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Discussion 
    To the best of our knowledge, it is the first study that explored the individual and combined 
effects of Life’s Simple 7 on IHD prevalence among the general Australians. We observed that 
physical inactivity, elevated BMI and raised TC are independent risk factors of IHD prevalence. 
The higher optimal metric number was associated with reduced IHD prevalence. 
    Physical inactivity was the most significant contributor to IHD prevalence in our study, with 
adjusted PAF of 46%. A recent meta-analysis revealed that, compared with insufficiently active 
participants (reporting less than 600 MET (Metabolic Equivalent) minutes/week of total physical 
activity), the risk of IHD among those in the low active (600-3999 MET-minutes/week), moderately 
active (4000-7999 MET-minutes/week), and highly active (≥8000 MET-minutes/week) categories 
has reduced by 16%, 23%, and 25%, respectively. 205 In our study, less than 1 out of 4 participants 
met the requirement of physical activity. Thus, the policy makers should pay greater attention to the 
physical activity promotion in general Australians.  
    High BMI was observed as a significant influencing factor of IHD, which is in agreement with 
several studies. A large-scale collaborative analysis identified one standard deviation (4.56 kg/m2) 
increase in BMI was independently associated with 11% higher risk of CHD incidence. 206 Another 
collaborative study demonstrated the positive relationship between BMI and IHD mortality. 207 It 
observed that, in the upper range of BMI (25-50 kg/m2), each 5 kg/m2 higher BMI was associated 
with a 39% higher IHD mortality. 
    We also found the independent and positive relationship between TC and IHD prevalence. A 
recent meta-analysis of more than one million persons from 97 prospective studies indicated that 
each one mmol/L increase in TC raised the risk of CHD incidence by 24% and 20% in male and 
female, which is consistent with our findings. 197 While, a recent study, using NHANES data, found 
a non-significant relationship between TC and IHD mortality. 30 Given the conflicting findings, 
more researches on the TC-IHD relationship are warranted. 
    Smoking, elevated BP, and raised FPG were significant IHD contributors in the unadjusted 
analysis. However, the associations were attenuated after adjustment for several socio-economic 
factors (Table 6.2). The potential role of those socio-economic variables on CVD risk was indicated 
by several previous studies. 3, 208-210 Also, the IHD prevalence varied by the status of those factors in 
the current study (Table 6.1). We failed to detect the role of dietary pattern in both univariate and 
multivariate models, which is in agreement with several studies. 27, 84, 144 While, others displayed its 
role in CVD risk reduction. 29, 42 The different measurements of dietary pattern may partially 
explain the conflicting findings. Another possible explanation is the non-IHD group contained 
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participants with other types of CVD and it could underestimated the associations between the CVH 
metrics and IHD prevalence in our study. The secondary prevention in IHD patients is another 
possible reason for the phenomenon. However, we can observe that IHD patients have lower 
prevalence of ideal status for most metrics compared to non-IHD patients. In addition, some key 
indicators of IHD secondary preventions, such as medications for hypertension and diabetes, were 
missing. We could not imply that the risk management among IHD patients was successful.  
    We have found that the higher number of ideal metrics was greatly related to IHD risk reduction. 
Our findings are consistent with several previous studies, which also found the inverse relationship 
between the overall CVH and CVD risk. 63, 143 Our results suggested that some components may not 
individually relate to IHD prevalence, but they are likely to interrelate with other Life’s Simple 7 
metrics and have synergistic effects on IHD prevalence. 
Our study has some limitations. First, it is a cross-sectional study and we are unable to examine 
the temporality between influencing factors and IHD incidence or mortality. Second, we used 
modified metric definitions compared to those outlined by the AHA 7 due to dataset structures, and 
the modifications may make our results incomparable to other studies. For example, the AHA 
guideline consisted five components for dietary assessment. 7 However, our study only included 
fruits and vegetables as other components were not available in the AHS. Thirdly, we did not 
compare the IHD risk differences for those in the same CVH groups giving the limited sample size. 
Fourthly, 17.7% of the total participants were self-reported CVD other than IHD, and they were 
classified as non-IHD group in our study. It may underestimate the associations between Life’s 
Simple 7 and IHD prevalence. Fifth, as there is very limited studies on the Life’s Simple 7 and IHD 
prevalence globally, it is difficult to make comparisons between our findings with others. Sixth, 
although the AHS is a nationally representative survey and we used biomedical weight, we are still 
suffering from the risk of selection bias as we noticed some differences for some demographic 
factors and CVH metrics between participants and non-participants (Table 4.2). In addition, some 
variables, like dietary pattern, smoking status, and the IHD status, were self-reported and thus may 
bring about misclassifications.   
Conclusions 
    In summary, we observed physical inactivity, high BMI, and elevated TC as significant risk 
factors and contributors to IHD prevalence in the general Australian adults. The higher number of 
optimal Life’s Simple 7 metrics was associated with a lower risk of IHD prevalence.  
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6.2 The CVH status and IHD prevalence in the Australian sex and age subgroups 
 
    This chapter was based on a paper submitted: 
    Peng Y, Wang Z. Could the cardiovascular health metrics account for the age and sex 
disparities in ischemic heart disease prevalence? Journal of Clinical Medicine, 2018; 7(10): 369. 
doi: 10.3390/jcm7100369. 
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Abstract: The AHA has outlined seven modifiable CVH metrics. However, the sex and age 
disparities in the association between those CVH and IHD risk are unclear. Our study sought to 
examine the possible sex and age variations in the association between the CVH metrics and IHD 
prevalence using an Australian nationally representative survey. We used the core sample of the 
2011-2012 AHS, and 7499 adults with FPG and TC values were included. We used Poisson 
regression analysis to measure the associations between individual metrics and IHD prevalence. 
Our study used both stratification and interaction analyses to compare the magnitude of associations 
between sex and age groups. Then, we calculated the PAFs to measure the contribution of each 
metric to IHD prevalence. In addition, we applied logistic regression analysis to examine the 
influences of the ideal CVH metrics number on IHD prevalence and used stratification and 
interaction analyses. BMI, physical activity, BP, and FPG have greater effects on IHD prevalence in 
young adults compared to older adults. We failed to detect sex variations in CVH metrics and IHD 
prevalence. The ideal CVH metrics number was inversely correlated to IHD prevalence and it has 
similar effects in four subgroups. These CVH metrics do not explain the sex and age disparities in 
IHD prevalence and the topic needs further explorations.  
Keywords: cardiovascular health; ischemic heart disease; Australian adults 
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Introduction 
    IHD is one common type of CVD and is a significant contributor to deaths worldwide. According 
to the Global Burden of Disease Study, IHD led to nearly 10 million deaths worldwide in the year 
2016, which accounted for 17.3% of all deaths. 1 There is evidence that a large proportion of IHD 
burden could be attributable to modifiable factors. A Chinese cohort found that almost half of the 
IHD cases could be prevented if the participants adhered to six healthy lifestyle factors, including 
smoking, alcohol consumption, physical activity, dietary pattern, and BMI. 5 In a US study, six 
lifestyle factors could explain 73% of CHD, another term for IHD, events in a 20-years follow-up 
period. 6 
    The AHA has outlined seven modifiable metrics (smoking, BMI, physical activity, dietary 
pattern, TC, BP, and FPG) to define and monitor the CVH status in the general population. 7 Some 
studies have reported that the ideal status of those metrics played a crucial role in the reduction of 
IHD risk. 30, 152 A few studies have suggested that the strengths of association between modifiable 
factors and IHD risk differed by age and sex 211, 212 while the variations were inconclusive due to 
very limited studies. 
    In our study, we analysed and compared the strengths of association between the CVH metrics 
and IHD prevalence in sex and age-specific subpopulations using a nationally representative survey 
in Australia. We hypothesized that the CVH metrics played a more significant role in IHD 
prevalence among males and older adults. 
Methods 
Study design and participants 
    Details of the study design and participants have been described previously. 152 Briefly, our study 
used the core sample of the 2011-2012 AHS, which is a nationally representative health survey of 
the general Australians. Among 24910 adults (≥ 18 years), we focused on those with available TC 
and FPG results, yielding to an overall sample size of 7499. Participants were classified into two 
age groups: young (< 60 years) and older (≥ 60 years). 
CVH metrics 
    The definitions of the seven CVH metrics were described elsewhere. 152 Subjects with 0-2, 3-4, 
and 5-7 ideal metrics were regarded as having overall poor, intermediate, and ideal CVH status. 84 
Outcome measurement 
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    The IHD prevalence was self-reported and based on the 10th version of ICD, codes I20-I25. To be 
more specific, participants were asked if they had been told by a doctor or nurse that they had IHD 
and they currently have IHD while taking the survey. They would be regarded as positive for IHD if 
they answered “yes” to both questions. 
Covariates 
    The following variables were adjusted as covariates in our study: age (continuous), sex, 
education attainment, income status, and residence region. Education attainment was categorized as 
high (≥ 12 school years) and low (< 12 school years). Income status was evaluated by household 
income and dichotomized as low (≤ 50th percentile equivalised weekly household income) and high 
(> 50th percentile equivalised weekly household income). Residence region was classified into 
major cities, inner regional areas and other areas (outer regional and remote). 
Statistical analysis 
    Firstly, we compared the proportions of IHD, ideal metrics, and covariates between sex and age 
groups using weighted chi-square tests.  
    Secondly, we explored the possible sex and age variations in the associations and contributions of 
individual metrics and IHD prevalence. We calculated crude (unadjusted) and adjusted IRRs and 
corresponding 95% CIs, using univariate and multivariate Poisson regression analyses, to clarify the 
association between the CVH metrics and IHD prevalence in each sex and age-specific group. We 
entered the interaction terms between sex/age and metrics in the adjusted models to explore the 
potential sex/age differences in the association. 
    Additionally, we calculated adjusted PAFs, for each sex and age group, based on the following 
equation to measure the effects of each metric on IHD reduction. Pe is the prevalence of unideal 
metric and RRs were replaced with adjusted IRRs. 
𝑃𝐴𝐹 =
𝑃𝑒 × (𝑅𝑅 − 1)
1 + 𝑃𝑒 × (𝑅𝑅 − 1)
 
    Thirdly, we calculated ORs using logistic regression analyses to explore the relationship between 
the overall CVH status categories and IHD prevalence in sex and age subgroups. Interaction terms 
between sex/age and the CVH categories were included in the adjusted models. Participants with 
missing values in at least one CVH metrics were not included in the analyses. 
To infer results for the in-scope population, we used biomedical weight and group Jackknife 
method with 60 replicate weights in the CVH metrics and IHD association analyses. All analyses 
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were conducted within the ABS’s RADL with Stata 10.0. A two-tailed P-value < 0.05 was used to 
determine statistical significance. 
Results 
Baseline characteristics 
The basic characteristics of the included participants were displayed in Table 6.4. Overall, 
weighted 3.3% participants were positive for IHD prevalence (357/7499). Males have higher IHD 
prevalence than did the females (4.2% versus 2.5%, P<0.01) and older adults have statistically 
higher IHD prevalence when compared to young adults (10.2% versus 1.1%, P<0.01). Females 
have higher proportions of ideal smoking, BMI, dietary pattern, BP, and FPG and lower ideal 
physical activity proportion and income status than did males. They have similar ideal TC 
prevalence, education level, and regional distribution. Compared to young adults, older adults had a 
significantly higher percentage of ideal dietary pattern and lower prevalence of ideal status for the 
other six metrics. Young adults have higher income and education level and more likely to reside in 
major cities as compared to older adults. 
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Table 6.4 Baseline characteristics of the included participants. 
Metrics Status Males, n (%) Females, n (%)        P Young, n (%) Older, n (%)        P 
IHD Yes       214 (4.2)       143 (2.5)   < 0.01         72 (1.1)     285 (10.2)   < 0.01 
 No   3115 (95.8)   4027 (97.5)    4751 (98.9)   2391 (89.8)  
Smoking Ideal   1420 (49.8)   2342 (61.1)   < 0.01   2521 (57.7)   1241 (49.0)   < 0.01 
 Non-ideal   1909 (50.2)   1828 (38.9)    2302 (42.3)   1435 (51.0)  
BMI Ideal     833 (32.3)   1562 (46.2)   < 0.01   1750 (43.1)     645 (27.2)   < 0.01 
 Non-ideal   2388 (67.7)   2344 (53.8)    2843 (56.9)   1889 (72.8)  
Physical activity Ideal     945 (32.7)     829 (20.9)   < 0.01   1320 (30.0)     454 (16.6)   < 0.01 
 Non-ideal   2382 (67.3)   3339 (79.1)    3500 (70.0)   2221 (83.4)  
Dietary pattern Ideal         93 (2.1)       341 (7.4)   < 0.01       223 (4.1)       211 (6.9)   < 0.01 
 Non-ideal   3236 (97.9)   3829 (92.6)    4600 (95.9)   2465 (93.1)  
TC Ideal   1259 (45.1)   1568 (45.8)      0.70   2246 (52.5)     581 (23.9)   < 0.01 
 Non-ideal   2070 (54.9)   2602 (54.2)    2577 (47.5)   2095 (76.1)  
BP Ideal   1047 (36.7)   1781 (51.6)   < 0.01   2234 (51.4)     594 (21.9)   < 0.01 
 Non-ideal   2189 (63.3)   2204 (48.4)    2427 (48.6)   1966 (78.1)  
FPG Ideal   2426 (79.4)   3513 (87.7)   < 0.01   4162 (88.6)   1777 (68.4)   < 0.01 
 Non-ideal     903 (20.6)     657 (12.3)      661 (11.4)     899 (31.6)  
Age < 60 years   2078 (76.2)   2745 (74.7)      0.01 4823 (100.0)           0 (0.0)       NA 
 ≥ 60 years   1251 (23.8)   1425 (25.3)            0 (0.0) 2676 (100.0)  
Sex Male 3329 (100.0)           0 (0.0)       NA   2078 (49.8)   1251 (47.8)      0.01 
 Female           0 (0.0) 4170 (100.0)    2745 (50.2)   1425 (52.2)  
Education level High   1620 (57.6)   2113 (58.1)      0.76   2969 (67.5)     764 (28.3)   < 0.01 
 Low   1709 (42.4)   2057 (41.9)    1854 (32.5)   1912 (71.7)  
Income High   1642 (56.5)   1758 (49.9)   < 0.01   2771 (62.0)     629 (26.6)   < 0.01 
 Low   1441 (43.5)   1976 (50.1)    1628 (38.0)   1789 (73.4)  
Region Major cities   2024 (72.0)   2538 (73.0)      0.71   3012 (74.2)   1550 (67.2)   < 0.01 
 Inner regional     760 (20.0)     949 (19.2)    1025 (18.3)     684 (23.7)  
 Other       545 (8.0)       683 (7.8)        786 (7.5)       442 (9.1)  
Numbers and percentages were expressed as unweighted and weighted and P values were from weighted chi-square tests. Abbreviations: IHD, 
ischemic heart disease; BMI, body mass index; TC, total cholesterol; BP, blood pressure; FPG, fasting plasma glucose; NA, not applicable. 
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Sex- and age-specific associations between individual metrics and IHD prevalence 
Table 6.5 and Table 6.6 list the sex and age-specific crude and adjusted IRRs and 95% CIs by 
the CVH metric for IHD prevalence, respectively. After adjusted for covariates, physical inactivity 
(IRR: 1.84, 95% CI: 1.00-3.39, P=0.048) and elevated TC values (IRR: 1.53, 95% CI: 1.04-2.25, 
P=0.03) were significant IHD risk factors for males. None of the metrics was associated with IHD 
prevalence for females. For the analyses of interaction terms, we failed to detect the sexual 
differences in the associations between those metrics and IHD prevalence (P interaction > 0.05). 
Physical inactivity (IRR: 1.63, 95% CI: 1.01-2.64, P=0.046) and elevated TC (IRR: 1.67, 95% CI: 
1.11-2.51, P=0.02) were significant IHD risk factors for older adults. None of the metrics was 
associated with IHD prevalence for young adults. The effects of high BMI (P interaction = 0.01), 
physical inactivity (P interaction = 0.03), elevated BP (P interaction < 0.01), and elevated FPG (P interaction = 
0.04) were more pronounced among young adults than in older adults.  
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Table 6.5 IRRs between the individual CVH metrics and IHD prevalence, stratified by sex. 
Metrics Population Crude IRR (95% CI)         P Adjusted IRR* (95% CI)         P Pinteraction 
Smoking Males 1.84 (1.21-2.79)       0.01 1.12 (0.77-1.63)       0.56   0.49 
 Females 1.30 (0.78-2.18)       0.31 1.41 (0.79-2.51)       0.24  
High BMI Males 1.93 (1.26-2.97)     <0.01 1.32 (0.91-1.90)       0.14 
2. 
  0.14 
 Females 2.13 (1.27-3.58)       0.01 1.51 (0.85-2.71)       0.15  
Physical inactivity Males 3.57 (1.94-6.55)     <0.01 1.84 (1.00-3.39)      0.048   0.38 
 Females 9.47 (1.88-47.73)       0.01 3.99 (0.79-20.12)       0.09  
Unhealthy dietary pattern Males 0.42 (0.17-1.06)       0.06 1.13 (0.52-2.43)       0.76   0.82 
 Females 1.24 (0.50-3.07)       0.64 1.33 (0.53-3.29)       0.54  
Elevated TC Males 2.56 (1.66-3.95)     <0.01 1.53 (1.04-2.25)       0.03   0.85 
 Females 5.22 (2.07-13.18)     <0.01 1.70 (0.65-4.42)       0.28  
Elevated BP Males 1.62 (1.07-2.45)       0.02 0.81 (0.57-1.16)       0.25   0.89 
 Females 3.46 (1.93-6.21)     <0.01 0.85 (0.43-1.69)       0.63  
Elevated FPG Males 2.56 (1.84-3.55)     <0.01 1.20 (0.85-1.67)       0.29   1.00 
 Females 2.98 (1.66-5.34)     <0.01 1.20 (0.56-2.57)       0.64  
*Adjusted for age (continuous), education attainment, income, and residence region. 
Abbreviations: IRR, incidence rate ratio; CI, confidence interval; BMI, body mass index; TC, total cholesterol; BP, blood pressure; FPG, fasting 
plasma glucose. 
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Table 6.6 IRRs between the individual CVH metrics and IHD prevalence, stratified by age. 
Metrics Population Crude IRR (95% CI)        P Adjusted IRR* (95% CI)        P Pinteraction 
Smoking Young adults 1.67 (0.89-3.14)      0.11 1.10 (0.55-2.18)      0.78      0.48 
 Older adults 1.35 (0.95-1.92)      0.09 1.22 (0.84-1.75)      0.29  
High BMI Young adults 4.42 (1.64-11.92)   < 0.01 2.28 (0.84-6.16)      0.10      0.01 
 Older adults 1.07 (0.78-1.47)      0.66 1.15 (0.86-1.52)      0.34  
Physical inactivity Young adults 7.08 (1.56-32.16)      0.01 4.34 (0.87-21.55)      0.07      0.03 
 Older adults 1.91 (1.17-3.12)      0.01 1.63 (1.01-2.64)      0.046  
Unhealthy dietary pattern Young adults 0.93 (0.21-4.11)      0.93 0.91 (0.21-3.95)      0.90      0.31 
 Older adults 1.27 (0.66-2.44)      0.47 1.26 (0.67-2.37)      0.47  
Elevated TC Young adults 2.69 (1.27-5.66)      0.01 1.12 (0.51-2.48)      0.77      0.51 
 Older adults 1.47 (0.98-2.21)      0.06 1.67 (1.11-2.51)      0.02  
Elevated BP Young adults 3.69 (1.92-7.12)   < 0.01 1.56 (0.67-3.62)      0.29   < 0.01 
 Older adults 0.78 (0.50-1.22)      0.28 0.61 (0.40-0.92)      0.02  
Elevated FPG Young adults 3.60 (1.77-7.30)   < 0.01 1.72 (0.77-3.83)      0.18      0.04 
 Older adults 1.29 (0.92-1.80)      0.14 1.05 (0.74-1.47)      0.79  
*Adjusted for age (continuous), sex, education attainment, income, and residence region. 
Abbreviations: IRR, incidence rate ratio; CI, confidence interval; BMI, body mass index; TC, total cholesterol; BP, blood pressure; FPG, fasting 
plasma glucose. 
 
 
 
 
 
 
 
126 
 
The sex and age-specific adjusted PAFs were displayed in Figure 6.2 and 6.3, respectively. 
Among males, physical inactivity and elevated TC contributed to 37.6% and 24.8% of IHD burden 
(Figure 6.2). Elevated TC and physical inactivity contributed to 34.4% and 34.3% of IHD burden 
(Figure 6.3). None of the seven metrics was a significant contributor to IHD in females and 
younger adults. 
 
 
 
 
Figure 6.2 Adjusted PAFs of the CVH metrics to IHD prevalence, stratified by sex. 
Abbreviations: PAF, population attributable fraction; TC, total cholesterol; BP, blood 
pressure; FPG, fasting plasma glucose; CVH, cardiovascular health; IHD, ischemic heart 
disease. 
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Figure 6.3 Adjusted PAFs of the CVH metrics to IHD prevalence, stratified by age. 
Abbreviations: PAF, population attributable fraction; TC, total cholesterol; BP, blood 
pressure; FPG, fasting plasma glucose; CVH, cardiovascular health; IHD, ischemic heart 
disease. 
 
Sex- and age-specific associations between the number of ideal CVH metrics and IHD 
prevalence 
We explored the association between the number of ideal CVH metrics and IHD prevalence 
based on 7002 participants who have no missing data on the seven metrics and the crude and 
adjusted ORs were shown in Table 6.6. We observed a negative association between the number of 
ideal CVH metrics and IHD prevalence in all sex and age subpopulations. Among females and 
young adults, we noticed a 59% (OR, 0.41; 95% CI, 0.19-0.88) and a 65% (OR, 0.35; 95% CI, 
0.15-0.83) reductions in the odds of IHD prevalence for those with the intermediate CVH status and 
none of those with the ideal CVH status had self-reported IHD. For males and older adults, we 
observed non-significant reductions in the odds of IHD prevalence for those with the intermediate 
and ideal CVH. In addition, one more ideal CVH metric was associated with 11-31% reduced IHD 
prevalence while the association failed to reach a significant level for males and older adults. The 
analyses of interaction terms indicated that the impacts of the overall CVH status on IHD 
prevalence were similar among the four subgroups. 
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Table 6.7 ORs between the number of ideal metrics and IHD prevalence, stratified by sex and age. 
Participants Ideal Metrics Number IHD cases/Participants Crude OR (95% CI)      P Adjusted* OR (95% CI)      P 
Males 0-2       150/1741 Reference     NA Reference     NA 
 3-4         44/1147 0.34 (0.21-0.56) < 0.01 0.65 (0.42-1.01)    0.06 
 5-7             4/285 0.06 (0.01-0.51)    0.01 0.47 (0.05-4.30)    0.50 
 One more ideal metric                NA 0.61 (0.53-0.70) < 0.01 0.86 (0.73-1.02)    0.09 
Females 0-2         99/1601 Reference     NA Reference     NA 
 3-4         29/1639 0.22 (0.11-0.45) < 0.01 0.41 (0.19-0.88)    0.02 
 5-7             0/589 NA     NA NA     NA 
 One more ideal metric                NA 0.52 (0.45-0.60) < 0.01 0.73 (0.59-0.91)    0.01 
Young 0-2         54/1708 Reference     NA Reference     NA 
 3-4         15/2028 0.18 (0.09-0.37) < 0.01 0.35 (0.15-0.83)    0.02 
 5-7             0/792 NA     NA NA     NA 
 One more ideal metric                NA 0.49 (0.40-0.60) < 0.01 0.69 (0.52-0.91)    0.01 
Older 0-2       195/1634 Reference     NA Reference     NA 
 3-4           58/758 0.61 (0.39-0.95)    0.03 0.68 (0.44-1.03)    0.07 
 5-7               4/82 0.35 (0.04-2.91)    0.32 0.55 (0.06-5.09)    0.59 
 One more ideal metric                NA 0.83 (0.71-0.97)    0.02 0.89 (0.76-1.05)    0.17 
*Adjusted for age (continuous), sex, education attainment, income, and residence region. 
Abbreviations: IHD, ischemic heart disease; OR, odds ratio; CI, confidence interval; NA, not applicable. 
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Discussion 
    By analyzing the nationally representative survey, we did not reveal the sexual variations in the 
strength of seven metrics and IHD prevalence. Our results demonstrated that the impacts of high 
BMI, physical inactivity, elevated BP, and elevated FPG were more apparent in young adults than 
in older adults. The association between ideal metrics number and IHD prevalence are similar 
among the four subgroups. 
    Although we found physical inactivity and elevated TC were significant IHD risk factors and 
contributors for only males, we did not reveal the differences in the IHD association strengths for 
all the metrics between men and women. However, a few recent meta-analyses have suggested the 
possible sex disparities in the effect sizes between the CVH metrics and IHD. 197, 199, 213 It appears 
that smoking and diabetes have a more potent influence on CHD risk in women whereas 199, 213 
elevated TC has a more adverse effect on men. 197 We observed that physical inactivity and elevated 
TC were significant IHD risk factors for older adults instead of young adults. While the findings of 
interaction terms did not further support the possible age variations. Instead, the interaction term 
analyses implied the increased BMI, physical inactivity, elevated BP and elevated FPG are 
associated with greater prevalence in young adults than older adults are. To our knowledge, no 
meta-analysis explored the age disparities between the CVH metrics and IHD risk. The decreasing 
effects of high BMI, 17 elevated BP, 17, 191 and elevated FPG 17, 214 with age were also noticed in a 
few observational studies. The age variations in the physical inactivity-IHD relationship were 
unclear. However, a study has noted the association between physical inactivity and overall CVD 
was stronger among young adults. 215 The different study designs (cohort versus cross-sectional) 
and outcomes (incidence/mortality versus prevalence) may partly explain the inconsistent findings. 
The secondary prevention in IHD patients could partly explain why some metrics loss significance 
in some subgroups. However, we can still observe the significant differences in distribution of CVH 
metrics, except for dietary pattern, among IHD and non-IHD participants, and some factors of 
secondary prevention, like medicines for diabetes and hypertension, were not evaluated in our 
study. Therefore, more studies should focus on the secondary prevention of IHD in sex- and age-
specific populations. Given the inconclusive findings, more large-scale prospective studies are 
warranted. 
    We observed that an increasing number of ideal metrics was associated with reduced IHD 
prevalence and the negative association was also found in other studies. 5, 30 The very few IHD 
cases in those with the ideal CVH status, especially in females and young adults, suggested the 
apparent protective effect of the CVH status. The strengths of association were similar among the 
four groups, which indicate the disparities in IHD prevalence was less likely to be explained by the 
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CVH metrics. A number of other factors, including education, 216 income, 217 and 
knowledge/awareness of IHD 218 were found to be associated with IHD prevalence and whether 
they could explain the sex and age disparities in IHD prevalence still need further explorations. 
Our study has several strengths: we firstly explored sex and age variances in the associations 
between the CVH metrics and IHD prevalence in Australian adults; we have drawn our conclusions 
based on a nationally representative sample; we adjusted some factors that could be potential 
confounders. Our study also has several limitations. Firstly, the IHD status was self-reported and it 
may lead to overestimation or underestimation of IHD prevalence. Previous studies have explored 
the accuracy of self-reported myocardial infarction, a common type of IHD, and they observed 
moderate 186, 187 or substantial 185, 219 agreement between self-reported questionnaire and medical 
record data. We need studies with medical record diagnosed IHD to focus on the topic. Secondly, 
demographic factors, smoking, physical activity, and dietary pattern were self-reported, and they 
may not be wholly accurate. Thirdly, we could not explore the sex and age variations in the 
associations between the CVH metrics and IHD incidence or mortality as our study was a cross-
sectional study. Fourthly, we may still suffer from the selection bias even though, as recommended 
by the ABS, we applied biomedical weights. We noticed the differences for some demographic 
factors and CVH metrics between participants and non-participants (Table 4.2). Fifthly, we 
modified the classifications of CVH metrics compared to the AHA’s guideline due to the dataset 
structure. For instance, we only included fruits and vegetables as dietary components as other 
dietary components were not available in AHS. Sixthly, 17.7% of the total participants were self-
reported CVD other than IHD, and they were classified as non-IHD group in our study. It may 
underestimate the associations between Life’s Simple 7 and IHD prevalence. 
Conclusions 
    In summary, we noticed the associations between high BMI, physical inactivity, elevated BP, and 
elevated FPG and IHD prevalence were greater in young adults relative to that in older adults. No 
sex differences were observed between the individual CVH metrics and IHD prevalence. The 
impacts of the ideal metrics number on IHD prevalence were similar among the four subgroups. 
Further large-scale prospective studies are warranted to confirm the possible sex and age disparities.  
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Chapter 7 – Discussion 
 
Key findings of the thesis 
    Chapter 2 evaluated the proportions of ideal status for the seven CVH metrics and percentages of 
the overall poor and ideal CVH status, defined by the number of ideal metrics, in adults worldwide 
using a systematic review and meta-analysis. As a result, the proportion of ideal status was high for 
some metrics (eg, smoking, FPG), but was low for other metrics (eg, dietary pattern, BP). In 
addition, we observed the alarming high (> 30%) overall poor CVH status and relatively low (< 
20%) overall ideal CVH status and is generally in agreement with a previous systematic review. 11 
Females and young adults (< 60 years) generally have better CVH status compared to males and 
older adults (≥ 60 years). Our findings also indicate the unsatisfactory CVH status was prevalent in 
nearly all areas and very few studies have conducted in Oceania and Africa. Although we noticed 
the improvement of the CVH over study time, more studies are needed to monitor the trend. 
    Chapter 3 summarized the findings on the separate and combined effects of the CVH metrics and 
CVD related events using a systematic review. The results indicated a greater number of ideal 
metrics was associated with a substantial reduction in CVD risk and two previous systematic 
reviews suggested similar results. 13, 14 There existed inconsistent findings regarding the effects of 
the seven CVH metrics on the risk of various CVD events. Furthermore, few studies have explored 
the sex and age variances in the magnitude of the association between separate and combined 
effects of CVH metrics and CVD risk.   
    Chapter 4 explored the CVH status in Australian adults using the core sample of the 2011-2012 
AHS, which is a nationally representative survey. We noticed the overall CVH status was poor in 
the overall population and sex/age subgroups. The proportion of ideal status was highest for FPG 
and lowest for dietary pattern. Compared to males and older adults, females and young/middle-aged 
adults appeared to have higher proportions of ideal status for most CVH metrics, higher prevalence 
of the overall ideal CVH status, and lower prevalence of the overall poor CVH status. 
    Chapter 5 illustrated the separate and combined associations between the CVH status and CVD 
prevalence in the overall and sex/age subpopulations in Australian adults. Smoking, high BMI, 
elevated BP, elevated TC, elevated FPG, and physical inactivity were significant risk factors and 
contributors of CVD prevalence in the overall population. High BMI, elevated TC, elevated BP, and 
elevated FPG were significant CVD risk factors and contributors for males while smoking, high 
BMI, elevated BP, and elevated FPG were significant for females. Smoking was the only one 
significant risk factor and contributor of CVD prevalence in young adults. High BMI, elevated BP, 
and elevated FPG were independently associated with CVD prevalence in middle-aged adults. High 
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BMI, physical inactivity, and elevated FPG were significant risk factors and contributors of CVD 
prevalence in older adults. The analyses of interaction terms indicated that the associations between 
non-ideal status of TC/BP and CVD prevalence were more apparent in males than in females. The 
association between physical inactivity and CVD prevalence was more obvious in older adults. The 
unhealthy dietary pattern has a greater impact on young adults. The increased ideal number of the 
CVH metrics was associated with CVD reduction in overall and most age/sex subpopulations and 
the association was more obvious for males than females.  
Chapter 6 studied the separate and combined associations between the CVH status and IHD 
prevalence in the overall and sex/age subpopulations in Australian adults. Physical inactivity, 
elevated BMI, and elevated TC were significant IHD risk factors and contributors in the overall 
population. Physical inactivity and non-ideal TC were significant IHD risk factors and contributors 
for males and older adults. None of the seven metrics was a significant IHD risk factor and 
contributor for females and young adults. The analyses of interaction terms demonstrated that the 
associations between elevated BMI, physical inactivity and non-ideal BP/FPG and IHD prevalence 
were more apparent in young adults. The number of ideal metrics was inversely associated with 
IHD prevalence in the overall and subgroups while the strengths of impact in IHD prevalence 
reduction were similar among the four sex/age groups.  
Implications of the findings 
Our study highlighted the importance of primordial prevention in reducing the population-wide 
CVD burden. Our findings indicated that the prevalence of the overall ideal CVH status was 
extremely low in adults from worldwide and Australia. Moreover, the findings indicated a graded 
association between the number of ideal metrics and the risk of CVD and IHD. The situation 
reminded the policy makers, health professionals, and researchers to not only focus on those already 
at highest risk of CVD/IHD (the high-risk strategy) but also pay attention to the promotion and 
improvement of the cardiovascular risk distribution in the whole population (the population-wide 
strategy). A number of population-wide primordial prevention strategies, including smoking 
cessation, salt reduction, weight loss, and physical activity promotion, were shown to reduce the 
risk of CVD. Several systematic reviews and meta-analysis documented the smoke-free legislations 
could substantially reduce the CVD events in many countries. 220-222 In Australia, there are national 
and state/territory legislations in restricting smoking in indoor environments, such as public transit, 
shopping malls, schools and cinemas. 223 However, the regulations for managing smoking in 
outdoor areas varied across regions. 223 Moreover, the regulations of electronic cigarette are very 
limited. 224 Recent studies documented the effectiveness of population-wide salt reduction programs 
in lowering the CVD risk. 225, 226 A number of programs have conducted to reduce the salt intake in 
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Australia. 227 However, there is no campaign to influence consumer behavior regarding salt and no 
mechanism to monitor the changes in salt intake national wide. 227 It has been suggested that a 
population-wide weight loss was associated with a marked reduction in CVD mortality in Cuba. 228 
A few community-based weight loss programs have initiated in Australia; 229, 230 however, there is 
no national-level strategies or programs to manage the weight loss. The intervention of increased 
physical activity and reduced sedentary time could substantially lower the CVD burden. 231, 232 An 
Australian interventional study proved that reduced sitting time and increased physical activity in 
the workplace could dramatically improve the cardiometabolic biomarkers. 233 Hence, 
interventional programs of physical activity should be advocated and implemented in the national 
level. Several studies have proposed the consumption of fish oil 234 and mobile health devices 235 as 
potential CVD prevention strategies. We need more studies to explore their population-wide effects 
in primordial prevention of CVD.  
Another striking implication is the sex and age disparities in the distribution of CVH metrics and 
their associations and contributions to CVD/IHD risk. Previous studies suggested that males and 
older adults have significant higher risk of CVD mortality as compared to their females and young 
adults counterparts. 236, 237 Additionally, the sex and age differences in the prevalence of modifiable 
cardiovascular risk factors has been observed. 212, 238 Therefore, we hypothesized that there may be 
sex and age variances in the distribution of CVH metrics, and those variances could explain the 
gaps in CVD or IHD risk. As a result, the females and young adults have marked higher prevalence 
of ideal status for most CVH metrics and have better overall CVH status compared to their males 
and older counterparts in worldwide (chapter 2) and Australia (chapter 4). Very few studies have 
focused on the sex and age differences in the associations between CVH metrics and CVD, 
including IHD, risk (chapter 3). In males, the non-ideal TC and BP have greater association and 
contribution to CVD prevalence, and the overall CVH status has stronger association to CVD 
prevalence. However, the separate and combined effects of Life’s Simple 7 and CVD prevalence 
were similar among the age subgroups (chapter 5.2). The CVH metrics have similar associations 
with IHD prevalence in both sex, and some of them even have stronger associations with IHD 
prevalence among young adults. There is no sex and age differences in the association between the 
overall CVH status and IHD prevalence. Thus, the CVH metrics could not explain the sex and age 
differences in the risk of IHD prevalence (chapter 6.2). Giving the higher prevalence and stronger 
CVD associations of non-ideal TC and BP in males, the two metrics should be drivers of sex 
differences in CVD prevalence. Older adults have higher rate of physical inactivity, and the 
magnitude of association between physical inactivity and CVD prevalence was greater in older 
adults. Thus, we should pay more attention to increase the physical activity level in older adults. 
The current evidence demonstrated that the CVH metrics could not explain the sex and age 
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variances in IHD prevalence. More large-scale cohort and interventional studies are warranted to 
explore the topic and closing the gaps of CVD and IHD risk across the sex and age subgroups.  
Our study indicated Life’s Simple 7 could be a useful tool to estimate and monitor the CVH 
status in Australia. Life’s Simple 7 have several advantages over other established CVD risk 
stratification tools. Firstly, Life’s Simple 7 could evaluate the CVH status in broader population. It 
could provide the information on CVH status for all adults and children. 7 However, the general 
cardiovascular risk profile 8 and CHD prediction model, 9 developed by the Framingham Heart 
Study, could only calculate the future risk of CVD and CHD among participants aged ≥ 30 years 
and 30-74 years, respectively. The guideline for absolute CVD risk, established by the Australian 
National Vascular Disease Prevention Alliance, could only evaluate the CVD risk for adults aged 
45 years or over. 10 Secondly, Life’s Simple 7 considers more CVD risk factors. For example, it 
included five dietary components; 7 however, other tools failed to consider dietary pattern. 8-10 
Thirdly, Life’s Simple 7 is more easily to measure. It only considered the status of seven metrics 
and the number of ideal metrics. 7 The other tools 8-10 need to calculate a score based on the 
combinations of several factors, and it may difficult for some participants. There are some 
limitations for Life’s Simple 7 as well. For instance, it does not included sex and age as predictors 
and it does not provide individualized score for future CVD risk. 7  There are a few Australian 
studies, apart from ours, that used Life’s Simple 7 to evaluate the CVH status in children 239 and 
adults. 111, 239 Life’s Simple 7 should be applied in larger Australian samples to monitor the CVH 
status over time and its association with CVD mortality and incidence.  
    Our findings indicated the significance of secondary prevention of CVD and IHD in Australia. 
We observed that the associations between some CVH metrics and CVD/IHD prevalence were 
attenuated in overall and sex/age subgroups. It could be possible that the CVD and IHD patients 
received medication or taken some lifestyle modifications after diagnosed with the diseases. 
However, we still observed the significant differences in the distribution of CVH metrics among 
patients and non-patients. In addition, the AHS lacked a few key indicators of secondary 
prevention, such as medications for BP and diabetes. Therefore, our study failed to answer the 
performance of CVD/IHD clinical management. The Australian government has realized the needs 
of secondary prevention and worked out a blueprint of reform for secondary prevention of CHD. 240 
Recently, a few studies have evaluated the performance of CVD secondary prevention. 3, 241 A 
cross-sectional study in South Australia reported the poor situation of secondary prevention among 
CVD patients. 241 It indicated that only 30% of CVD patients have adequate fruits and vegetables 
consumption and 31% of participants have adequate physical activity. 241 A cohort study in New 
South Wales suggested the possible socioeconomic variations in CVD secondary prevention. 3 
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Among CVD patients, those with low education level have greater risk of developing major CVD 
events than those with high education level and the variance was more apparent in males. 3 To the 
best of our knowledge, there are very few studies on the clinical management of CVD and IHD 
patients from the national level. Therefore, monitoring and improving the clinical management of 
CVD and IHD patients with special attention to the disadvantaged persons, such as those with low 
education level, should be one of the priorities of Australia.  
Strengths of the study 
First, the two systematic reviews summarised the recent findings in the CVH status and its 
association with CVD/IHD risk in adults worldwide, which provided reliable evidence for the 
policy makers and researchers. 
Second, to the best of our knowledge, we firstly evaluated the CVH status and its association 
with CVD and IHD prevalence in Australian adults using a nationally representative survey. The 
findings are crucial for prioritize the CVD and IHD prevention strategies and promote the CVH 
status in Australian adults. 
Limitations of the study 
    For the systematic review and meta-analysis on the CVH status worldwide, it suffered from 
significant heterogeneity, and age, sex, study period and regions could not fully explain the 
heterogeneity. In addition, we could not compare the CVH status of Australia with other regions 
accurately because of the very limited studies in Australia. 
    For the systematic review on the CVH status with CVD/IHD risk, as most studies could not 
strictly follow the AHA’s definition of Life’s Simple 7, and it may bias the true association between 
Life’s Simple 7 and CVD-related events. Although there are several studies focused on the risk 
factors of some relative rare CVD subtypes, like HF 242 and cardiac arrest, 243 there existed 
significant regional variances and the separate and combined effects of CVH on their risks were not 
well documented, especially for sex and age subgroups. 
There are several drawbacks for analyses based on the 2011-2012 AHS. Firstly, the 2011-2012 
AHS is a cross-sectional study, and we could not establish the causal relationship between Life’s 
Simple 7 and incidence/mortality of CVD or IHD. It could also induce reverse causality as those 
diagnosed with CVD/IHD may take lifestyle modifications or medicines, and it may bias the 
associations between CVH metrics and CVD/IHD prevalence. Secondly, although we used the 
biomedical weight to make our findings nationally representative, we may still suffering from the 
risk of selection bias as we observed the differences in distribution of some demographic and CVH 
metrics among participants (those with TC and FPG) and non-participants (those without TC and 
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FPG) (Table 4.2). Thirdly, we did not explore the associations of other possible factors, like 
socioeconomic and genetic factors, with risk of CVD or IHD. Fourthly, we modified the 
classification of several CVH metrics due to dataset structure of the AHS. For example, we assessed 
dietary pattern based on consumption of fruits and vegetables as other dietary components outlined 
by the AHA were not existed in the AHS. The modifications may partially explain why the dietary 
pattern was not associated with CVD and IHD prevalence in the overall and sex/age specific 
population. Fifthly, the CVD and IHD prevalence in our study were self-reported, and they may not 
entirely accurate. Some other metrics and covariates were also self-reported. Sixthly, we used 
poisson and logistic regression analyses in our study as the log-binomial regression analyses were 
not allowed by the system of ABS. It may overestimate the effect sizes. Seventhly, we could not 
explore the associations between the CVH metrics and some types of CVDs as they were not 
separately listed as conditions and/or have very limited cases. Eighthly, we did not compare the 
CVH status and the strengths of its association with CVD and IHD prevalence between non-
indigenous and indigenous Australians as indigenous Australians were not included in the AHS. 
Ninthly, as very few studies explored the associations between CVH metrics and CVD/IHD 
prevalence, it is difficult to make direct comparisons between our findings with others. In addition, 
the AHS only collected one single measurement of the CVH metrics. We could neither monitor the 
CVH status over time nor explore the cumulative impacts of the CVH metrics on CVD/IHD 
incidence and/or mortality. 
Directions for future studies 
    As we noticed, very few studies have used Life’s Simple 7 to measure the CVH status and 
explore its association with future CVD mortality and incidence in Australian adults, including in 
the indigenous Australian adults. More studies with larger sample size are needed to focus on these 
topics. 
    As most studies have one single measurement of the CVH metrics, more studies with multiple 
measurements of CVH metrics are warranted. It will not only facilitate the monitor of the CVH 
status over time but also explore the cumulative effects of the CVH status on mortality and 
incidence of CVD. 
    More studies should pay attention to the effectiveness of population-based intervention strategies 
to the prevention of CVD. Moreover, the combined effects multiple interventions were still unclear 
and they need further explorations. 
The interactions between the CVH metrics and several other factors, such as socioeconomic and 
genetic factors, on the risk of CVD were largely unknown, and we need more studies on this topic. 
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We classified participants into three CVH categories (poor CVH: 0-2 ideal metrics; intermediate 
CVH: 3-4 ideal metrics; ideal CVH: 5-7 ideal metrics), and explored the associations between CVH 
categories and CVD/IHD prevalence. Using poor CVH status as reference, moderate and ideal CVH 
status was associated with a 33% and a 66% reduced CVD prevalence. Using poor CVH status as 
reference, moderate and ideal CVH status was associated with a 45% and a 78% reduced IHD 
prevalence. The graded association was also noticed in sex and age subgroups. However, we 
assumed the CVH status was similar within categories. In future studies with larger sample size, we 
could divide CVH status into more categories, for example eight categories, and evaluate the 
association between CVH status and CVD risk in more details.   
Conclusions 
In summary, the overall CVH status was poor among adults in worldwide and Australia. The 
proportions of ideal status were extremely low for metrics like dietary pattern and physical activity. 
Both the meta-analysis and the AHS indicated females and young adults have better CVH status 
than did males and older/middle-aged adults.  
The systematic review revealed the negative association between number of the ideal CVH 
metrics and risk of multiple CVD outcomes. It produced mixed findings on the associations 
between individual metrics and CVD related outcomes, and very few studies focused on the sex and 
age differences in the magnitude of associations between Life’s Simple 7 and CVD risk. The AHS 
suggested that smoking, high BMI, physical inactivity, elevated TC, elevated BP, and elevated FPG 
were significant CVD risk factors and contributors in the overall population. High BMI, physical 
inactivity, and elevated TC were significant IHD risk factors and contributors in the overall 
population. There existed sex and age variances in the separate and combined associations between 
the CVH metrics and CVD/IHD prevalence in Australian adults. 
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